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SUMMARY
The biosynthesis of cryptosporiopsinol was investigated, 
in particular the nature of the contraction of the 6- 
membered ring to the 5-membered ring. The feeding of 
different labelled acetates to Periconia macrospinosa has 
been studied. The feeding result of C H g ^ C ^ C ^ N a  
suggests that the ring contraction previously proposed 
cannot be correct and that the ring contraction must go 
via an alternative mechanism. The isocoumarin isolated
1 o
from feeding of CD3J-JC02Na to Periconia macrospinosa 
showed in its ^ C  n.m.r. spectra two different ^-shifts at 
C-4a arising from the axial and equatorial deuteriums at 
C-4. A number of deuterium labelled 5-chloro-3,4- 
dihydro-8-hydroxy-6-methoxy-3-methylisocoumarins were 
synthesised. The results obtained confirmed that 
^-shifts are additive and it was also shown that the 
equatorial deuterium exerted a greater £-shift than the 
axial deuterium.
The biosynthesis of microline and dechloromicroline was 
studied. 3,4-Dihydro-6,8-dihydroxy-3-methylisocoumarin 
was synthesised with a -^C at C-3. This isocoumarin was 
also synthesised with deuterium atoms at C-4 and the 
methyl group. These compounds were fed to Gilmaniella 
humicola and shown to be incorporated into 
dechloromicroline intact.
A synthetic route was developed which gave the dimethyl 
ether of perimacol a metabolite of Periconia macrospinosa. 
It was shown that a trans arrangement exists between the 
methyl group and methoxyl group at C-3 and C-4 
respectively. Previously it was thought that a cis 
arrangement existed between the substituents at C-3 and
-  1 -
1.1 Int.roduct.ion
Man has used natural products, albeit as crude plant 
extracts, since the dawn of time and these 'recipes' 
are still possessed today!. The term 'natural 
product' or secondary metabolite is commonly reserved 
for those organic compounds of natural origin that are 
unique to one organism, or common to a number of 
closely related organisms. Secondary metabolites are 
distinguished more precisely from primary metabolites 
by the following c r i t e r i a ^ / 3 , 4 .  they have a 
restricted distribution being found mostly in plants 
and micro-organisms, and are often characteristic of 
individual genera, species or strains; they are formed 
along specialized pathways from primary metabolites, 
and appear to serve no useful purpose to the organism 
that produces them. By contrast primary metabolites 
e.g. amino acids, carbohydrates etc. have a broad 
distribution in all living things and are intimately 
involved in essential life processes.
Primitive man found these natural extracts efficient as 
medicines for the relief of pain or alleviation of the 
symptoms of disease, as poisons for use in warfare and 
hunting, as effective agents for euthanasia and capital 
punishment, and as narcotics, hallucinogens, or
stimulants to relieve the tedium, or alleviate the 
fatigue and hunger in his life. Man may also have used 
the more odiferous and spicy compounds to obscure the 
odour of unwashed humanity, and to disguise the putrid 
or bland flavour of his food.
Many of these natural products are still used today, 
and usually for the same general purpose. Ephedrine 
(1), the basis of an ancient Chinese remedy for 
respiratory ailments is now used in the treatment of 
asthma and hay fever. Caffeine (2) was and still is, 
the active principle of many beverages. Crude extracts 
of bark, leaves and seeds produce concoctions of 
considerable potency. In many ways our modern coffee, 
cocoa, tea and cola are but poor imitations of these 
native brews.
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Examples of the odiferous and spicy compounds that have 
been used through the ages are the naturally occurring 
compounds linalol (3) from rose oil and eugenol (4). 
Faced with a plethora of natural brews and remedies/ 
the chemists of the early nineteenth century were 
highly motivated to isolate and characterise these 
natural products. Between 1815 and 1860 more than 
twenty of these active principles were isolated/ 
including caffeine (2), morphine (5), quinine (6), 
codeine (7) and cocaine (8). However accurate analyses 
were not possible before 1835 and even then it was 
rarely possible to do more than present molecular 
formulae and describe the characteristic reactions of 
the compounds. Many of these reactions were novel, and 
new ideas of molecular structure and reactivity 
followed. Thus it was only a matter of time before 
total syntheses of these compounds were then attempted, 
not only as a final confirmation of the structures but 
because their structural complexity represented a 
considerable challenge to the synthetic chemist.
As the structures of an increasing number of natural 
products became known, attempts were made to classify 
them in terms of structural type. This led to 
speculation concerning their assembly or biogenesis.
In some areas it was not difficult to spot
-  4 -
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characteristic structural features which suggested a 
particular progenitor or precursor. For example many 
alkaloids incorporate the skeletons of simple amino 
acids, while terpenes and steroids usually contain an 
integral number of five-carbon units, originally 
thought to derive from isoprene (2-methylbuta-l, 3- 
diene).
The most important biosynthetic role in the secondary 
metabolism in fungi is the acylpolymalonate or 
polyketide pathway. The idea that naturally occurring, 
highly oxygenated compounds might arise by condensation 
of acetate units was suggested as long ago as 1893 by 
J.N. C o l l i e .  ^ This inspired speculation was largely 
ignored for over half a century until Birch restated 
the hypothesis and provided experimental evidence in 
the form of l^C-labelled acetate incorporations into 
6-methylsalicylic acid (9) a metabolite of Penicillium 
griseofulvum and other fungi.6-Methylsalicylic 
acid (9) can be regarded as a typical example of a 
polyketide derived aromatic metabolite. Bu'Lock showed 
that 6-methylsalicylic acid (9) was formed from one 
acetate and three malonate units.®
3 CH2
\
COO
e
©coo
This led to many investigations of polyketide 
biosynthesis over the years. From these results a 
picture of polyketide biosynthesis has been built up in 
which a 'polyketide synthase', structurally related to 
fatty acid synthetase, assembles the enzyme-bound 
intermediates as shown in Scheme 1.1. Fully aromatic 
metabolites which retain the oxidation level of a 
classical poly-^-ketide are built up by a cyclic 
process (path a) analoguous to fatty acid 
biosynthesis^ but omitting the reduction-elimination- 
reduction sequence responsible for the loss of acetate 
derived oxygen. The majority of metabolites however,
-  7 -
show varying degrees of reduction and/or 
deoxygenation. It is envisaged that after each 
malonate condensation step, the synthase has the choice 
of which paths a-d is utilised before the next 
condensation reaction occurs.
SCHEME 1.1
tbl
COOH CO
COSR
OHR
O
In this way 'polyketide' precursors which show varying 
degrees of reduction and deoxygenation can be assembled 
in a stepwise manner on the synthase before being 
released from the enzyme by a stabilizing ring 
condensation or some other such process.
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Substitution of acyl CoA starter units, other acetate 
and methylmalonate, ethylmalonate etc. as chain 
extending units accounts for the other polyketide 
derived structural types formed in nature.
In the study of secondary metabolism the ongoing 
problem is two fold:
1) To identify the source(s) in primary metabolism 
from which a secondary metabolite has its genesis.
2) To identify by what mechanisms and manner of 
intermediates it is thus fashioned.
The wealth of intelligent speculation about the 
biosynthesis of secondary metabolites has provided a 
firm base from which to mount wide-ranging experimental 
forays into secondary metabolism in search of origins 
and mechanisms of formation. The dominant technique 
involves the administration of likely precursors to an 
organism and examination of the secondary metabolite 
produced to determine if the compounds 'fed' were used 
in the formation of the metabolite. To track the 
likely precursor through to the metabolite the 
precursor must be labelled, or marked in some way. Two 
different types of label are generally used:
-  9 -
1) Radioactive isotopes/ e.g. ^C, 32p#
2) Stable isotopes, e.g. 2^ 1®0, and
1%.
There are several reviews 10/11/12,13,14 which cover 
the use of stable isotopes in biosynthesis. The use of 
radioactive isotopes in biosynthetic studies 
predominated during the period between 1946 and 1970 
even though was the isotope first used to study 
metabolic processes. The main reason for their 
preferential use over stable isotopes is sensitivity.
It is possible to detect and quantify accurately 
compounds labelled with radioactive isotopes after 
mixing up to 10^ times with their non-labelled 
forms. Since dilutions of 10^ fold are commonly 
encountered when studying the biosynthesis of secondary 
metabolites, it is often necessary to use isotopes that 
can be detected with high sensitivity. On the other 
hand, the use of radioactive isotopes has several 
disadvantages, e.g. the tedious method of degradation 
of the final metabolite to confirm that the label is in 
the postulated position in the metabolite; the 
inability to analyze intramolecular events during bond 
making and breaking processes during biosynthesis.
Such drawbacks have hindered the progress of research 
in the field.
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Developments during the 1970's have resulted in a 
marked increase in the use of stable isotopes to study 
biochemical processes governing the formation of 
secondary natural products. Firstly, the problem of 
low sensitivity for the detection and quantification of 
stable isotopes characteristic of the period before 
1970 has been overcome by the commercial availability 
of mass and nuclear magnetic resonance (n.m.r.) 
spectrometers. These instruments have high resolution 
and sensitivity adequate for the accurate measurement 
of stable isotopes at low levels.
Secondly, the study of biosynthetic pathways received a 
major new impetus in the 1970's with the advent of 
pulsed Fourier transform n.m.r. spectrometers. This 
has allowed the development of n.m.r.
spectroscopy to provide a non-destructive detection 
system capable of determining the location and relative 
concentration of at each chemically
non-equivalent carbon in a molecule. It also enables 
the presence of H^, ^®0, and to be
demonstrated from a study of the isotope induced shifts 
in 13C n.m.r. resonance frequencies or by spin-spin 
coupling to Since the nucleus has a
nuclear spin (I=H) nuclear magnetic resonance signals 
may be observed. With the development of sensitive 
instruments with the means to accumulate (and thus 
enhance) weak signals, the amount of data
-  11 -
available on !^c chemical shifts and spin-spin 
coupling constants!7 to 13C, !h and is
increasing rapidly. The undecoupled natural abundance 
!^C n.m.r. spectrum shows coupling to both directly 
bonded hydrogens and longer range couplings to 
non-bonded hydrogens. Analysis of these couplings is 
often of great utility in both structural elucidation 
and spectral assignments. The spectra are often 
proton-noise decoupled so that a single line is 
obtained for each carbon in the molecule. Thus, 
although the natural abundance of !^C is only 1.1% it 
is now relatively easy to obtain !^C n.m.r. spectra 
for any compound given a minimum amount of material.
One great advantage of !^C n.m.r. is the considerable 
spread of shifts commonly observed: about 200 p.p.m. 
compared with 10 p.p.m. for !h shifts.
1.2 N.M.R. Studies Using Stable Isotopes
The complete assignment of !h and !^C n.m.r.'s of a 
natural product is usually a prerequisite for ensuing 
biosynthetic experiments in which stable isotopes are 
used.!'! Although the ever-increasing variety of new 
pulse sequences may dismay the uninitiated, the use of 
a relatively small number of these can simplify routine 
spectral assignment. The exact choice depends on the 
type of information sought. Generally after the normal 
!h n.m.r. and broad-band proton decoupled !^C nmr.
-12  -
spectra have been obtained the most widely useful 
sequence would be:
i) determination of the complete proton-proton 
coupling scheme by correlation of 1h homonuclear 
chemical shifts (e.g. COSY, correlated 
spectroscopy 18,19)
ii) determination of the number of hydrogen atoms that
are attached to each carbon by spin-echo Fourier
transform^ or polarisation transfer 
experiments!® (e.g. DEPT, distortionless 
enhanced polarisation transfer)21
iii) determination of which protons are connected to 
particular carbon nuclei (e.g. correlation of Ifi 
and 1®C heteroscalar chemical shifts )18,22,23
iv) determination of the complete carbon connectivity
pattern by 1®C homonuclear chemical shift 
correlation (e.g. 2 D - i n a d e q u a t e ) 1®» 2 4
1.3 Use of 13-C in Biosynthetic Studies
The early studies using singly 1®C labelled 
precursors did not provide any information which could 
not have been obtained by classical radioisotope
-  13 -
methods. They merely facilitated the determination of 
information, such as complete labelling patterns by 
observation of enhancements of individual -^C 
resonances. However, these studies soon led to the use 
of precursors doubly labelled with This enabled
the mode of incorporation of intact biosynthetic units 
and the integrity of particular carbon-carbon bonds to 
be established by observation of 13c_13c spin-spin 
couplings. Bond fragmentation and rearrangement 
processes could be detected by the loss of 13c_13c 
couplings. This in fact represented the real advance 
offered by -^C labelling techniques. This type of 
information could not be obtained, even in principle by 
classical radioisotope methods.
Since one bond carbon-carbon coupling constants are 
much larger than those of two or three bond couplings, 
13C n.m.r. spectroscopy is an ideal method to detect 
adjacent carbon nuclei in a secondary metabolite.
There are several ways in which such coupling may arise 
- see Figure 1.1.14
i) two singly labelled precursor molecules may form a 
new bond in the product (path a)
ii) a singly labelled precursor may be metabolised by 
a branch pathway to a doubly labelled form (path
b).
-  14 -
iii) a doubly labelled precursor in which there are
isolated carbon-13 atoms, may form a bond between 
them (path c).
iv) a doubly labelled precursor in which the carbon-13 
atoms are adjacent, may be incorporated intact.
Figure 1.1
Path a
13CA —  CB 13Ca — CB
path b
13cA —  CB ^ 13cA— 3cB— CC— CD
13cA““ >cB— CC— CD
path c
path d
13Ca 13cB 13c£ 13cB— CC— CD
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In most cases, a sufficient pool of unlabelled 
precursor is naturally present during biogenesis, such 
that paths a and b invariably le'ad to a much lower 
concentration of product molecules in which adjacent 
carbon atoms are labelled than paths c and d. This 
usual dilution of -^C-labelled precursor permits 
'bond labelling'. Therefore, a high concentration of 
coupled species in the product generally indicates that
SCHEME 1 . 2
CH3 COOH
M
COOH
COOHMe.
.Me COOH
COOH
MeMe
Me.
COOH
0
HOO
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the bonds between the carbon-13 atoms in a doubly 
labelled precursor have not been cleaved to give 
separate fragments.
An early application of this technique was reported by 
Seto et al^5 Wh0 studied the incorporation of 
from sodium [1/2-13c]acetate into the polyketide 
mollisin (10), a metabolite of Mollisia Caesia (see 
Scheme 1.2). Two biosynthetic pathways for mollisin 
(10) had been suggested by Bentley et al^6 based on 
the labelling pattern obtained by l^C-tracer 
experiments (pathways (a) and (b)). Pathway (a) was 
favoured since this route uses an activated methylene 
for the chlorination reactions. For pathway (a) to be 
the correct one, 13c_13c couplings should be 
observed between C-ll and C-7, and between C-12 and C-2 
but not with C-14. For pathway (b) to take place 
coupling between C-ll and C-7, and between C-14 and 
C-13 and no coupling between C-12.
In the Fourier Transform l^C n.m.r. spectrum of 
mollisin obtained from doubly labelled acetate,
13c_13c coupling was observed with C-3 and C-4, C-6 
and C-7, C-2 and C-12, and C-13 and C-14 but not with 
C-ll. Therefore, the operation of either pathway (a) 
or (b) in the biosynthesis is excluded and another 
pathway e.g. (c) may be involved in the formation of 
mollisin (10). This was an early example which showed 
the undoubted capabilities of this technique, by
-  17 -
establishing how the polyketide was arranged before 
cyclisation.
Another example of this technique was shown in the
biosynthesis of multicolic acid (11) from Penicillium
multicolor. The biosynthesis was studied by
incorporations of singly and doubly ^C-labelled
acetate into multicolic acid (11). The observations of
13c-13c couplings and more significantly their
13absence from the . C resonances of certain carbons led 
to the proposal that multicolic acid (11) and related 
tetronic acids from Penicillium multicolor *^? were 
biosynthesised via oxidative cleavage of an 
intermediate containing a benzenoid ring. These 
proposals were subsequently
c o 2h
♦ HO
CH  COOH
OH
confirmed by the incorporation of 6-pentylresorcylic 
acid (12)28 into rnulticolic acid and from 
1^0-labelling studies.29
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The use of doubly labelled acetate can also reveal 
whether an intramolecular 1,2-migration of a bond has 
taken place during the biosynthesis of a metabolite.
An intramolecular 1,2-migration may be seen by using a 
precursor which is isotopically substituted at adjacent 
atoms with carbon-13. 1,2-Migrations would result in 
the metabolite containing a two bond coupling rather 
than a one bond coupling. This has been observed in 
the biosynthesis of aspyrone (13) 30 ancj asperlactone 
(14)31 Aspergillus melleus (see Scheme 1.3).
SCHEME 1.3
0
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The incorporation of -^C from sodium [1;2-13C2]- 
acetate results in the appearance of a two-bond 
coupling of 6.2Hz between C-2 and C-8 in both (13) and 
(14) as well as the indicated one-bond couplings from 
intact acetate units. The lack of other coupling 
between carbon nuclei of adjacent units is a critical 
requirement in this type of experiment to establish 
completely that both C-2 and C-8 come from the same 
molecule of acetate. This was the first observation of 
such a coupling in biosynthetic studies.30,31
At about this time the idea was conceived that the 
involvement of a symmetrical intermediate at any stage 
in a biosynthetic pathway would result in a 
randomisation of labelling. Griseofulvin (15) was 
chosen as a model to test this hypothesis.
[1,2-13C2]Acetate was incorporated using a high
MeO OMe
>=0
Me
(15)
yielding commercial strain of Penicillium patulum. The
-  20 -
results obtained in this study turned out to be very 
complicated. Rapid metabolic turnover of exogenous 
acetate resulted in multiple labelling of individual 
molecules and the observation of extensive 
inter-acetate and long range !3c_13c couplings in 
addition to the desired intra-acetate couplings. In 
fact the most efficient route for incorporation of 
label from acetate was via the Cl pool into the 
methoxyl carbons.32
However, the hypothesis was soon proven to be correct 
when a study on the xanthone, ravenelin (16), was 
carried out. Incorporation of [1,2-13^2]acetate 
into ravenelin in cultures of Helminthosporium 
ravenelii resulted in the predicted randomization of 
13c_13c couplings in ring C. This is consistent 
with the intermediacy of a symmetrical benzophenone 
intermediate (Scheme 1.4), which is derived from 
cleavage of an anthraquinone.33 This type of 
information has subsequently found use in biosynthetic 
studies.
-  21 -
SCHEME 1.4
CH3 C 0 2Na
RINGC
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1.4 Isotope-Induced Shifts in 13C n.m.r.
In studying the nature of the intermediates on a 
biosynthetic pathway and in particular elucidating the 
detailed mechanisms of their interconversions, it is 
essential to determine the origins and fates of the 
hydrogen and oxygen atoms. Hydrogen and oxygen can be 
monitored directly by using n.m.r. active isotopes 
^h , 3h , or 17q .10,34 However, all of these 
have distinct disadvantages and a great advance has 
been made by the use of 13c as a reporter nucleus in 
labelling studies. The presence of 3h alpha or beta 
to a atom can be deduced from the appearance in
the proton noise decoupled 13c n.m.r. spectrum of 
13c-2h coupling and/or an isotope induced shift. 
Similarly the presence of l^O alpha to a 13c atom 
can be detected by an isotope induced shift in the 
13C n.m.r. spectrum. Before discussing these methods 
some general points to note a r e : 3 5
a) Substitution by a heavy isotope shortens the
average length of the bond holding the isotope, 
and, less so, the remaining bonds of the 
molecule. This almost always shifts the n.m.r. 
signal of neighbouring nuclei to higher field, 
although the magnitude of the shift is inversely 
dependent on the remoteness of the substitution.
-  23 -
b) The shift is largest where the fractional change 
in mass is largest and is also proportional to 
the number of atoms substituted.
c) The magnitude of the shift decreases with an 
increase in 's' character of the bond holding the 
isotope and depends also on the resonant nucleus, 
correlating with the range of shifts observed for 
that nucleus.
1.5 Tracing the fate of hydrogen atoms
1.5.1 Tritium n . m . r . 36
The nuclear properties of tritium are ideal for 
detection by n.m.r. spectroscopic methods.10 The 
magnetogyric ratio is the highest known for any 
isotope. The nuclear spin of \ results in proton like 
spectra with narrow width lines being obtained.
Chemical shift values are very similar to those of the 
equivalent proton. Hence signals can be readily 
assigned by reference to the n.m.r. spectrum. 
Coupling constants are also easily evaluated as the 
ratio of coupling constants J (^ H-^-H)/J ( )  
is proportional to the ratio of magnet ogyric constants 
(1.067). The Nuclear Overhauser Effect (n.O.e.) 
observed with tritium is small and negative, the
-  24 -
theoretical maximum being 47% compared with 199% with
therefore be integrated to give a measure of isotopic 
content at each site which has been found to agree 
reasonably well (±1 0 %) with tritium analysis by 
conventional counting methods. Its extremely low 
natural abundance further enhances the sensitivity of 
detection of tritium label. Unfortunately, the 
relatively high radioactivity that is associated with 
the levels of tritium that are observable by 3H 
n.m.r. spectroscopy discourages its use. It is not 
uncommon for well in excess of lOOhCi to be required at 
a single site if it is to be detected, even with high 
field n.m.r. instruments.
The first reported biosynthetic application of 3H 
n.m.r. was a study of [3H]acetate into penicillic 
acid (17)38 a metabolite of Penicillium cyclopium 
which has been studied extensively with carbon 
isotopes.38
Ifi decoupling.3  ^ Tritium n.m.r. spectra may
OMe
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In fact, more information came directly from the use of 
tritium labelled precursors and 3H n.m.r. 
spectroscopy than from the isotopic carbon studies.48 
This was because of the ability of isotopic hydrogen to 
distinguish between non-equivalent hydrogen atoms at 
sp2 methylene groups.
The 3H n.m.r. spectrum of the penicillic acid (17) 
was assigned by reference to the corresponding 
n.m.r. spectrum. Tritium was found to be present at 
the 3-, 5- and 7-positions, consistent with the mode of 
biosynthesis as outlined in Scheme 1.5.
The 7-position showed greatest incorporation of tritium 
(least exchange loss of label), with the 3- and
5-positions having progressively less tritium. This is 
in agreement with chain initiation by an acetate methyl 
group rather than an activated chain building methylene 
group derived from malonate via acetate. The
5-methylene group in penicillic acid (17) had 
preferentially been labelled trans to the 7-methyl 
group as can be seen from Scheme 1.5. Subsequent 
incorporation studies using [3H2 ]malonate led to 
labelling of only the 3- and 5-positions of penicillic 
acid. In addition [3,5-3H2 ]orsellinic acid (18) 
was established as an advanced precursor by being 
incorporated into penicillic acid with the same
-  26 -
SCHEME 1.5
OH
CH2T  C02H
CH?THO
T
(18)
OHMeO MeOMeO CH,TOH
CH2T HOCH2T HO
t
OH
MeOMeO CH2T
HOX
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distribution of label between the 5-trans and 5-cis 
positions as from simple precursors.
1.5.2 Deuterium n.m.r.
The magnetic properties of deuterium and the advantages
and drawbacks of n.m.r. spectroscopy in 
biosynthetic applications have been reviewed. -*-0 The 
major disadvantages are the inherently low sensitivity 
for detection of n.m.r. (relative to or ^H).
The chemical shift values obtained in deuterium n.m.r. 
spectra are closely similar to those of the equivalent 
protons; however the scale in Hz is only 15% that of 
the proton n.m.r.Coupling constants J(2h -^ -H) 
are approximately one sixth the value of 
The relaxation behaviour of deuterium is dominated by a
quadrupole exchange mechanism and this results in 
extensive line broadening. The two major limitations 
of deuterium n.m.r. are spectral crowding and poor 
resolution, but there is one major advantage over other 
n.m.r. techniques. The short relaxation times combined 
with the absence of an n.O.e. effect, minimise the 
possibility of partial saturation. The extent of 
enrichment in a partially deuteriated molecule may 
therefore be determined accurately by integration.
Other advantages of using deuterium n.m.r. in
-  28 -
biosynthetic study are, firstly, that it is an 
inexpensive tracer which, unlike tritium, does not 
require special handling. Secondly, compared with 
!3c (natural abundance 1 .1%), the low natural 
abundance (0.016%) enables the incorporation of 
deuterium-labelled precursors to be positively 
identified even after 6600 fold dilution of the 
precursor in the metabolic p o o l .14 The incorporation 
of molecules singly labelled with can only be
detected with confidence at dilution levels of less 
than 100 fold. Thus, 2H n.m.r. is effectively sixty 
times more sensitive than 1 -^C n.m.r. when applied to 
biosynthetic study.
Deuteriated precursors that are used in biosynthetic 
study now employ some form of multiple labelling with 
another isotope (usually l^C). However, direct 2H 
n.m.r. is often the most reliable way to determine the 
actual content of deuterium at a particular site. In 
the biosynthesis of polyketides, a starter acetate unit 
(incorporated without the intermediacy of malonate) 
usually retains most of the deuterium of [2H3 ]- 
acetate. However, extensive loss of the hydrogen 
label, by exchange with the medium, often occurs at 
subsequent units along the chain. The number of 
deuterium atoms at a particular site, their relative 
stereochemistry, and the extent of exchange can provide
-  29 -
valuable clues to the process of assembly of 
polyketides. Even though a majority of studies now 
employ detection of 2H by n.m.r. (see Section
1 .6 .1 ), deuterium n.m.r. provides an important check on 
deuterium content and is often the most direct means to 
obtain stereochemical information.
Recent work on the formation of colletodiol (19) 
produced by a Cytospora species illustrates that 2H 
induced ^-isotope shifts in n.m.r. spectra
(Section 1.6.1) can have values close to zero. This 
may have given the impression that deuterium is absent
Me
OH
.Me
OH
(19)
CD,- CO,Na CD,
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at an adjacent site. However, the use of direct ^E 
n.m.r. revealed that deuterium was there.41 
[l-l^c, 2^2 ]Acetate was fed and administered to 
cultures of Cytospora Sp. (ATCC, 20502). No ^E 
isotope induced shifts could be observed for C-l or 
C-ll in the proton noise decoupled l^C n.m.r. 
spectrum of colletodiol. However, carbonyl groups are 
known to be poor reporter groups^ for 2^ shifts 
and the presence of ^E label at both C-2 and C-21 was 
shown by 2h n.m.r. analysis of the enriched 
metabolite.
The low natural abundance of deuterium, makes it a very 
sensitive probe for studying the incorporation of 
advanced precursors into secondary metabolites.
Simpson et al^3 whilst working on the formation of 
austin (21) from Aspergillus ustus and of terretonin 
(22) from Aspergillus terreus fed a sample of 
ethyl-3,5-dimethylorsellinate (2 0 ), bearing three 
deuterium atoms in the methyl group at C-3, to the 
cultures. The ^E spectra of the two enriched 
metabolites (2 1 ) and (2 2 ) each consisted of only one 
signal, corresponding in chemical shift to the hydrogen 
atoms of the methyl group CIO .
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1.6 Det.ect.ion of Deuterium by ^ n.m.r.
1.6.1 Deuterium that is directly attached to
Tracing the fate of hydrogen is an important aspect of 
biosynthesis which allows detailed information to be 
gained concerning the pathway under investigation.
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Both of the direct n.m.r. methods discussed in the 
previous two sections allow the average degree of 
enrichment at each labelled site to be measured. They 
therefore yield evidence for the retention or transfer 
of hydrogen, from which it is possible to deduce 
information about transformations in the carbon 
skeleton. An attractive alternative is to substitute
deuterium for hydrogen that is directly attached to a
13C nucleus. This is an extremely powerful tool for 
detection of the label and can be seen to great effect 
in the case of complex polydeuteriated molecules. The 
high dispersion of values of chemical shifts that is 
available in the carbon spectrum can overcome the 
problems of overlap of peaks that are common with 
n.m.r. or n.m.r. methods. In addition, double 
labelling of a precursor with 2jj and 13c can be 
used as a marker to show that a bond has remained 
intact, in a fashion analogous to labelling with two 
nuclei.
The effects on n.m.r. spectra of the substitution of 
deuterium for hydrogen that is attached to carbon-13
are described in reviews by Garson and Staunton1-0 and
by Stothers.44 Each deuterium atom shifts the 
position of resonance of a directly attached nucleus 
upfield by 0.3 to 0.6 p.p.m.45 The presence of each 
additional deuterium shifts the signal a further 0.3 to 
0 . 6 p.p.m. upfield and increases the multiplicity of 
the resonance. This is because deuterium has a nuclear
spin of one, thus io__ . .JCD appears as a triplet of lines
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of equal intensity, a 1 3CD2 group produces a 
quintet (1:2:3:2:1) and a -^3CD3 produces a septet 
resonance (1:3:6 :7:6 :3:1). The different signals for a 
methyl group overlap to a certain extent and are also 
superimposed upon the normal signal for protonated 
nuclei. A partially deuteriated methyl thus gives rise 
to a complex signal comprising lines from -CD3-,
-CD2H-, -CDH2” as well as -CH3 labelled species.
The spectral analysis can be simplified by re-running 
the spectrum with deuterium decoupling instead of 
proton decoupling. Interference from protonated nuclei 
is greatly reduced in this mode of operation because of 
the loss of n.O.e.
-*-3C-3H n.m.r. is limited by the relative weakness 
of the 13C-2H n.m.r. signal.46 This is the 
result of three factors
1) 1 3C-2H relaxation is much less efficient than
relaxation, since the rate of 
relaxation is proportional to the square of the 
magnetogyric ratio.
2) The replacement of hydrogen by deuterium is 
accompanied by loss of n.O.e. enhancement.
3) Increased multiplicity causes loss of signal 
strength in individual lines.
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1.6.2 Application to polyketide biosynthesis
Often much of the hydrogen label is lost by exchange 
from the activated methylenes of the polyketide chain. 
However, the possibility remains that more than one 
isotopic label may be retained at positions derived 
from the methyl group of acetate. The number of 
deuteriums detected at a given site can be used to 
identify the chain starter unit or to distinguish 
between possible biosynthetic intermediates. This can 
give information about the mode of biosynthesis. The 
extent of deuterium retention may be correlated to the 
amount of hydrogen exchange during biosynthesis. This 
may provide clues to the complex mechanisms involved in 
the construction of the carbon skeleton.
An example of this technique used in studies of 
polyketide biosynthesis was completed in 1977 with two 
reports on terrein biosynthesis.47,48 Terrein (24), 
a metabolite of Aspergillus terreus, has been 
extensively studied with carbon isotopes.49 The 
biosynthesis is known to proceed through the 
condensation of five acetate units to give, after 
aromatisation, the dihydroisocoumarin (23) which then 
undergoes an interesting ring contraction.
- 3 5  -
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In the proton-decoupled 13^ n.m.r. spectrum of 
terrein enriched with [2-33c, 2- ^ 3 ]acetate, the 
signal for C-5 was enriched five-fold relative to that 
for C-6 which was unlabelled. Using C-5 as internal 
standard (since the proton at this position is derived 
from the medium) the signals for C-3; C-8 and C-l were 
less intense than expected, indicating the presence of 
a deuterium. The signal for C-l was a broad envelope 
of peaks from which signals at 13.4 and 18.7 p.p.m., 
indicated respectively, molecules containing -CH3 and 
-CH2D at this position.
A more detailed analysis was undertaken after
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re-running the spectrum with deuterium decoupling.
They showed that the C-l was present as CD3 as well 
as CD2H. The detection of some molecules with three 
deuteriums at C-l confirmed that this methyl is derived 
intact from C-2 of acetate and is therefore part of a 
chain starter unit. This technique provides a useful 
alternative to the standard procedure of using either 
!4c or l^C-labelled malonate to pick out the chain 
starter unit. It was also shown that after deuterium 
decoupling two sharp singlets were seen at C-3 and C-8 
thus indicating that both carbons carry deuterium. The 
retention of some deuterium at C-8 rules out the 
involvement of a 5-hydroxyderivative (25) in terrein 
biosynthesis.
1.6.3 Deuterium that is two or more bonds away from
13C
For complex polydeuteriated molecules, though deuterium 
spectroscopy is very sensitive, the n.m.r. often 
include broad overlapping signals. The peaks in the 
13C n.m.r. spectra from carbon atoms that are 
directly attached to deuterium suffer from poor 
relaxation, increased signal multiplicity, and loss of 
n.O.e. The spectra can be further complicated by the 
overlap of signals due to co-occurrence of different
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isotopic species at a particular site.
Many of the problems associated with directly attached 
deuterium are avoided by placing the deuterium label 
two bonds away from the 13c reporter nucleus. The 
isotope shift, although reduced, is still observable. 
The yS-hydrogens only contribute markedly to the 
relaxation of non-protonated 13c nuclei. Therefore 
the shifted signals otherwise retain any n.O.e. effect 
also experienced by the unshifted signals over proton 
decoupling. Geminal carbon-proton couplings are 
generally small, 15 an(j carbon-deuterium couplings are 
over six times smaller again: thus the shifted signals 
are effectively singlets, even without deuterium 
decoupling. This gives a further increase in the 
signal to noise ratio compared with the corresponding 
ot-shift experiment.
The method was first applied by Abell and Staunton^O 
to biosynthesis in a study of 6 -methylsalicylic acid 
(9).
[l-l^c, 2-2h3 ]acetate was fed to cultures of 
Penicillium griseofulvum. The proton noise decoupled 
13c n.m.r. spectrum of the methyl ester of the 
resulting 6 -methylsalicylic acid showed shifted signals 
for C-2, C-4 and C-6 . This corresponded to the 
presence of deuterium label at positions 3, 5 and 7
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respectively. Thus this method permits the detection 
of two adjacent bonds which have remained intact during 
biosynthesis.
The ^-isotope shifts that are observed are most 
frequently upfield (0 . 0 1 to 0 . 1 p.p.m. per deuterium) 
but they can also be downfield or zero especially if 
next to a carbonyl. 41 / 51-53 Simpson and Stenzel^ 
showed y3-shifts to be additive whilst working on 
O-methylasparvenone (26a), a metabolite from 
Aspergillus parvulus.
L1-13c 2)‘2L-2h 3 jAcetate was incorporated into
OH
(26 b) (26®)
O-methylasparvenone (26a). The resulting proton noise 
decoupled -^C n.m.r. spectrum showed that C-9 had two 
isotopically shifted signals corresponding to the 
presence of one and two deuteriums on the adjacent 
methyl carbon. The furthest shifted signal was (+)0.16 
p.p.m. (upfield) for C-9 which corresponds to (+)0.08 
p.p.m. per deuterium and clearly shows that the ,3-shift 
is additive. However C-l showed a downfield shifted 
resonance ((-)0.06 p.p.m.) .with the intensity being 
much lower than that expected from the observed level
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of incorporation of deuterium to the 2-axial position. 
The amount of deuterium label found at the 2-axial 
position was determined by n.m.r. In addition, as 
a consequence of a high level of multiple labelling of 
individual molecules from the precursor, the at 
the 2-axial position resulted in a small isotopically 
shifted resonance ((+) 0.13 p.p.m.) being observed 
for C-3.
[2 -2h2 ]-0-Methylasparvenone (26b) was prepared by 
base-catalysed exchange (NaOMe in MeO^H). The p.n.d. 
13C n.m.r. spectrum showed isotopically shifted 
resonances at (” )o.08 and (+ )o.l7 p.p.m. for C-l 
and C-3 respectively. This suggests that either the 
induced isotope shifts are non-additive or that 
equatorial has a much smaller effect than axial 
. They examined this further by carrying out a 
second exchange experiment in equimolar MeOH and 
MeO^H. Deuterium n.m.r. spectroscopy of the product 
confirmed that equal exchange of the axial and 
equatorial hydrogen had occurred. The p.n.d. l^C 
n.m.r. spectrum for C-3 showed three isotopically 
shifted resonances at (+ )o.03, (+ )o.l3, and
(+)o.l7 p.p.m. of similar intensities. This was as 
expected for the statistical mixture of molecules 
labelled at the 2-equatorial and 2-axial positions 
separately, and both 2 -equatorial and 2-axial 
positions. C-l also showed three isotopically shifted 
resonances at (")q.0 2 , (” )o.Q6, and (~)o.08
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p.p.in./ but their intensities decreased as the number 
of deuterium atoms increased. These results show that 
the ,3-isotope shifts are additive and moreover are 
dependent on the stereospecificity of labelling. A 
further example of this is found in Chapter 2 when 
[l-l^c, 2-2H3 ]acetate was fed to Periconia 
macrospinosa and the metabolites isolated showed 
similar results.
To ensure that all deuterium labels have been detected 
correctly, results from the ,3-isotope shift technique 
are often checked by another method, usually 
n.m.r.
The incorporation of [l-^C, 2-^H3 ]acetate into 
polyketides has provided a wealth of information about 
possible intermediate oxidation states and mechanisms 
of cyclisation. The incorporation of mono- and 
tri-deuteriated acetate precursors into
6-methylsalicylic acid (9) has been studied in order to 
investigate the degree of stereocontrol in the 
aromatisation sequence.^ A possible sequence of 
late enzyme-bound intermediates on the pathway to (9) 
is outlined in Scheme 1.6 and the consequence of using 
[^H3 ]acetate which would produce [2-2hi] 
malonate are compared. In the actual experiments, the 
relative amounts of label retained at C-3 and C-5 
were compared using both direct n.m.r. and 
indirect 13q n.m.r. analysis (,3-isotope shifts) using
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mono-and tri-deuteriated acetates. In both cases, the 
relative amounts of retention at both C-3 and C-5 
were the same. The l^C n.m.r. experiment indicated 
that the necessary hydrogen removal from the C-3 and 
C-5 methylenes during aromatisation occurs with no 
isotope effect. Overall, the results are therefore 
consistent with stereospecific hydrogen removal at both 
C-3 and C-5 in the aromatisation sequence. This in 
turn indicates that aromatisation occurs in a chiral 
environment and so the steps required are under 
enzymatic control. This experiment provided the first 
direct evidence to support this long held assumption.
The biosynthesis of the naphthopyrone rubrofusarin (27) 
from Fusarium culmorum has been studied.55 
Incorporation of both [1,2-13C2] and [l-^C,
2-2h3 Jacetates substantiate the folding pattern as 
shown in Scheme 1.7.
The important point to note is that the ^-isotope shift 
has shown an unusual folding pattern, which contrasts 
with the folding pattern assumed for this and several 
other metabolites in many textbooks. Deuterium n.m.r. 
analysis of [^^Jacetate enriched rubrofusarin (27) 
revealed a surprisingly high retention of label at 
C-3 when compared to similar Y” p y ro ne  positions in 
previous studies. This led to the proposal that the 
closure of the y-pyrone ring occurs early in the 
pathway as shown in Scheme 1.7. As for 6 -methyl-
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salicylic acid (9) discussed above, on feeding
Dacetate and comparing the relative enrichments 
with those observed when feeding [ ^ 3  Jacetate, no 
significant differences were observed. This provides 
more support for the theory that the removal of the 
extra hydrogens from methylene sites during
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aromatisation must be under enzymatic control.
The detection of deuterium-induced ^-isotope shifts in 
n.m.r. is an excellent tool for observing the 
migrations of hydride that commonly occur during the 
biosynthesis of terpenoids. These migrations can also 
be detected by using advanced doubly labelled 
precursors in conjugation with n.m.r. The 'yS-hop' 
technique of Stoessl and Stothers^/57 provides a 
very attractive alternative in cases where there is 
severe overlap of resonances. These workers 
studied the incorporation of sodium [2 -^ -^ C,
2-2H3 jacetate into potato tubers that were being 
stressed with Monilinia fruticola and isolated the 
resulting phytoalexins lubimin (28), hydroxylubimin 
(29), and rislutin (30).
CHO
Me
(28)
CHO
Me' VD Me
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Me
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In each of these compounds, deuterium was originally 
directly attached to at C-5 of an intermediate
cationic species. This underwent a 1,2-migration of 
hydride to C-4, thereby causing a ,3-isotope shift at 
C-5 in the l^C n.m.r. spectrum.
1.7 Determining the Source of Oxygen Atoms
1.7.1 Labelling with Oxygen-17
Two less abundant isotopes of oxygen are readily 
available for labelling studies. These are oxygen-17 
(natural abundance 0.037%) and oxygen-18 (natural 
abundance 0.204%). Both are routinely detected by mass 
spectrometry,58 bUt only oxygen-17 has a nuclear spin 
(5/2) and can be directly observed by n.m.r. 
s p e c t r o s c o p y . 59# 80 Extensive reviews of 1^0 
n.m.r. techniques are available. 57,58 use
170 in biosynthetic studies has been partly limited 
by its expense. However the major problems have been 
low n.m.r. sensitivity and very broad lines in its 
n.m.r. spectra due to its quadrupole. Although the 
range of chemical shifts is very large (>1,500 p.p.m.), 
complex polyoxygenated molecules with labels at
multiple sites can show extensive overlap of resonances 
in their n.m.r. spectra. However, the common 
contamination of relatively inexpensive ^O-labelled
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compounds by 1 7 0 61 and the possibility of using 
lanthanide shift r e a g e n t s ^  may encourage the greater 
use of 1 7 0 n.m.r. in biosynthetic work.
The first successful application of 170 n.m.r. to 
biosynthetic work was performed by Sankawa et al^4,63 
when studying the biosynthesis of citrinin (31) a 
metabolite from Aspergillus terreus (Scheme 1.8).
Different feedings were carried out on the metabolite.
2- ^ 3 ] and [l-^C, I80 2 ]acetate 
were fed to Aspergillus terreus and the results 
obtained are consistent for the proposed pathway 
(Scheme 1.8). The feeding of [l-^c, l7o]acetate 
also gave positive results. In the 170 n.m.r. 
spectrum, three signals of the labelled citrinin (31) 
were obtained and were tentatively assigned according 
to published data.64,65 17q chemical shift values
are very sensitive to the changes of electron density 
on oxygen atoms. The chemical shift value of C-6 
oxygen (279 p.p.m.) is infact smaller than those of 
normal carbonyl groups. The shifts of C-8 oxygen and 
0- 2 (179 and 148 p.p.m. respectively) are larger than 
those observed for phenol or enol g r o u p s . 65,66 These 
facts may be explained by keto-enol tautomerism of 
citrinin (31a and 31b).
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A recent application of the use of 1^0 n.m.r. in 
biosynthesis has been performed by Staunton et al^7
H
(31b)
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who studied the biosynthesis of hydroxymellein (3 3 ) 
from Aspergillus melleus. The origin of the four 
oxygen atoms in hydroxymellein was studied using 1 7 0 
n.m.r. spectroscopy. The four resonances were assigned
SCHEME 1.9
CH3C02Na
OH
HO
H0+
(32)
0  —  Acetate
0 — Water
0*— Oxygen gas
(34)
(35)
H0f
CH
HO.
(33)
CH
OH
HOHO
(33)
HO
,CH
(33)
- S O -
on the basis of chemical shift^^ to the carbonyl 
oxygen, 0-2, the phenol oxygen and the C-4 hydroxyl 
group. The spectrum obtained after incorporation of 
[1 70] acetate into hydroxymellein (33) showed 
incorporation from acetate into all the oxygens except 
the C-4 hydroxyl group. They grew the fungus in a 
closed system under an atmosphere of oxygen, 2 0 % 
enriched with 1 7 0 , this yielded hydroxymellein 
labelled uniquely and unambiguiously in the C-4 hydroxy 
group. These results are consistent with (33) being 
derived by stereospecific hydroxylation of mellein 
(32). These results also ruled out the possibility of 
epoxides (34) and (35), Scheme 1.9.
1.6.2 Labelling with Oxygen-18, Detection by jj.C 
n.m.r.
The indirect detection of oxygen-18 by -^C n.m.r. 
spectroscopy is a powerful means by which the position 
and•the extent of labelling in complex polyoxygenated 
molecules can be directly detected. Investigations by 
Boyer and c o - w o r k e r s ,^8 Risley and Van Etten,^9 
Davensbourg et al,70 and Vederas71 confirmed 
Jameson's prediction7  ^that isotopic substitution 
with oxygen-18, induced an upfield shift in the 
position of nuclear magnetic resonances of a directly 
attached carbon-13 atom. The magnitudes of these 
isotopic shifts range from about 0.010 to 0.035 p.p.m.
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for singly bonded oxygen atoms and from about 0.030 to 
0.055 p.p.m. for doubly bonded oxygen atoms. Their 
sizes have been tabulated and structural influences on 
this effect have been reviewed.45 Ttie first 
application in biosynthesis was reported in 1980. ^ 3
SCHEME 1.10
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Sodium I8O2 ]acetate administered to a
mutant of Aspergillus parasiticus gave labelled 
averufin (36). It was shown that there was an intact 
incorporation of acetate derived carbon-oxygen bonds at 
all positions except at C-10. The oxygen at C-10 was 
shown to originate from oxygen gas by allowing the 
fermentation to take place in an atmosphere that 
contained -*-®C>2 (Scheme 1.10).
The use of stable isotopes in biosynthetic studies can 
yield a wealth of information about possible 
intermediates on the pathway to the secondary 
metabolites which could not be obtained from 
radioactive isotopes.
An example of this is the metabolite multicolosic acid 
(37) produced by Penicillium multicolor. Incorporation 
experiments with sodium [l-^c]-, [2-1^C]-/
[1 / 2-1^C2 ]-/ [l-^c, ^ 0 2 ] acetate and
6-pentyl-resorcylic acid (12) have indicated that (37) 
is a polyketide metabolite derived from oxidative 
cleavage of an aromatic precursor (Scheme 1.11)28,29
In particular, labelling studies with [l-l^C,
•*-®0 2 Jacetate have shown that the bond between C-4 
and the lactone oxygen remains intact during the 
biosynthesis of (37). Also such an intact bond can 
be found in the C-ll carboxy group. Recently,
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studies were carried out by Holker et al^ -9 who 
monitored incorporations with 1 ® 0 2 gas which 
defined the origin of all the oxygen atoms in 
multicolosic acid (37).
Incorporation of 1^0 was detected by observation of 
upfield l ^ O - i n d u c e d  shifts in the n.m.r.
spectrum of (38). All carbons bearing oxygen, except 
C-4 showed ct isotope shifts. Unexpectedly large
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upfield yS-isotope shifts (7.2, 22.3, 29.9 p.p.b.) were 
observed for C-2 which bears no oxygen. Since such 
isotope shifts are additive,^4 the 29.9 p.p.b. shift 
is caused by molecules of (38) bearing at both
C-l and C-3.
Generally l^O-induced ,3-isotope shifts are less than 
10 p.p.b.74,75 Recently two other examples have been 
found in which an olefinic carbon two bonds away from 
an enolic oxygen displays a very large y3-isotope 
shift.76 On this basis it would appear that the 22.3 
p.p.b. shift at C-2 results from molecules of (38) 
bearing -^®0 at C-3 and only 1^0 at c-l. Hence the
7.2 p.p.b. shift at C-2 is due to molecules bearing 
at C-3 and at the C-l carbonyl oxygen. No
/3-shifts were found for C-10 or C-8 .
In the following chapters many of the techniques 
discussed above are used to study the biosynthesis of 
the metabolites cryptosporiopsinol, microline and 
dechloromicroline. The different methods are dealt 
with in the appropriate chapters.
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CHAPTER 2
THE BIOSYNTHESIS OF CRYPTOSPORIOPSINOL
2.1 Int.roduct.ion
In 1969 the isolation of cryptosporiopsin (39) was 
first reported from the coprophilous fungus Sporomia 
affinis^-? and a Cryptosporiopsis sp. isolated from 
the yellow birch Betula alleghaniensis.^8 The 
structure of cryptosporiopsin (39) was demonstrated by 
chemical degradation, spectroscopic analysis and by an 
x-ray analysis.
(39)
Thereafter, cryptosporiopsin was detected in extracts 
of Periconia macrospinosa.^
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A number of chlorine containing metabolites are found 
with cryptosporiopsin. In Sporomia affinis it occurs 
with dechlorocryptosporiopsin (40) and its C-5 epimer 
(41) as well as the dihydroisocoumarins (42), (43) and
(4 4 ) . 8 0
Cl
MeO CHMeO.
OH
(44)
HO
Cl
c r
H oh
C 0 2Me
(45)
CHMeO.
OH
OH
MeO CH
(46) (47)
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In Periconia macrospinosa cryptosporiopsinol (45) and 
the dihydroisocoumarin (46) are the major metabolites. 
Small amounts of other metabolites have also been 
detected (47) (48) and (49).81
2.2 Early Studies Done on the Biosynthesis of 
Cryptosporiopsinol (45)
The first investigation to be carried out into the 
biosynthesis of cryptosporiopsinol (45) was done by 
Holker and Young in 1975.81 Cultures of Periconia 
macrospinosa were supplemented with [l-l^C],
[2-13c ] and [i#2-13c]acetate. By assignment of the 
peaks in the n.m.r. spectra of the metabolites
(45) and (46), the compounds were found to be enriched 
in the positions shown.
Cl Cl
From his doubly labelled acetate feedings and related 
work done on the biosynthesis of terrein (24)47,48/
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Holker proposed that cryptosporiopsinol was derived by 
a ring cleavage of a dihydroisocoumarin precursor.
RO
OR
CH,
(51)
CO,Me
(45)
From Holker1s l^C-acetate feeding results in 
cryptosporiopsinol/ the ring cleavage of the 
dihydroisocoumarin (51) must involve extrusion of C-8 
from the aryl ring. This contrasts with the formation 
of terrein (24) in which C-7 is lost from the aryl ring 
(50) .
Another feature to be taken into account is the 
introduction of chlorine into cryptosporiopsinol.
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2.3 Int.roduct.ioii of Chlorine into Cryptosporiopsinol
Little is known about the mechanism of biological 
chlorination. The process is thought to involve the 
oxidation of chloride to chlorine cations or some 
equivalent. This could be accomplished by a peroxidase 
enzyme (a chloroperoxidase) together with a suitable 
oxidising agent. Such an enzyme has been isolated from 
the mould Caldariomyces fumago.Q2 The purified 
preparation was shown to catalyse the formation of 
carbon-halogen bonds in the presence of 
hydrogen peroxide.
Details of the structure of the enzyme are known: it 
contains one mole of ferriprotoporphyrin IX as a 
prosthetic group and has a molecular weight of 42,000 
of which 25-30% is carbohydrate. However, details of 
the structure of the active site and the mechanism by 
which the halogen atom is transferred to the substrate 
is lacking. Specifically, the nature of the group to 
which the halogen atom is added during transfer is not 
known. In studies of the Caldariomyces fumago
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chloroperoxidase, the relative non-specificity of the 
enzyme was noted: it catalysed the chlorination, 
bromination and iodination of a number of cyclic or 
acyclic 1,3-dicarbonyl compounds.
With these considerations in mind Henderson®^ 
synthesised the eight dihydroisocoumarins (42), (43),
(44), (46), (50), (52), (53), and (54) with a
l^C-label at C-3 and fed them to Periconia 
macrospinosa as their sodium salts. Of the eight 
labelled dihydroisocoumarins only (42), (50) and (52)
were incorporated into the dihydroisocoumarin 
metabolite (46) at significant levels, but each of the 
eight was incorporated into cryptosporiopsinol (45). 
Degradation showed that the compounds were being 
incorporated intact. Considering the incorporation 
into the dihydroisocoumarin metabolite (46), Henderson
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MeO t^CH3 MeO 1>C H 3
Cl
MeO
OH
CH3
(44)
+ /C H 3
Cl
MeO CH,
(46)
Cl
HO
OH
(52)
Cl
HO
OH
(54)
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TABLE 2.1
Incorporations of [3-jL^ C] Dihydroisocoumarins into
5-Chloro-3,4-dihydro-8-hydroxy-6-methoxy-3-methyliso-
coumarin (46)
COMPOUND FED INCORP INTO (46) % % ACTIVITY AT
C-3
MeO CH,
OH
(42)
1.66 89
HO CH,
m  o
[50)
17.60 83
Cl
HO CH
OH
(52)
16. 20 85
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TABLE 2.2
Incorporations of [3-j^C] Dihydroisocoumarins into
Cryptosporiopsinol (45)
COMPOUND FED INCORP INTO (45) % % ACTIVITY AT
C-2
MeO CH 0.97 85
MeO< CH
1.75 96
Cl
MeO CH
2.30 87
Cl
MeO
OH
(46)
0.13
-  64 -
TABLE 2.2 (cont)
Incorporations of C3-j^bc] Dihydroisocoumarins into
Cryptosporiopsinol (45)
COMPOUND FED INCORP INTO (45) % % ACTIVITY AT
C-2
HO. CH
OH
4.60 89
Cl
CHHO
5.0 82
8.0 84
CHHO
OH
17.60 81
(54)
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postulated that/ since the demethylated
dihydroisocoumarins (50) and (52) were incorporated far 
more efficiently (17.6 and 16.2% respectively) than the 
0-methyl derivative (42) (1.66%), chlorination of the 
ring occurs after aromatisation but before 
0-methylation (see Table 2.1). The fact that the 
0 -methyl derivative was incorporated was explained as 
due to the relatively low specificity of the 
chlorinating enzyme. The enzyme was able to accept 
substrates having both hydroxyl and methoxyl groups at 
the 6-position.. Alternatively, the 6-methoxy 
derivative (42) could be incorporated via 
O-demethylation to the 6 ,8-dihydroxy derivative (50), 
followed by chlorination and subsequent 0 -methylation. 
Biological O-demethylations are known to occur.83-85
The incorporations of the 6-0-methyl dihydroiso­
coumarins (42), (43), (44) and (46) into crypto­
sporiopsinol (45) were found to be significantly less 
than those of the corresponding 6-hydroxy analogues 
(50), (52), (53) and (54) (Table 2.2). Henderson thus
proposed the 6-0 -methyl derivatives were unlikely to be 
on the direct pathway to cryptosporiopsinol (45).
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To prove that the dihydroisocoumarins (53) and (54) 
were true intermediates, precursor trapping experiments 
were performed.The unlabelled 
7-chloro-dihydroisocoumarin (53) and the 
5,7-dichlorodihydroisocoumarin (54) were fed in large 
quantities in separate experiments along with sodium 
[l-14c]acetate to the organism. Radioactive 
isocoumarins (53) and (54) were recovered from the 
fungus. By increasing the metabolite pool of a 
potential precursor and feeding radioactive labelled 
acetate, the proposed intermediate may be 'trapped' in 
radiolabelled form if it is produced by the organism 
and if it is derived from acetate. Thus the production 
of these metabolites in Periconia macrospinosa was 
established and since they are both incorporated into 
cryptosporiopsinol, they are probably both 
intermediates.
Interestingly, on growing cultures of Periconia 
macrospinosa without a chloride ion source (normally 
present as potassium chloride), no reduction in 
mycelium growth was observed. On work-up no ring 
cleaved products were detected and the 
dihydroisocoumarins (50) and (42) were isolated.
To test the fate of the proton at C-3, Henderson made 
the 5 ,7-dichloro-6 ,8-dihydroxy-3,4-dihydro-3-methyl- 
isocoumarin (54) with a deuterium label at C-3 and
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Cl
CHHO
Cl
(54)
fed it to the fungus.
Using n.m.r. spectroscopy and applying the
^-shift technique, the position of the deuterium atom 
was detected in the isolated cryptosporiopsinol (45) in 
the allyl group.
Thus Henderson showed that the proton at C-3 was 
retained throughout the biosynthesis of 
cryptosporiopsinol (45) and other possible precursors 
such as (55) and (56) could be disregarded.
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c o 2h
Cl
HO
Cl
OH
CH,
(56)
In order to test the possible involvement of hydroxy 
quinones to affect the ring-contraction reaction of a 
six-membered system to the cyclopentenone system of 
cryptosporiopsin, Henderson made the hydroxyquinones 
(57) and (58) and showed that on treatment with 
N-chlorosuccinimide in methanol at room temperature 
they cleaved to give the cyclopentenone ring system 
(59) and (60).
R
NCS 0 = = ^ y ^ ^
MeOH c K r f OH
Cl C 02Me
R = H  [59)
R =  Cl (60)
Armed with these results Henderson proposed the 
following scheme for the biosynthesis of 
cryptosporiopsinol (Scheme 2.1). The first step 
involves cyclisation of a pentaketide chain to give the 
dihydroisocoumarin (50).
OH 
R =  H (57) 
R = C I (58)
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SCHEME 2.1
c h 3— co sx
+
COOH
c h 2c o s x
cosx
CHHO
OH
Path BPath A
CHHO HOCHMeO
OHOH
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Cl
CH
PathD
Path C
Cl
H H
CH
OH
HO
Cl
OH
(61)
HO
OH
OH
(62)
Cl
HO""
/OH 
CO. Me
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The intermediate (50) is chlorinated at the 5-position 
(PATH A) or at the 7-position (PATH B). Either of these 
intermediates can be chlorinated to give the 
5, 7-dichloro-6,8-dihydroxy-3, 4-dihydro-3-methyl- 
isocoumarin (54).
Consideration of the functional changes which the 
dihydroisocoumarin precursor (54) must undergo leads to 
the recognition that at least 3 operations must take 
place: formation of the allyl group; oxidation and 
decarboxylation at C-8a, and ring cleavage.
A plausible mechanism for the formation of the allyl 
goup and oxidative-decarboxylation involves initial 
enzymic oxidation at C-8a and subsequent loss of C-l as 
carbon dioxide to give the trihydroxyphenylprop-l-ene 
(62). This could occur in a concerted manner (path C) 
or via the acid (61). The trihydroxyphenylprop-l-ene 
(62) could be oxidised to the quinone (63) which could 
undergo ring contraction, O-methylation and reduction 
to give cryptosporiopsinol (45).
2.4 Feeding of Phenylprop-l-enes to Periconia
As a continuation of the study of the biosynthesis of
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cryptosporiopsinol Maclachlan®6 investigated the 
plausible intermediacy of the dichlorotrihydroxyphenyl- 
prop-l-ene (62). Attempts to synthesise and purify the 
postulated precursor (62) were met with difficulty as 
it was found that compounds of this nature were 
difficult to handle due to oxidation and 
polymerisation.
Thus it was thought that the desired acetate (67) which 
was easier to purify and was more stable, could be fed 
to Periconia macrospinosa and would be incorporated via 
acetate hydrolysis in the fungal broth. Hence all the 
possible chlorinated derivatives (64), (65), (66) and
(67) were synthesised and fed to the fungus. This was 
to study the significance of chlorination at the 4- and 
6-positions of the aryl ring in the ring contraction 
reaction to form cryptosporiopsinol (45).
AcO
OAc
OAc
(64) R, = R2 = H
(65) R.j = Cl R2= h
(66) Rt=H R2=CI
(67) R1 = R2 =CI
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All the triacetoxyphenyl propenes were fed with a 
deuterium at the C-2 position of the propene system. 
Detection of the label in the final metabolite could be 
accomplished by making use of the /d-shift 
technique. That is, if any of these compounds were 
incorporated into cryptosporiopsinol (45) then the 
deuterium would appear at C-2 in the propene system of 
cryptosporiopsinol (45). Hence in the n.m.r.
spectrum of cryptosporiopsinol, shifted ^-signals 
should be observed for C-l, and C-3 of the propene 
system.
On feeding the four deuterium labelled triacetoxyphenyl 
propenes (64), (65), (66) and (67) it was found that
the non-chlorinated compound (64) inhibited the 
production of cryptosporiopsinol (45). The remaining 
chlorinated triacetoxyphenylprop-l-enes (65), (66) and
(67) did not block cryptosporiopsinol production but 
were not incorporated into cryptosporiopsinol to any 
detectable degree.
Henderson had shown 5,7-dichloro-6,8-dihydroxy-3,4- 
dihydro-3-methylisocoumarin (54) to be a true precursor 
of cryptosporiopsinol. Therefore, it was postulated 
that the dichlorotrihydroxyphenyl propene (62) formed 
by oxidation and decarboxylation of (54) would have 
been incorporated well into cryptosporiopsinol. Thus
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the non-incorporation of the chlorinated compounds
(65), (66) and (67) began to throw some doubt on the
proposed biosynthetic pathway (Scheme 2.1).
There may be several reasons why (65), (66) and (67)
were not incorporated into cryptosporiopsinol (45)
1) They may not have been hydrolysed in the aqueous 
fungal medium. However, there was no trace of the 
triacetoxyphenylpropenes in the work up of the 
fungus.
2) They may have been hydrolysed to the corresponding 
trihydroxyphenylpropenes, but were then oxidised 
or polymerised.
3) They may not be true precursors of crypto­
sporiopsinol .
However, these results are inconclusive and the feeding 
of the free phenols should be carried out. Maclachlan 
did not have the available time to carry out the 
feeding of the free phenols.
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2.5 Application of >6—shift. Technique to Crypto— 
sporiopsinol Biosynthesis
As mentioned earlier the ,3-shift method is a new 
technique which is being used more and more nowadays in 
obtaining information about biosynthetic pathways to 
metabolites. Therefore, in order to throw some light 
on the biosynthesis of cryptosporiopsinol this 
technique was applied.
Two feedings were carried out:
1) CD3l3c!02Na was to Periconia macrospinosa
2) CH3-*-^ C-*-®02Na was fed to Periconia 
macrospinosa
The fungus was also grown in an 1®02 atmosphere to 
determine which oxygen atoms were derived from acetate 
and which were derived from the atmosphere.
The fact that the chlorinated derivates (65), (66) and
(67) were not incorporated into cryptosporiopsinol (45) 
may suggest that the pathway outlined in Scheme 2.1 was 
not altogether correct.
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AcO
OAc
OAc
Rr CI R2 = H (65) 
R1=H R2=CI (66) 
R1 = R2 = CI (67)
*
CK /^OH 
C02Me
(45)
SCHEME 2.2
HO
Cl
(45) (68)
aOH
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A possible pathway may be as shown in Scheme 2.2 
starting from the isocoumarin (50). It may be oxidised 
in the manner shown, the oxygen may come from the 
atmosphere and be enzymatically bound in the active 
site. Formation of the carbonyl, loss of carbon dioxide 
and hydride or some equivalent would produce the 
quinone (63). The quinone (63) being the oxidised form 
of the trihydroxyphenyl propene (62), could be the key 
intermediate and not the fully aromatic compounds as 
earlier suggested by Henderson. This quinone (63) 
could then undergo the same ring contraction as shown 
in Scheme 2.1 giving the acid (68) which could be 
esterified and reduced giving cryptosporiopsinol (45).
Thus it was hoped that the ^®02 and 
CH3 1^C1^0 2Na experiments would give some 
information about the ring-contraction from the
6-membered to the 5-membered ring.
2.5.1 Feeding of CD3jj.CO?Na to Periconia 
macrospinosa
CD313C02Na was fed to Periconia macrospinosa on 
day 14 and the broth was extracted on day 21. The 
^-shifts were obtained from the 13C proton noise 
decoupled spectrum of the isocoumarin (46) and are 
given in Table 2.3. Likewise the ^-shifts were 
obtained for cryptosporiopsinol (45) and are also given 
in Table 2.3.
COzNa
TABLE 2.3
ISOCOUMARIN (46)  CRYPTOSPORIOPSINOL (45)
CARBON $-SHIFT (ppm) CARBON %-SHIFT (ppm)
3 0.04, 0.08, 0.12 2 0.04, 0.08, 0.12
4a 0.03, 0.07, 0.1 4 0.04
8 0.04
For the isocoumarin (46) carbon 3 shows shifts of 0.04 
p.p.m., 0.08 p.p.m., and 0.12 p.p.m. corresponding to 
carbon 9 having one, two, or three deuteriums attached
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to it respectively. Thus at carbon-3 if carbon-9 has 
one deuterium attached a shift of 0.04 p.p.m. is 
observed. If carbon-9 has two deuteriums a shift of 
0.08 p.p.m. is observed, and if carbon-9 has three 
deuteriums attached a shift of 0.12 p.p.m. is 
observed. Therefore each deuterium gives an additive 
shift value of 0.04 p.p.m.
An interesting result occurs for C-4a of the 
isocoumarin. Here there are three observed shifted 
signals:
1) Deuterium at the equatorial site on C-4.
2) Deuterium occupying an axial site on C-4.
3) Two deuteriums attached to C-4.
From studies carried out on the ^-shifts arising from
deuterium attached at various carbons on the 
isocoumarin (46) (see Chapter 5) it has been shown that 
the lowest shifted signal (0.03 p.p.m.) is due to the 
equatorial deuterium attached to C-4. The shifted 
signal 0.07 p.p.m. is due to the axial deuterium.
Where two deuteriums appear on the same carbon a 
shifted signal of 0.1 p.p.m. is observed. This again 
shows the additive feature of the yS-shifts. These 
findings are similar to results obtained by Simpson and 
Stenzel53 when they studied the biosynthesis of
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O-methylasparvenone (26) (see Chapter 1).
OH
CH
MeO
OH
(26)
The /S-shifted signals could also be observed for 
cryptosporiopsinol (45) i.e. carbon 2 showed shifted 
signals which were also additive corresponding to one, 
two or three deuterium atoms being attached to carbon 1 
of the propene chain.
2.5.2 Feeding of CH^jjc-jj^OaNa to Periconia 
Macrospinosa
CH3l^ C-*-®02Na was fed to Periconia Macrospinosa 
on day 14 and the broth was extracted on day 21.
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COSX
CHMeOi
OH
Cl" 9^  OH 
o// \> M e
(46) (45)
TABLE 2.4
ISOCOUMARIN (46)
CARBON SHIFTED SIGNAL
0.035
0.034
0.017
0.010
CRYPTOSPORIOPSINOL (45) 
CARBON SHIFTED SIGNAL
0.016 p.p.m. 
0.017 p.p.m.
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The 180 isotope effect on 13c nuclear shielding has 
been studied.69/70»87-89 The findings are as 
follows: (i) For unhindered alcohols and ethers the
value of the ot-shift is 0.025 p.p.m. (ii) For 
aldehydes and ketones the ot-shift is 0.050 p.p.m.
(iii) For carboxylic acid derivatives the double bonded 
oxygen gives a higher ot-shift value than that for a 
single bonded ^80. Also the effects observed in 
phenols are smaller than in aliphatic alcohols.71/89
c = 0  C =0  r __ ’b
< /  «</ < /  X c
+ 0-038ppm +0-015pp m  +0,0 2 9 p p m
Vederas^ has observed for carbonyl compounds the 
following trend in ot-shift values: ketones > aldehydes 
> esters > amides and that conjugation reduces the 
effect by 0.002-0.006 p.p.m.
The results obtained for the isocoumarin (46) were in 
agreement with those observed by Holker.8 -^ The 
largest shifted signal found was that at carbon-1 
which implied the carbonyl had been incorporated as an 
intact unit, and the pentaketide moiety folds as shown.
However, the acetate feeding results for
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cryptosporiopsinol (45) are in contrast to those anticipated. 
The carbon-6 of cryptosporiopsinol has retained its 
oxygen which can be visualised as being derived from 
the carbon-6 oxygen bond of the isocoumarin (46).
The only other shifted signal is that due to carbon-9 
(0.017 p.p.m.) which is in agreement for a carbon- 
oxygen single bond. This now suggests that the 
pathway outlined in Scheme 2.2 is not altogether 
correct.
SCHEME 2.2
Cl
c h 3 < V V ^
CH 0
Cl
ENZ O H ' °
Cl
OH
(54)
O — ENZ (63)
Cl ClCl
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By considering Scheme 2.2 it was envisaged that the 
quinone intermediate (63) would undergo a ring 
contraction mechanism in the manner shown to give the 
acid (6 8 ). If this is the correct pathway, then the 
carbonyl oxygen of the acid (6 8 ) will be derived from 
the 8 -hydroxyl group of the isocoumarin (54). Thus if 
the acid (6 8 ) were an intermediate then the label would 
be attached to the carbonyl group of the ester in 
cryptosporiopsinol (45). It may be possible that the 
acid (6 8 ) exists as the carboxylate anion. If this 
were so then a scrambling of the label could occur
giving a 50:50 mixture of the label on the carbonyl and 
on the single bond oxygen. Further manipulation of the 
intermediate (6 8 ) would give cryptosporiopsinol which 
should contain scattering of the -^®0 label. However, 
the cryptosporiopsinol (45) isolated from the feeding 
of [l-l^c, 1 8 0 2 ]acetate had no label in the 
carbonyl group of the ester. This rules out the 
probability of the acid (6 8 ) being an intermediate on 
the pathway to cryptosporiopsinol.
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These results also help to clarify the findings of 
MacLachlan8 4 who fed the chlorinated triacetoxyphenyl 
propenes (65), (6 6 ) and (67) and found they were not
incorporated. One suggestion was that the acetate
R =  CI R = H (65)
R=H R=CI (66)
R = R = Cl (67)
groups were not hydrolysed in the fungal broth.
However, it now seems .likely that these compounds are 
not true intermediates. The pathway would seem more 
likely to follow that of Scheme 2.3 in which the 
quinone (63) is the key intermediate. The ring 
contraction must go via another process and one 
plausible way is as shown in Scheme 2.3.
One way to test this hypothesis would be to synthesise 
the quinone (63) and methylate with to give
the radiolabelled species (69).Feeding this 
intermediate (69) and checking for radioactive 
cryptosporiopsinol would confirm whether the quinone 
(69) was a true intermediate or not.
AcO
OAc
OAc
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SCHEME 2.3
(63)
MeOOH
(69)
(45)
CK^
OK
HO
I^OH
C02Me
Evidence to support the Michael addition of water to a 
fungal metabolite was reported recently by Barber et 
ad.90 These workers have shown by spectroscopic 
means that citrinin (31) in aqueous solution at 
physiological pH exists not as the quinone rnethide (31) 
but as a diastereomeric mixture of hydrates (70).
It was thought that the pathway could be more fully 
understood if the origins of the other two oxygen atoms 
in cryptosporiopsinol could be established.
2.6 Gas Experiment
Periconia macrospinosa was grown in an 1 ® 0 2  
atmosphere for 21 days. However/ after work up of the 
fungal broth, there was only a small amount of 
metabolite produced. The -^C n.m.r. revealed the 
compound obtained to be cryptosporiopsin (39), the 
oxidised form of cryptosporiopsinol. Unfortunately it 
was difficult to tell which atoms had been shifted due 
to the small amount of material obtained. There was 
not enough time to repeat this experiment during the 
course of this work.
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DIAGRAM 5.1
180? gas experiment
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2.7 Feeding of Labelled Isocoumarins
In the biosynthesis of cryptosporiopsinol (45) 
Henderson^ has already established that various
isocoumarins are incorporated into this metabolite. 
Indeed the best incorporated was the isocoumarin (54). 
As well as studying the nature of the ring contraction 
from the 6 -membered to the 5-membered ring it is also 
of interest to establish which proton is lost in the 
conversion of the isocoumarin (54) to 
cryptosporiopsinol (45).
Thus to show which hydrogen is lost a synthesis is 
required which will give two isocoumarins, one having 
an a-deuterium and one having a ,3-deuterium at the 
4-posit,on.
C02MeOH 0
54 45
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SCHEME 2.4
CD. MeOMeOMeO CD-
C02H
MeOMeOMeO
CD.MeOCD.HO
MeO
OH
Reagents: (i) Na, D2O, (ii) HC1 0 4 , AC2O, EtOAc,
(iii) H2 /Pd, (iv) BBr3 , (v) SO2CI2
2.7.1 Synthesis of Deuterio-isocoumarin (75)
A synthesis of the keto acid (71) is outlined in 
chapter 3. Dissolving sodium in deuterium oxide and 
refluxing for 2 hours exchanged all the a-hydrogens, 
giving the pentadeuterio compound (72). Cyclising to 
the isocoumarin (73) was performed as before (chapter
91
3) by standing in a solution of perchloric acid and 
acetic anhydride for 10 minutes. Hydrogenation of the 
double bond using palladium on charcoal as catalyst 
afforded the required 4/8-deuterioisocoumarin (74).
This is because cis reduction of the double bond places 
the deuterium on the same side as the methyl group.
The methyl group will occupy an equatorial site, and 
therefore in order for the deuterium to be on the same 
side it will occupy an axial site. Demethylation with 
boron tribromide and chlorination with sulphuryl 
chloride afforded the desired deuterioisocoumarin (75).
2.7.2 Synthesis of Deuterio-isocoumarin (78)
SCHEME 2.5
MeO MeO CH
Cl Cl
Me0(7l) M eO. . 0(76)
MeO
Cl
OH 0
(78)
£H2D
i77)
(i) HCI04, Ac20, EtOAc ; (il) D2 ; (iii) BBr3; (iv) S02CI2
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Reduction of the isocoumarin (76) with deuterium gas, 
formed by the dropwise addition of deuterium oxide onto 
lithium metal afforded the isocoumarin (77). By 
n.m.r. there was no proton at the 3-position and the 
4-position integrated solely as one proton. However, 
integration of the methyl group revealed that one of 
the protons had been exchanged with a deuterium.
2.7.3 Feeding Results
The deuterio-isocoumarins (75) and (78) were fed as 
their sodium salts to Periconia macrospinosa. Several 
metabolites were produced from these feedings. The 
fungus appeared to have changed its metabolite 
production by the time this work was performed. It was 
not possible to obtain meaningful results from the 
13C n.m.r. and n.m.r. spectra of the metabolites 
due to insufficient quantities of cryptosporiopsinol 
obtained. There was not sufficient time to repeat this 
experiment with a new Periconia macrospinosa culture.
V
2.8 Conclusions
The feeding of C^l^CllQc^Na to Periconia 
macrospinosa has given more information about the 
biosynthesis of cryptosporiopsinol (45). The -^C
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c K
OMe
(69)
AcO
OAc
AcO
R= R = H (64)
R = CI R = H (65)
R=H R-CI (66)
R = R = Cl (67)
n.m.r. spectrum obtained for the metabolite revealed 
that dnly the carbon-oxygen single bond of the ester 
showed an isotope shift. This result means that it is 
unlikely that the trihydroxyphenylprop-l-ene (62) is an 
intermediate as had been believed. Therefore/ the 
finding by MacLachlan that the triacetoxyphenylpropenes 
(64), (65), (6 6 ) and (67) were not incorporated into
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cryptosporiopsinol (45) is because they are probably 
not true intermediates on the biosynthetic pathway.
The proposed pathway outlined in Scheme 2.1 would now 
seem unlikely. A more plausible route is outlined in 
Scheme 2.3 and the quinone (69) would now appear to be 
the key intermediate.
V
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3. BIOSYNTHESIS OF MICROLINE AND DECHLOROMICROLINE
3.1 Introduction
Microline (79) is the most complex of a family of 
isoprenoid-polyketide metabolites isolated from the 
fungus Gilmaniella humicola and an ectendomycorrhizal 
fungus found on the roots of wonotropa hypopitys.
These metabolites have antifungal properties and some 
antibacterial action; presumably the metabolites are 
produced in self-defence. The metabolites or their 
analogues also may be of interest as fungicides for 
crop protection. Little is known about the 
biosynthesis of this class of metabolite/ although 
there has been some speculation in the literature. The 
metabolites isolated from Gilmaniella humicola include 
microline (7 9 ) ,91/92 dechloromicroline (80),91,92 
gilmicolin (8 1 ),93 mycorrhizinol (82) and
3,4-dihydro-6,8-dihydroxy-3-methylisocoumarin (50).91
The biosynthesis of microline (79) and 
dechloromicroline (30) and similar metabolites may 
formally arise through the intermediacy of a polyketide 
chain and an isoprene unit as in Scheme 3.1. The 
simultaneous occurrence of 3,4-dihydro-6,8-dihydroxy- 
3-methylisocoumarin (50)94
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"OH
CH OH'3 un 
R = CI (79)
CH
OH
OH
R = H  (80)
Cl
HO
HO
CH3 CH
(82)
H°r}g r
HO °
(50)
and other biogenetically related metabolites tend to 
support this hypothesis.^5
Before carrying out various feeding experiments with 
-^c-labelled precursors Chexal and Tamm assigned
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the n.m.r. spectra of microline and
dechloromicroline.96 The X-ray structure of 
microline (79) had been obtained and shown to be 
(79a). However, in solution microline (79) and 
dechloromicroline (80) exist as a 3:1 ratio of their 
tetracyclic (79a, 80a) and tricyclic structures (79b, 
80b) .
CH
OH
(""OH
OH
OHCHCH;
R=Cl(79a) R = CI (79b)
R=H (80a) R=H (80b)
Chexal and Tamm studied the incorporation of a number 
of l^C-labelled precursors into
dechloromicroline.96 The non-incorporation of 
phenylalanine ruled out the possibility of prephenic 
acid/shikimate intermediates in the biosynthetic 
pathway.
The labelling pattern observed on supplementing the
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media with sodium [l-^C]-, [2-13c]- and
[1 / 2-13c]ace-t:ates is shown below.
• = [1 - 13C] Acetate
t =[2-13Cl Acetate
OH
CH,
R = CI (79) 
R = H (80)
[1,2-C] Acetate
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The alternate labelling of carbon atoms with [l-^C] 
and [2-13c]acetates supports the polyketide mode of 
biogenesis. The origin of C(8), C(9), C(10), C(13) and 
C(14) from an isoprene unit is also confirmed. In the 
n.m.r. spectrum of di-O-acetylmicroline (exists 
exclusively as the tricyclic structure) labelled by 
[1,2-13c]acetate 12 of the 14 signals showed a 
doublet. This is due to ^3q_13q coupling in the 
doubly labelled acetate unit - in addition to the usual 
singlet arising for -^C present at natural 
abundance. Thus C(l) - C(2), C(3) - C(4), C(5) - C(6)/ 
C (7) - C(ll)( C (8) - C (9) and C(10) - C(13) all showed 
coupling. However, the signals for C(12) and C(14) 
appeared as singlets in the spectrum.
The appearance of C(12) as a singlet and C(5) - C (6) as 
a doublet (Jcc 54 Hz) in the -^C n.m.r. spectrum can 
only be accommodated if the biosynthesis of microline
(79) and dechloromicroline (80) proceeds according to 
pathway a. If pathway b were correct then C(5) would 
have appeared as a singlet and C(ll) - C(12) would have 
exhibited C-C couplings. Similarly, the appearance of 
C(14) as a singlet and C(10) - C(13) as a doublet 
clearly defined the origin of C(13) from the methyl 
group attached to C(3) in the mevalonate precursor.
Thus Chexal and Tamm using singly and doubly labelled
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l^c-acetate precursors have elucidated the
biosynthetic pathway of microline (79) and 
dechloromicroline (80). However, the nature of the 
intermediates still has to be proven. An investigation
3,4-dihydro-6,8-dihydroxy-3-methylisocoumarin (50) in 
the biosynthesis of microline and dechloromicroline was 
undertaken.
The occurrence of 3,4-dihydro-6,8-dihydroxy-3- 
methylisocoumarin (50) along with microline (79) and 
dechloromicroline (80) in Gilmaniella humicola led to 
the belief that the aforementioned isocoumarin (50) may 
be a true intermediate in the pathway to these 
metabolites.
of one of these postulated intermediates
R R
HO
OH 0
CH CH.
1
R = CI (79) 
R =  H (so)
It was thought that the 4-chloroisocoumarin (83) may
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also be an intermediate, and if this were so, it would 
establish that chlorination of microline (79) occurred 
at an early stage in the biosynthesis. Thus to confirm 
or disprove this, a synthesis of 3,4-dihydro-6,8- 
dihydroxy-3-methylisocoumarin (50) and 4-chloro-3,4- 
dihydro-6,8-dihydroxy-3-methylisocoumarin (83) was 
required which would allow a label to be introduced at 
a position in the isocoumarins (83) and (50) which 
would be detectable in the final metabolites (79) and
(80) respectively.
3.2 Synthesis of labelled dihydroisocoumarins
j
There are several syntheses of dihydroisocoumarins to 
be found in the literature.97,98 However, since 
labelled dihydroisocoumarins were sought, a synthesis 
was required which would allow the label to be 
introduced at as late a stage as possible.
3,5-Dimethoxyhomophthalic acid (84) was the key 
intermediate since there are only a few steps from this 
compotind to the dihydroisocoumarin (50). This is a key 
intermediate because reacting the homophthalic acid 
(84) with [l-14c]acetic anhydride would introduce the 
radioactive label at the 3-position of the 
isocoumarin. This corresponds to the 2-position of 
microline (79) or dechloromicroline (80) if the
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anticipated mode of incorporation is correct.
HOMeO
co2H
OMe
(84) R=CI (83) 
R=H (50)
CH OH
CH,
R = CI (79) 
R=H (80)
A recent synthesis®^1 of 3,5-dimethoxyhomophthalic 
acid (84) is outlined in Scheme 3.2.
SCHEME 3.2
HO
C02Et
O
OEt
Br
B r > ^ A Co2Et
OH
Me0^ ^ N / CH MeO
£1 ►
C02Et CO,H
Me
vV ^ V ^ C 0 2H
y ^ c o 2H
OMe
(84)
Reagents: (i) Br2 / HOAc; (ii) Raney Nickel, KOH;
(iii) Me2S04, K2C03, (CH3)2CO; (iv) KOH;
(v) LDA, Me2C03, H2O.
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The synthesis of 3,5-dimethoxyhomophthalic acid (84) 
was that employed by H e n d e r s o n . T h e  route had 
moderate yields, although the condensation between 
ethyl acetoacetate (85) and ethyl crotonate (8 6 ) 
proceeded with a yield of 45%. An improved route to
3,5-dimethoxy- homophthalic acid (84) was developed, 
see Scheme 3.3.
SCHEME 3.3
CH CH MeOHO MeO CH
OMeOH OMe
(88) (89)
CHMeO
C02H
C02H
OMe OMe
(84)
Reagents: (i) Me2SC>4 , K2CO3 , (CH3 )2CO;
(ii) Br2, C1-CH2CH2 -C1 ; (iii) nBuLi, CO2
(iv) LDA, Me2C03, H20.
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Methylation of orcinol (87) proceeded in good yield to 
give the dimethyl ether (8 8 ). Treatment of the 
dimethyl ether (8 8 ) with one equivalent of bromine in 
1,2-dichloroethane afforded 2-bromo-3,5- 
dimethoxytoluene (89) in 75% yield. This was confirmed 
by mass spectroscopy which gave parent ions m/z 196 and 
198. In the n.m.r. spectrum the aromatic 
multiplet associated with (8 8 ) collapsed giving two 
doublets (J 2 Hz) which is consistent for a meta 
coupling between two aromatic protons. Treatment of 
the bromo derivative (89) with n-butyllithium afforded 
the 2-lithio species which reacted with carbon dioxide 
to give 6-methyl-3,5-dimethoxybenzoic acid (90). This 
again was confirmed by mass spectroscopy which had a 
parent ion m/z 194. The ir spectrum showed absorptions 
at 1650 and 3300 cm~l which are consistent for a 
carboxylic acid. When the acid (90) was treated with 
lithium diisopropylamide and dimethyl carbonate, it 
gave 3,5-dimethoxyhomophthalic acid (84) after 
hydrolysis and work up.
Homophthalic acids have been converted into 
isocoumarins by a number of routes.^ Tirodkar and 
Usgaonkar 1^0 reported that 4-methoxyhomophthalic 
acid (91) could be converted into 4-carboxy-7-methoxy-
3-methylisocoumarin (92) on treatment with acetic 
anhydride and pyridine.
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CO,H
CH
MeOC02HMeO MeO
(91)
(92) (93)
Decarboxylation afforded 7-methoxy-3-methylisocoumarin 
(93). Thus it was decided to adopt this approach for 
the synthesis of these substituted 3-methyl- 
isocoumarins. Henderson®^ found that a mixture of 
products was obtained when the homophthalic acid (84) 
was treated with acetic anhydride and pyridine. He 
found that is was better to isolate the intermediate 
homophthalic anhydride (94) which could thus be 
converted to the desired isocoumarin (95) in better 
yield (Scheme 3.4). The synthesis of 3,4-dihydro-6,8 - 
dihydroxy-3-methylisocoumarin (50) is as outlined in 
Scheme 3.4. Treatment of 3,5-dimethoxyhomophthalic 
acid (84) with acetyl chloride afforded
3,5-dimethoxyhomophthalic anhydride (94). Acylating 
the homophthalic anhydride with acetic anhydride and 
pyridine gave 4-carboxy-6,8-dimethoxy-3 
-methylisocoumarin (95). Heating at 160°C resulted
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in loss of carbon dioxide affording 6 ,8-dimethoxy-3- 
methylisocoumarin (96).
SCHEME 3.4
MeO CH, f > HO
Jvi]
0
Reagents: (i) CH3CCI; (ii) AC2O, pyr; (iii) A :
(iv) NaBH4 ; (v) H2 / Pd; (vi) BBrg
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Reduction of the 3,4-double bond to give (97) can 
either be achieved by hydrogenation in the presence of 
a palladium catalyst, or by treatment with sodium 
borohydride in refluxing aqueous sodium hydroxide 
solution. Demethylation of (97) was achieved by 
treatment with boron tribromide which gave the desired
3,4-dihydro-6,8-dihydroxy-3-methylisocoumarin (50) in 
67% yield.
However, the main problem encountered in the synthesis 
was the conversion of 3,5-dimethoxyhomophthalic 
anhydride (94) to the 4-carboxyisocoumarin (95). The 
procedure adopted by Henderson®^ involved stirring 
the anhydride (94) in a solution of acetic anhydride 
and pyridine in dry THF for lh followed by refluxing 
for lh. Variable yields were obtained when this was 
performed. Varying conditions and amounts of reagents 
failed to produce 4-carboxy-3,4-dihydro-6,8 -dihydroxy-
3-methylisocoumarin (95) in good yield.
There have been several reports published-*-^^”-*-^  ^
concerning the synthesis of various
4-carboxyisocoumarins starting from the related 
homophthalic acids. The synthesis involves treatment 
of the homophthalic acids with acetic anhydride and 
pyridine obtaining a chroman-1 ,3-dione which when 
treated with concentrated sulphuric acid at 0°C
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readily rearranges to give the desired 4 -carboxy- 
isocoumarins.
MeO MeO CH3
iMe OOMe OMe O
C02H
(84) (98) (95)
The aforementioned reactions were applied to
3,5-dimethoxyhomophthalic acid (84). Treatment of the 
acid (84) gave a crystalline compound (98) which when 
treated with concentrated sulphuric acid at 0°C gave 
a poor yield of 4-carboxy-6,8 -dimethoxy- 
3-methylisocoumarin (95). Attempts to improve the 
yield of this intermediate failed. Due to the low 
yields in the formation of the 4-carboxyisocoumarin 
(95), another route was required which would give a 
better yield of 3,4-dihydro-6,8 -dihydroxy- 
3-methylisocoumarin (50).
Tirodkar and Usgaonkar^OO reported that treatment
of the intermediate (99) with aqueous sodium hydroxide
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NaOH
gave the keto-acid (1 0 0 ), which on treatment with acid 
cyclised to the isocoumarin (101). Therefore/ this 
synthetic strategy was applied to 3,5-dimethoxy­
homophthalic acid (84).
8<N ^ V ^ c o 2h
lY^C0>H
MeO
OMe
M
co2h
Reagents: (i) A<&2°/ pyr; (ii) NaOH; (iii) AC2O,
HC104/ EtOAc
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Thus treatment of the homophthalic acid (84) with 
acetic anhydride and pyridine at room temperature 
afforded an intermediate which was not isolated. This 
was refluxed with sodium hydroxide solution, and after 
work-up gave the keto compound (102) in 70% yield.
Ring closure to the isocoumarin (96) was achieved by 
standing in a solution of ethyl acetate, acetic 
anhydride and perchloric acid as reported by Edwards 
and Rao.104 Reduction and demethylation gave the 
dihydroisocoumarin (50). Therefore an efficient route 
was now obtained which permitted a label to be 
introduced into the desired isocoumarin (50).
The synthesis of radioactive 3,4-dihydro-6,8 - 
dihydroxy-3-methylisocoumarin (50) was achieved as 
outlined in Scheme 3.5. If the radioactive isocoumarin 
were incorporated into microline and dechloromicroline 
then a degradation would be required to show that the 
label had been incorporated at the expected position in 
the final metabolite. An alternative method of 
investigating tfte incorporation of the isocoumarin 
precursor (50) is to use deuterium labelling as in the 
pentadeuterioisocoumarin (103). Deuterium n.m.r. would 
reveal where the deuterium atoms were situated in the 
metabolites microline (79) and dechloromicroline (80). 
Thus a degradation of the metabolites would not be 
required. The pentadeuterioisocoumarin (103) was
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SCHEME 3.5
MeO.MeO CHMeO
C02H
Me
(102)
Me OMe
MeO HO
OMe
Reagents: (i) ( CHg^ CO )Qf pyr; (ii) NaOH;
(iii) HC104/ AC2 O, EtoAc; (iv) H2 -Pd; (v) BBrg
synthesised by the route outlined in Scheme 3.6. 
Refluxing the isocoumarin (96) in sodium deuteroxide 
exchanges all the acidic protons and after treatment
-  113 -
with sodium borohydride and cyclisation affords the 
pentadeuterioisocoumarin. This is then demethylated 
with BBr3 to give (103).
SCHEME 3.6
CHMeO MeOC02H
OMeOMe
(84) H
MeO CD HO CD.
OMe
(103)
Reagents: (i) AC2 0 , pyr; (ii) NaOH; (iii) HCIO4 ,
AC2 0 , EtoAc; (iv) NaOD, NaBH4 7 (v) BBr3
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3.3 Feeding of labelled 3,4—dihydro—6,8—dihydroxy—
3-methyl isocoumarins (50) + (103)
Growth of Gilmaniella humicola/ on the medium used by 
Bollinger et al^ 1 gave no detectable quantities of 
microline/ however, large quantities of 
dechloromicroline were obtained. The biosynthetic 
studies were performed on this compound. The two 
isocoumarins (50) and (103) were fed as their sodium 
salts to Gilmaniella humicola on day 4 of fungal 
growth.
w OH °
(50) (103)
The fungus was extracted on day 7 as described in the 
experimental section(Chapter 6 ). Dechloromicroline was 
isolated as an oil. It was necessary to convert the 
dechloromicroline (80) into a crystalline derivative
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which could be recrystallised to constant activity for 
the radioactive sample. Chexal and Tamm^ converted 
dechloromicroline (80) into the crystalline bislactone 
(104) by oxidation using Jones reagent. The 
dechloromicroline obtained from each feeding experiment 
was oxidised to the bislatone (104).
CH J
Jones
Reagent
OH
(80) (104)
3.3.1 Feeding results from isocoumarin (50)
The bislactone (104) was recrystallised to constant 
activity. The percentage incorporation of the 
dihydroisocoumarin (50) into the bislactone (104) and 
hence dechloromicroline (80) can be expressed as:
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% Incorporation = counts from bislactone (104)
-----------------------------  x 1 0 0 %
counts from isocoumarin (50)
From the results obtained (see experimental section) it 
was found that 8 .2 % of the radioactivity from the 
isocoumarin (50) was found in the bislactone (104). 
Therefore, the isocoumarin (50) was converted into 
dechloromicroline with an incorporation of 8.2%. The 
radioactive technique is a good method of determining 
percentage incorporation of postulated precursors into 
metabolites. However, it does not give any information 
about bonds that have been broken or remained intact in 
the conversion of the precursor to the metabolite. It 
was hoped that the results obtained from the feeding of 
the pentadeuterioisocoumarin (103) would give more 
information about the nature of the construction of 
dechloromicroline (80) and hence microline (79).
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3.3.2 Feeding results from the isocoumarin (103)
Before any feedings were carried out a 360 MHz 'H 
n.m.r. of the compound (104) was obtained and the 
protons were assigned as shown in Table 3.1.
The singlets which appear at 51.45 p.p.m. (3H) and 
66.06 p.p.m. (1H) were assigned to the protons at 
carbons 14 and 5 respectively.
The two doublets which appear at 5 5.22 p.p.m. and 64.07 
p.p.m. were assigned to the two protons at carbon-13 
since they show a geminal coupling constant of 11.45 
Hz. The proton which appears at 54.07 p.p.m. was 
assigned H-13a whilst the proton that appears at lower 
field was assigned H-13b. This is because H-13b 
occupies a region which is close to the oxygen atom 
between carbon-10 and carbon-11. This causes a 
deshielding of this proton and thus accounts for its 
appearance at lower field. The signal at 51.87 p.p.m. 
(3H) which has coupling constants of 0.8 Hz and 6.4 Hz 
was assigned to the protons attached to carbon-1. The 
larger value of J 6.4 Hz was due to coupling with H-2 
and the smaller value J 0.8 Hz was attributed to 
allylic coupling with H-3. The signals centred at 
56.13 p.p.m. and 66.09 p.p.m. were assigned to H-3 and 
H-2 respectively on the basis of the splitting pattern
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Table 3.1
Assignment, of 'H n.m.r. spectrum
Ha 7
1
CH,
Proton 5
CH3 -I 1.87 (3H, dd, J 0.8 and 6.4 Hz)
H-2 6.09 (1H, dq, J 6.4 and 15.8 Hz)
H-3 6.13 (1H, dq, J 0.8 and 15.8 Hz)
H-5 6.06 (1H, s)
H-8 a 1.76 (1H, dd, J 5.5 and 8.0 Hz)
H-8b 1.10 (1H, dd, J 4.9 and 5.5 Hz)
H-9 2.34 (1H, dd, J 4.9 and 8.0 Hz)
H-13a 4.07 (1H, d, J 11.4 Hz)
H-13b 5.22 (1H, d, J 11.4 Hz)
CH3-I4 1.45 (3H, s)
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and their coupling constants. The signal centred at 
56.09 p.p .m. has coupling constants of 15.8 Hz and 6.4 
Hz. The larger coupling constant J 15.8 Hz was due to 
coupling across the trans double bond with H-3 and the 
smaller coupling constant J 6.4 Hz was attributed to 
vicinal coupling between this proton and the methyl 
group. Similarly, the signal centred at 56.13 p.p.m. 
showed coupling of J 15.8 Hz and J 0.8 Hz. The smaller 
value was due to the allylic coupling with the methyl 
group. The signals at 51.10 p.p.m. andbl.76 p.p.m. were 
attributed to the protons at carbon-8 since both signals 
exhibit a coupling constant of 5.5 Hz which is 
characteristic of a geminal coupling in a three membered 
ring. Therefore, the signal centred at 52.34 p.p.m. was 
due to the proton attached to carbon-9. The assignment 
of the individual protons at carbon-8 was based on 
coupling constants between these protons and H-9. The 
larger value (J 8 Hz) arises through coupling between H-9 
and H-8a. These two adjacent protons are almost 
eclipsed which corresponds to a very small dihedral 
angle. The observed coupling constant is found to be in 
agreement to the value suggested for a dihedral angle of
0° from the Karplus equation.
A ^H n.m.r. of the compound (104) was obtained after the 
feeding of the pentadeuterioisocoumarin (103). The 
chemical shift values in ^H n.m.r. correlate directly
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with those in 'H n.m.r., therefore it is possible to 
know which protons had been substituted by deuterium in 
the final compound (104), on the basis of chemical 
shift.
The n.m.r. contained two peaks in the spectrum.
The two peaks were found at 51.83 p.p.m. and 56.13 
p.p.m. which corresponds to the three protons on 
carbon-1 and to H-3 respectively. This is obtained 
from comparison of the 'H n.m.r. spectrum of (104) with 
the n.m.r. spectrum of the same compound. There 
was no signal found at 56.06 p.p.m. in the n.m.r. 
spectrum which corresponds to H-5 and therefore shows 
that (103) had not been broken down to CD3CO2H and 
then incorporated into (23). The isocoumarin (103) is 
therefore incorporated into dechloromicroline intact.
These results support the biosynthetic pathway proposed 
in Scheme 3.1.
The isocoumarin (50) is an early intermediate in the 
biosynthesis of microline and dechloromicroline. Much 
work has to be done to establish latter intermediates 
which would help solve many of the questions associated 
with dechloromicroline biosynthesis.
The use of different isotopes of carbon has highlighted
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HO
OH
CD,
D D
*
(23)
CD
OH
OHCH
the benefits available to organic chemists as they try 
to understand biosynthetic pathways. The radioactive 
isotope gave a quantitative measure of how well the 
precursor (50) was incorporated into dechloromicroline 
(80). The use of stable isotopes e.g. and
showed that the molecule had not been broken down and 
was incorporated intact.
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3.4 Attempted Synthesis of 4-Chloroisocoumarins
The main problems encountered in synthesising 
4-chloroisocoumarins or indeed any 4-substituted 
isocoumarins are discussed in chapter 4.
A report by Tirodkar and U s g a o n k a r ^ - ^ 6  stated that 
when the ester (105) was treated with 2 moles of 
phosphorus pentachloride the 3-alkoxy-4- 
chloroisocoumarin (106) was formed.
CO.
R = Me or Et
COM
CO-H
C02H
O
(108)
Reagents: (i) PCI5 ; (ii) NaOH; (iii) H+
They found that treating the isocoumarin (106) with 
aqueous sodium hydroxide solution gave the carboxylate 
ion (107)
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which cyclised under acidic conditions to give 
phthalide-3-carboxylic acid (108). The mechanism of 
the cyclisation to the isocoumarin (106) from the 
half-ester (105) is thought to take place as follows:
H Cl
OR
(105)
(106)
Homophthalic acid (110) was used in a model study 
towards the synthesis of 4-chloroisocoumarins. This 
was obtained by oxidation of indene (109) using chromic 
acid.
A report by Becker et al^OQ states that chlorination 
of saturated carboxylic acids can be achieved in good 
yield using lead tetraacetate. Therefore, it was 
anticipated that the conversion of 4-carboxy-3,4- 
dihydro-3-methylisocoumarin (113) to 4-chloro-3,4- 
dihydro-3-methylisocoumarin (114) could be accomplished 
by using lead tetraacetate. The 4-carboxyisocoumarin
(113) was prepared by the analogous route used for 
3,5-dimethoxyhomophthalic acid (84).
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SCHEME 3.7
M
(109)
0) ocr-a- ccr
(110) (111) O
c o2h
c h 3
12
COjH
113.
c h 3
,114.
A
Reagents: (i) Cr0 3 ; (ii) CH3CCI (iii) AC20, pyr
(iv) H2 -Pd; (v) Pb(OAc)4, NCS, DMF.
The reaction conditions employed were identical to 
those used for the corresponding dimethoxy- 
derivatives. As found with the 3,5-dimethoxy-series 
the unsubstituted homophthalic anhydride (1 1 1 ) was not 
converted to 4-carboxy-3-methylisocoumarin (112) in 
good yield. Attempts to improve the yield of the 
synthesis of this isocoumarin (1 1 2 ) were not 
successful. Hydrogenation of isocoumarin (112) reduced 
the double bond to give the 3,4-dihydroisocoumarin
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(113). Replacement of the acid group was achieved by 
treatment of the isocoumarin (113) with
N-chlorosuccinimide and lead tetraacetate in a solution 
in dimethyl formamide yielding the 4-chloroisocoumarin
(114).
Encouraged by these results obtained for the model 
compounds/ it was envisaged that this synthetic 
strategy could be used to produce 4-chloro-3,4- 
dihydro-6 ,8-dimethoxy-3-methylisocoumarin (116). 
Demethylation using boron tribromide would yield the 
desired 4-chloro-3,4-dihydro-6, 8 -dihydroxy-
3-methylisocoumarin (83). The synthetic strategy 
analogous to the model study is shown in Scheme 3.8.
However all attempts to produce the 4-carboxydihydro 
derivative (115) failed. The hydrogenation reaction 
gave a variety of products and after much effort this 
route was abandoned.
Attempts to reduce the double bond using sodium 
borohydride resulted in decarboxylation producing 
3/4-dihydroisocoumarin (97).
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SCHEME 3.8
02HCO,H
CHMeCH3Me
MeOMe
(95) (115)
HO CHMeO. CH
OMe
M  (83)
Reagents: (i) H2 “Pd; (ii) Pb(OAc)4 , NCS, DMF;
(iii) BBr3
Due to difficulties encountered in the reduction of the 
double bond of the 4-carboxyisocoumarin (95) and also 
the problems encountered with the actual synthesis of 
the 4-carboxy derivative (95) it was decided to 
investigate alternative syntheses of 4-carboxy-3,4- 
dihydroisocoumarins.
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CHMeO
OMe 0
CHMeO
NaBH
OMe
(95) (97)
Hurd and Shah^O^ reported Stobbe condensations of 
dimethyl 3,5-bis (benzyloxy)homophthalate (117) with a 
variety of aliphatic aldehydes in the presence of 
sodium hydride to give the Stobbe half-esters of type 
(118). Treatment of these half-esters with acid gave 
the corresponding isocoumarins (119).
CO,CH
PhCH20
CHR
RCHOCO,CH C02H
PhCH PhCH20
117
PhCH20
i119
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In 1893 StobbeHO had demonstrated that when acetone 
and diethyl succinate were treated with sodium 
ethoxide, the expected acetoacetic ester type of 
condensation to give a $-diketo compound (120) or (121) 
did not occur. The main reaction product was the acid 
(122) formed by aldol condensation between the carbonyl 
group of the ketone and an a-methylene group of the 
ester.
0Et NaOEt 
OEt
CH
CH
(122)
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The success of the Stobbe condensation is not 
attributed to a high reactivity of the a-methylene 
group of succinic esters as shown by the failure of 
diethyl malonate to condense with benzophenone. The 
specificity of succinic esters in this reaction may be 
associated with the juxtaposition of a carbethoxy group
EtO
RO
CO?Et
RO
CO
OR
H©
C02Et
RO
CO,H
OR
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for ring formation. This would explain why esters of 
homophthalic acid were found to undergo the Stobbe 
condensation with a variety of aldehydes. The ester 
group is situated in such a way that ring formation 
occurs readily. This synthetic strategy was applied 
with a view to making the 4-carboxy-3,4- 
dihydroisocoumarin (115).
(110) M
c o2c h 3
00
COjHM
o
(113)
Reagents: (i) MeOH/SOCl2; (ii) CH3CHO, NaH;
(iii) H+
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Dimethylhomophthalate (123) was obtained by treatment 
of the corresponding acid with thionyl chloride and 
methanol. Reaction of this ester (123) with 
acetaldehyde should give the intermediate (124) which 
on treatment with acid will cyclise to the isocoumarin
However/ the condensation between dimethyl 
homophthalate (123) and acetaldehyde did not proceed 
smoothly and the desired intermediate (124) was 
obtained in poor yield. Attempts to improve the yield 
of this reaction were unsuccessful. A report in the 
literature stated that these condensations proceed in 
high yield if a few drops of ethanol are added.m 
This also proved fruitless.
Awad et al^-^ reported that treatment of the 
half-ester (126) with acetic anhydride and fused sodium 
acetate gave the corresponding isocoumarin (127).
(125) .
NaOAc
0
R = H (124)
R =Ar (126)
R = H (125) 
R = Ar (127)
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However, treatment of the half-ester (124) with acetic 
anhydride and sodium acetate gave a number of compounds 
by t.l.c. Again due to the low yielding reactions and 
uncertainty about some of the steps, this route was 
abandoned.
Thus it was thought that the way to the 4-chloro­
isocoumarins would be via the 4-hydroxyisocoumarins, 
via treatment with sulphuryl chloride.
CH CH3OCH,0 CHSO,CI
OCH
The synthesis of 4-hydroxyisocoumarins is discussed in 
chapter 4. Unfortunately a route to this type of 
compound was not developed and likewise a synthesis of
4-chloroisocoumarins was not obtained. Therefore, the 
question of whether chlorination occurs early or not in 
the biosynthesis of microline (79) and dechloro­
microline (80) remains unanswered.
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4. THE STRUCTURE OF PERIMACOL
4.1 Int.roduct.ion
Cryptosporiopsinol (45) and 5-chloro-3,4-dihydro- 
8-hydroxy-6-methoxy-3-methylisocoumarin (46) ars the 
main metabolites produced by the fungus Periconia 
macrospinosa. H e n d e r s o n ^ O  isolated three new 
chlorine containing metabolites (47), (48) and (49) in
minor quantities.
Cl
HO
(45)
Cl Cl OR
CHMeO
(46)
CHMeO
OR
R = H (47)
R =CH3 (128)
(48) (49)
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On the basis of spectroscopic data they were assigned 
the structures as shown. Structure (49) being the 
diastereomer of cryptosporiopsinol (45). The 
metabolite (47) was given the trivial name perimacol 
and after spectroscopic tests the structure was 
assigned. Henderson showed that perimacol gave a
OR
CHMeO
OR
R = H (47)
R = CH3 (128)
positive ferric chloride test and that it formed a 
dimethyl derivative (128) when treated with methyl 
iodide and silver oxide. This derivative was not 
ferric chloride active. There are two interesting 
features to note about the structure of perimacol (47)
1) the S-configuration at the 3 position
2) the cis orientation between the hydroxyl and 
methyl group at carbons 4 and 3 respectively.
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FIGURE 4.1
5-Chloro-3,4-dihdro-8“hydroxy-6-methoxy-3-methylisocoumarin (Curve 
perimacol (Curve B)
260 <+> 21240 300 320 340
(— )
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The absolute stereochemistry at C-3 was determined by 
utilising the technique of optical rotary dispersion 
(ORD). Much information has been obtained about 
structure, conformation, and configuration of organic 
compounds from measurements of optical rotation as a 
function of wavelength (i.e. optical rotatory 
dispersion). Like other phenomena involving 
interactions between electro-magnetic radiation and 
organic molecules, as in infrared, ultraviolet and 
n.m.r. spectroscopy, optical rotatory dispersion curves 
are quite sensitive to small changes in structure. 
Arakawall^ showed that dihydroisocoumarins having a 
3R-substituent gave rise to a negative Cotton effect 
near 260 nm. SteynH^ used the ORD technique to 
determine the absolute stereochemistry of
4-hydroxyochratoxin A (130), a metabolite of 
Penicillium viridicatum. The configuration at C-3 had 
also been established by degradation studies. The ORD 
curves of perimacol (47) and the major 
dihydroisocoumarin metabolite (46) of Periconia 
macrospinosa are shown in Figure 4.1.The ORD curve of 
the dihydroisocoumarin (46) shows a negative extremum 
at 269 nm and is similar to the curve obtained by 
Arakawall^ for a number of 3R substituted
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9  H R
PhCH
C02H ° OH 0
R = H (129)
R = OH (130)
dihydroisocoumarins. Similar curves were obtained by 
Steynll4 for ochratoxin A (129) and
4-hydroxyochratoxin A (130). On the basis of this 
result the dihydroisocoumarin (46) was assigned the R 
configuration at the 3-position.
Cl
OH 0
(46)
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The ORD curve for perimacol (47) shows a positive 
extremum at 267 nm and is almost the mirror image of 
the curve obtained for the major dihydroisocoumarin 
metabolite (46) of Periconia macrospinosa. On the 
basis of this result perimacol would appear to have the
S-configuration at the 3-position. Henderson 
postulated that the small coupling constant between H-3 
and H-4 (J 2 Hz) in the ^H n.m.r. spectrum was 
consistent with a dihedral angle of approximately 
60°. This agrees well with a cis orientation.^05 
Therefore, the structure proposed by Henderson is shown 
and is (3S5, 4S)-5-chloro-3,4-dihydro-4,8-dihydroxy-6- 
methoxy-3-methylisocoumarin (47).
HO,
C H O
CH
(47)
It would have been preferable to determine the absolute 
configuration of the new metabolite by degradation. 
However, owing to small amounts of material obtained, 
Henderson was unable to perform any degradation
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experiments on the metabolite. It is unusual that two 
similar metabolites perimacol (47) and the 
dihydroisocoumarin (46), of the same fungus, Periconia 
macrospinosa appear to have different configurations at 
the 3-position. The only structural difference is that 
perimacol (47) has a hydroxyl group at C-4. There are 
two possible explanations for the opposite ORD curves 
obtained.
1) The ORD technique is not rigorous. Although two 
opposite ORD curves were obtained for similar 
metabolites indicating opposite configurations, 
the stereochemistry may be the same.
2) In the biosynthesis of perimacol (47), the enzyme 
responsible for the hydroxylation at C-4 may 
require the methyl group to have an
S-configuration to allow the molecule to sit in 
the active site of the enzyme.
To unambiguously determine the structure, a synthesis 
of perimacol was thus investigated.
4.2 Synthesis of 4-Hydroxydihydroisocoumarins
Consultation with the literature revealed that the 
synthesis of 4 -hydroxydihydroisocoumarins has been 
little studied. Thus as well as a synthesis of
~  140 -
perimacol (47) being undertaken, it was hoped that a 
general synthesis of 4-hydroxydihydroisocoumarins could 
be found. Chatterjea e_t a l ^ ^  reported a synthesis of
4-oxodihydroisocoumarins. This synthesis, starting 
from 3,4-dimethoxyphthalic acid (131) is shown in 
Scheme 4.1.
SCHEME 4.1
CO?H CHQ
^ C H N ;
c o 2c h3CHO
OCH OCH OCH
(131) (132) (133J
Reagents (i) (a) AC 2 O, (b) MeOH (ii) (C0CL)2. CH 2 N 2 
(iii) H+
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Treatment of the half-ester (132) with oxalyl chloride 
and then diazomethane afforded the diazoketone (133). 
Heating the diazoketone (133) in dilute acid yielded
7,8-dimethoxy-4-oxodihydroisocoumarin (134). However, 
applying the same reaction sequence on the half-ester 
(13 5) the isocoumarin (134) is not formed. The ketone 
(136) is formed instead (Scheme 4.2).
SCHEME 4.2
C02Hc o2h CH
CHOCH OCH,
(1S!) (135)
CH,0‘
©O-
CH
C02CH3
^ c h n ,
o
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Substituting diazoethane for diazomethane it was 
anticipated that a synthesis of 4-oxo-3-methyl- 
dihydroisocoumarins could be obtained. The acid (90) 
was obtained by the route outlined in Scheme 
A Vilsmeier-Haack formylation of orcinol (87) gave the 
benzaldehyde derivative (137). This was protected as 
the dimethyl ether (138) by treatment with dimethyl 
sulphate and was subsequently oxidised to give the acid 
(90). Oxidation of this acid (90) with potassium 
permanganate gives the corresponding phthalic acid 
(139). However, after very low yields of the acid
(139) were obtained it was decided to investigate 
another route for the synthesis of 
4-hydroxyisocoumarins.
SCHEME 4.3
CH30.CHHOCHHO
CHOCHO
OH
(1S7)
OH
CH COzH
>CH^VM3 w\.n3
(90) (139)
Reagents: (i) POCI3 , DMF; (ii) Me2S0 4 ,
K2C03/ (CH3 )2CO 7 (iii ) KMn04
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Chatterjea et al115 also reported that treatment of
3,4-dihydroisocouinarin (140) with chromic acid gave
3-hydro-4-oxoisocoumarin (141) in poor yield. However, 
treatment of 3,4-dihydro-5,6-dimethoxyisocoumarin (142) 
by the same method gave 2,3-dimethoxyhomophthalic acid 
(143).
(140)
CrO
O
(141)
OCH
c h 3o .
O
(142)
o c h 3
CrOj CH3° - v ^ v ^ C 0 ,H
(143)
Bertie-7 investigated the reaction of trans and cis 
stilbene-2-carboxylic acid (144 R=Ph) with organic 
peroxides and discovered that the
3,4-dihydro-4-hydroxy-3-phenylisocoumarins (145 R=Ph) 
were formed. No evidence was obtained for the 
formation of the corresponding epoxides. It was found 
that treatment with base opened the lactone which
- 144 -
recyclised to give the phthalide derivative (146 R=Ph) 
under acidic conditions.
R = Ph (144)
v
R = Alky I
0
R = Ph
HO
O
R= Ph (145) R=Ph(l46)
R=CH,(U7)
However, when R was alhyl, no formation of the 
4-hydroxyisocoumarin was observed. The phthalide 
derivative (147 R=Me) was produced solely. Since it is 
believedH^ that the compounds (145) and (147) are 
formed from their epoxides (148 R=Ph), (149 R=Me), 
these results suggest that for 4-hydroxyisocoumarin
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formation, R needs to be a group capable of supporting 
a positive charge. It can be seen that this route 
could not be used in a synthesis of perimacol (47). 
Therefore a new synthesis of 4-hydroxyisocoumarins was 
investigated.
4.3 Synthesis of 4-Alkoxyisocoumarins
6,8-Dimethoxy-3-methylisocoumarin (96) is formed by the 
treatment of the keto-acid (102) with acid. This 
keto-acid (102) is synthesised from 3,5-dimethoxyhomo- 
phthalic acid (84) as described in Chapter 3.
J
By synthesising the corresponding keto-acids (153) and 
(154) from their homophthalic acids (150) and (151) it 
was hoped that the desired isocoumarins (156) and (157) 
could be formed. Grovel-8 has shown that the 
diketone compound (158) ring closes to the phthalide 
derivative (159). In a similar manner it was 
anticipated that the keto-acid (152) would also ring 
close giving the phthalide derivative (155). It was 
hoped that by forming the more stable ether derivatives 
(153) and (154) the possibility of cyclising to the 
phthalide derivative (155) under acidic conditions 
would be reduced. The required isocoumarins (156) and
(157) would be formed instead.
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MeO
CO,H
OMe 0
OROR
MeO CHMeOMeO
OMe
MeO
OMe
Henderson^O synthesised the dimethyl ether of 
perimacol (128) by treatment of perimacol (47) with 
methyl iodide and silver oxide. Converting the methyl 
ether derivative (150) to the 4-methoxyisocoumarin 
(156) followed by chlorination would give the dimethyl 
ether of perimacol. A. comparison could be made between
-  147 -
(158) (159)
synthetic product and the naturally derived product
MeOH
CHCH MeOMeO C H J
AgO
OMeOH
(47) (128)
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OR Cl OR
MeO
OR
C02H
c o2h
M<
MeO
OR 0
R = CH3 (128) 
R=H (47)
OMe
R=CH3 (150) 
R =CH2Ph (151)
OMe 0
R = CH3 (156) 
R = CH2Ph (157) 
R =H (160)
By synthesising the benzyl ether (151) and converting 
to the 4-benzyloxyisocoumarin (157) followed by removal 
of the protecting group it was anticipated would give 
the 4-hydroxyisocoumarin (160). Selective 
demethylation of the dimethoxy-4-hydroxyisocoumarin
(160) and chlorination would give perimacol (47). Thus 
it was hoped that this synthetic strategy could be used 
as a general route towards the synthesis of
4-hydroxyisocoumarins.
The strategy proposed for the synthesis of the 
substituted homophthalic acid compounds (150) and (151) 
is outlined in Scheme 4.5. The synthesis of ethyl 
orsellinate (161) is outlined in Chapter 5. The key 
step in the synthesis of the required compounds (150) 
and (151) is the monobromination of the dimethyl ether 
of ethyl orsellinate (162) to give (163). The ether
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SCHEME 4.5
CO,Et Br
(86)
+
o o
(85)
CHHO HO
CO,Et
OEt OH
CHMeOCHHO
C02Et
OMe
(162)
OH
M
MeO.
OR
MeOMeO
C02HOR
OMe
R = CH3 (164) 
R=CH2Ph (165)
r=ch3 (150)
R=CH2Ph(l5l)
Reagents: (i) Br2 / HOAc; (ii) Raney Nickel;
(iii) Me2S04# K2C03, (CH3)2CO; (iv) NBS,
CC14; (v) MeOH or PhCH2OH (vi) KOH (vii) LDA,
Me2CO3
CH*
C 02Et
^ ■ B r
C02Et
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(162) is obtained by treatment of ethyl orsellinate
(161) with dimethyl sulphate and potassium carbonate.
It was thought that nucleophilic substitution of the 
bromide by a suitable alkoxide ion followed by 
hydrolysis would give the appropriate ethers (164) and 
(165). These ethers it was envisaged could be 
converted to the required substituted homophthalic acid 
derivatives (150) and (151) by treatment with lithium 
diisopropylamide and dimethylcarbonate followed by 
hydrolysis.
However, when the dimethyl ether of ethyl orsellinate
(162) was refluxed with ^-bromosuccinimide (NBS) in 
carbon tetrachloride under the irradiation of U.V. 
light a mixture of products was formed. Using exactly 
one equivalent of NBS, there was a mixture of the 
required monobromo compound (163), the dibromo 
compounds (166) and starting material (162). Varying 
the reaction conditions always resulted in a mixture of 
products. The bromination of compounds using NBS is 
known to proceed via a radical type mechanism. 
Generally, it is known that in compounds with an active 
nucleus, side-chain bromination predominates in the 
presence of a catalyst such as dibenzoyl peroxide. 
Similarly, nuclear bromination predominates in the 
absence of a catalyst. In a review by PizeyH^ 
several examples are given where di- or
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poly-bromination occurs. For the dimethyl ether of
ethyl orsellinate (162) side chain bromination occurs 
predominately. Therefore, the occurrence of the mono- 
and dibromo- compound (163) and (166) as well as >
starting material must be related to the similar 
stability of the radical intermediates involved (167) 
and (168). Due to the low yield obtained for the 
monobromo compound (163), it was decided to investigate 
an alternative route to the required homophthalic acid 
derivatives (150) and (151).
The sequence of reactions involved in the synthesis of 
the homophthalic acid derivatives is outlined in Scheme 
4.6. The starting material for the synthesis is the 
commercially available 3,5-dihydroxybenzoic acid
(169). Methylation with dimethyl sulphate and 
potassium carbonate gave methyl 3,5-dimethoxybenzoate
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MeO MeOCHMeO.
OEtOEt C02Et
OMe
OMe
OMe O,
(167) (163)
Br
OMe
Me Mei Br
OEtOEt
OMe O OMe 0
(166)
(170). Reduction with lithium aluminium hydride in 
anhydrous THF gave 3,5-dimethoxybenzyl alcohol (171). 
Trost et al -^20 showed that treatment of 
3, 5-dimethoxybenzyl alcohol (171) with n-butyl lithium 
in the presence of tetramethylethylene diamine followed 
by carboxylation afforded 5,7-dimethoxyphthalide (173) 
in moderate yield. When this reaction was repeated by 
Noire and Franck, the phthalide (173) was produced in
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SCHEME 4.6
Me<M e o ^ ^ c o 2MeHO OH
OMeOMe
(170)
OH
(169) 171
Me Me<(iii) OR
OMe OMe
(172) R = C H 3 (175) 
R = C H 2Ph (176)
OR
MeO-Me OR
C02H
OMeOMe
R=CH3 (164) r = ch3 (150}
R = CH2Ph(l65) R = CH2Ph (151)
Reagents: (i) Me2S0 4 / K2CO3 , (CH3 )2CO;
(ii) LiAlH4; (iii) Br2 / C1CH2CH2C1; (iv) Mel or 
PhCI^Cl, NaH (v) l)nBuli, 2 )C0 2 , (vi) LDA, 
Me2C03/ H2O.
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OMe 
R = H (171) 
R = Br (172)
nBuLi, C02---------i---►
TMEDA
8% yield, ^-21 However, they found that treatment of 
2-bromo-3,5-dimethoxybenzyl alcohol (172) with n-butyl, 
lithium followed by carboxylation gave the phthalide 
derivative (173) in 75% yield. The increase in yield 
is due to direct metal-halogen exchange of the lithium 
for the bromine which is known to occur rapidly at low 
temperatures.122-124
It has been shown that lithium exchange can occur 
between two methoxyl groups-L25 giving rise to an 
intermediate such as (174) which can be further treated 
with a variety of electrophiles giving required 
substitution between the methoxyl groups.
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Me< MeO
OMe OMe
(174)
In the proposed synthesis of the acids (164) and (165), 
the brorao ethers (175) and (176) were thought to be key 
intermediates. Treatment with n-butyl lithium would 
lead to direct metal halogen exchange thus reducing the 
possibility of lithium exchange between the two 
methoxyl groups. Regioselectivity could be effected by 
treatment of these lithiated species with carbon 
dioxide.
These bromo-ethers were synthesised in two steps from
3.5-dimethoxybenzyl alcohol (171). Treatment of
3.5-dimethoxybenzyl alcohol (171) with bromine in
1,2-dichloroethane gave 2-bromo-3,5-dimethoxybenzyl 
alcohol (172) in 70%. When the benzyl alcohol (172) 
was treated with either methyl iodide or benzyl
- 156 -
MeO OR
nBuLi OMe
MeO OR
nBuLi
MeO
OR
Me
chloride and sodium hydride the required ethers (175) ■ 
and (176) were formed respectively. Treatment of these 
benzyl ethers (175) or (176) with n-butyl lithium at 
-78 °C followed by quenching with carbon dioxide gave 
the corresponding acid derivatives (164) or (165)
OCH
MeO / N p i j  MeO'
3 LDA , Me,CO,
H20c o 2h c o 2h
OMe Me
(164) (150)
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respectively in 75% yield. Treatment of acid (164) 
with lithium diisopropylamide and dimethyl carbonate 
followed by hydrolysis afforded the desired 
a,3/5-trimethoxy homophthalic acid (150). This 
compound was used in the synthesis of the dimethyl 
ether of perimacol.
4.4 Synthesis of the Dimethyl Ether of Perimacol
As described in Chapter 3, treatment of 3,5-dimethoxy 
homophthalic acid (84) with pyridine and acetic 
anhydride followed by base hydrolysis gave after 
work-up the keto-acid (102). This was cyclised to the, 
isocoumarin (96) by treatment with perchloric acid and 
acetic anhydride in ethyl acetate. Therefore/ applying 
this synthetic strategy to the homophthalic acid 
derivative (150) should give the 4-methoxyisocoumarin 
(156) via the keto acid (153).
Howeverf when a,3,5-trimethoxyhomophthalic acid (150) 
was treated with acetic anhydride and pyridine at room 
temperature followed by base hydrolysis/ only a small 
amount of the required keto-acid (153) was produced.
The major component was starting material. A small 
amount of another product was present which was shown 
to be 4/6/8-trimethoxyhomophthalic anhydride (177).
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CHCHMeOMeO-
C02H
OMeOMeOMe
MeO
R = H M
R = OCH, (150)
R = H (102) 
R = OCH3 (153)
R = H (96)
R=OCH3 (156)
Reagents: (i) AC20, pyr; (ii) NaOH/ reflux;
(iii) HC104/ A<20/* EtOAc.
4,6/S-Trimethoxy-S-methylisocoumarin (156) was formed 
in 64% directly from a,3,5-trimethoxyhomophthalic acid 
by refluxing in a solution of acetic anhydride and 
pyridine.
OR
c h 3MeO
>Me
MeO
(177) R=H (47) 
R=CH3 (128)
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Henderson assigned the structure of perimacol (47) and 
its dimethyl ether (128) as shown. Reduction of the 
double bond of 4,6,8-trimethoxy-3-methylisocoumarin 
(156) by catalytic hydrogenation would give the 
required relative cis stereochemistry between the 
methyl and methoxyl groups. This was achieved in very 
good yield. Chlorination of 3,4-dihydro-4,6,8- 
trimethoxy-3-methylisocoumarin (178) with sulphuryl 
chloride yielded the synthetic perimacol dimethyl ether 
(179) with relative cis stereochemistry.
OMe OMe Cl n M n
MeO CH
(178) (179)
9 ' o r
MeO. C H
R =  H (47j 
R =  CH3 (128)
Reagents: (i) H2~Pd; (ii) SO2CI2
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Comparing the n.m.r. of the synthetic dimethyl 
ether of perimacol (179) with that from the natural 
product (128) revealed that they were different. 
Although the two n.m.r.'s were very similar the major 
difference was found to be the chemical shift of the 
methyl doublet. In the synthetic product (179) the 
value was 51.53 p.p.m. whereas in the dimethyl ether of 
the natural product (128) the methyl doublet appeared 
at higher field at 51.14 p.p.m.8C* This suggests that 
the methoxyl and methyl groups of the natural product 
do not have a cis configuration for the substituents at 
carbons 4 and 3 respectively.
The spectroscopic data of the synthetic compound (179) , 
is consistent with the structure proposed for the 
dimethyl ether of perimacol (128). However, the 
chemical shift of the methyl doublets of the two 
compounds differed by O.fyp.p.m. Therefore, it is 
proposed that a trans arrangement exists between the 
methyl and methoxyl groups at carbons 3 and 4 
respectively.
Synthetically a trans arrangement between the methyl 
and methoxyl groups at carbons 3 and 4 could be 
achieved by reduction of the isocoumarin (156) with 
sodium borohydride in aqueous sodium hydroxide 
solution. When 4,6,8-trimethoxy-3-methylisocoumarin 
(156) was reduced with sodium borohydride the h^
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n.m.r. spectrum revealed that a 2:1 mixture of 
trans:cis isocoumarins (182) and (178) had formed.
OMeOMe OMe
CH3 MeOMeO.MeO
OH
ca
OMe
CH,
iMe OMe
CH3 © Me CHMe*
NaBH
CO-
Me
(181) (178J - C|s
(182) — trans
In basic solution the lactone of the isocoumarin (156) 
opens to give the acid derivative (180). This 
derivative tautomerises to give the ketone (153) which 
is reduced by sodium borohydride to yield the alcohol
(181). On treatment with acid cyclisation occurs 
forming the dihydroisocoumarins (178) and (182).
162
The reduction of Xetones using either sodium 
borohydride or lithium aluminium hydride in most cases 
gives the trans product as predicted by Cram's
represented as in (183), where S, M and L stand for 
small, medium, and large substituents respectively.
The oxygen of the carbonyl orientates itself between 
the small and the medium sized groups. The hydride 
attacks from the less hindered side i.e. the side 
containing the small group. Thus (184) will be formed 
as the major component and (185) as the minor 
component. In some cases the reduction is 
stereospecific. The stereochemical outcome of the 
reduction of ketones is generally known as the Rule of 
Steric Control of Asymmetric Induction.
rule.126,127 molecule is observed along its
axis it may be
0 oz oz
L L L
(183) (184) (185)
A report by Regan and S t a u n t o n ^ S  stated that a 
mixture of diastereomeric isocoumarins (186) and (187) 
could be converted to the isocoumarin (187) by a three
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CHCH
CH3 CHMeiMe
Me
CH
CHMeO
C02H
OMe
(188)
Reagents: (i) LiOH(aq); (ii) PDC; DMF; (iii) NaBH4 /
MeOH
step sequence. The key reaction is the reduction of 
the ketone (188) with sodium borohydride giving the 
solely trans product (187). The mixture was first 
hydrolysed to give the corresponding alcohols which 
were then oxidised to give the ketone (188). 
Stereoselective reduction of this ketone gave the trans 
isocoumarin (187). Applying Cram's rule to this ketone 
(188) the predicted product of reduction is in fact the
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isocoumarin with the two methyl groups trans to each 
other.
CH
CHMeO.
CO,H
OMe
(188)
"St1'
Ph 
(188)
However, borohydride reduction of the a-methoxy-ketone 
(156) followed by cyclisation gave a 2:1 mixture of 
trans:cis substituted isocoumarins (178) and (182).
The rule of asymmetric induction usually requires 
modification when the a-carbon bears polar substituents 
such as OH, or NH2 . The assumption that only 
torsional strain and steric interactions determine the 
favoured transition state is no longer valid.
CH
CHHO
Ph
(187)
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MeMeMe
CH CHMeOCH MeOMeO
Me OOMe
(156) (153) (178) —  cis 
(182) — trans
MeO
MeO
MeO OHCHCHHO
PhCH Ph
Ph
(153)
(182)
2
(178)
During the reduction of the a-methoxyketone (153) with 
borohydride, the oxygen of the methoxyl group can form 
a complex (189) with the reagent. The boron atom is 
now co-ordinated between the oxygen of the methoxyl 
group and the oxygen of the carbonyl group. The 
incoming hydride ion can attack from either side of the 
molecule. The most favoured mode of attack gives the 
trans product (182). The a-carbon is not sterically 
congested. Therefore, there is little differentiation 
between the planes of the molecule and the hydride can 
attack from either side. This results in an unusually
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CH
Ph
H
©
HO— BH3
\
c h3.
Ph
►
H
CH,
(153)
H H
\©/
©/B-H
0 \>
IIc.
CH,
©
bh2
c h 3>©/ \
O ow
(aK 0 N
(189)
Cl OMe
MeO CHHMeO 3 SO,CI
iMe
(178) - cis 
(l82] — trans
CIS(179) -
(l90) — trans
large amount of cis compound being formed.
The two diastereoisomers could not be separated, and 
therefore the mixture was chlorinated in the same 
manner as before using sulphuryl chloride giving the 
chlorinated isocoumarins (179) and (190). Similarly, 
this mixture of diastereoisomers could not be 
separated.
The 1h n.m.r. of the synthetic mixture was obtained. 
Subtracting the peaks that could be assigned to the cis 
compound (179) enabled a direct comparison to be made
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OR
MeO. CH
R= H (47} 
R = CH3 (128)
OMe
MeO CH
OMe 0
(1*0)
with the trans isocoumarin (190) and the dimethyl ether 
of the natural product (128). The 1h n.m.r. of the 
synthetic product (190) matched the n.m.r. of the 
dimethyl ether of the natural product (128).
Therefore, it has been shown synthetically that there 
exists a trans configuration between the methyl and 
methoxyl groups at carbons 3 and 4 respectively in the 
dimethyl ether of the natural product (128). Likewise, 
a trans configuration must also exist between the 
methyl and hydroxyl groups in perimacol (47). Thus the 
original structures proposed by Henderson for perimacol 
(47) and its dimethyl ether (128) in which a cis ' 
configuration between the groups at carbons 3 and 4 was 
suggested has now been shown to be incorrect.
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Examining the chemical shifts between the methyl 
doublet of the relative cis compound (179) and the 
methyl doublet of the relative trans compound (190) 
revealed a significant difference. The chemical shift
OMe
CHMeO.
OMe 0
Cl OMe
CHMeO
OMe 0
(179)— cis (190)— trans
obtained for the cis compound agrees with other similar 
isocoumarins with a cis configuration between 
substituents at carbons 3 and 4. For natural products 
with a cis configuration, the methyl group adopts a 
pseudo-equatorial site. Therefore, for the relative 
cis isocoumarin (179) which has a similar chemical 
shift value of its methyl doublet to other cis 
isocoumarins (33), 67,129 (1 9 1 ),130 (192),!32 
(1 9 3 ), ^ 32 is reasonable to assume that the methyl 
group will adopt a pseudo-equatorial site.
For the relative trans isocoumarin (190) however, the 
methyl doublet at 51. >4 occurs at slightly higher field 
which suggests that the methyl group is experiencing a
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CH3 CH:
>CHHO
(192)
c h3 CH,
h o 2c
(193)
slight shielding effect. For this to occur the methyl 
group must be adopting a pseudo-axial conformation.
When in the pseudo-axial conformation, the methyl group 
can occupy a region in space which overlaps the 
shielding ranges for a carbonyl group and an aromatic 
ring. This causes the methyl group to experience a 
slight shielding effect. Hence, the trans compound 
appears at slightly higher field. Therefore, the 
difference in the chemical shift values obtained for 
the methyl doublets in the cis and trans compounds can 
be explained by the methyl group adopting different 
conformations.
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Now that a trans arrangement has been shown to exist 
between the two groups at carbons 3 and 4, the 
structure of perimacol can be either (194) or (195).
Cl OR
MeO.
OR
H,
OR
CHMeO
(194) R = H (195) R = H
(190) R = Me (196) R = Me
In a similar manner the structure of the dimethyl ether 
can be (190) or (196). As mentioned earlier in this 
chapter Henderson^ had assigned the stereochemistry 
at carbon-3 to be S because this compound had an 
opposite ORD curve to the isocoumarin (46). The sign 
of the ORD curve of isocoumarin (46) is equal to that 
of ochratoxin A (129). Ochratoxin A was shown to be R 
at carbon-3 by degradative studies. Therefore, the 
isocoumarin (46) was assigned R at this centre. On
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this basis the structure would be (195) and its 
dimethyl ether (196). However, ORD is not a rigorous 
technique and it will be shown that the correct 
structure of perimacol is (194) in which there is R 
stereochemistry at carbon-3.
Cl
►CHMeO
OH
PhCH
,CH
r «
c o 2h OH
(46) (129)
An alternative way of using ORD data makes use of the 
octant rulel33 This is a generalisation which is 
essentially qualitative and relates the sign of the ORD 
curve with the configuration or conformation of a 
carbonyl compound.
Three mutually perpendicular axes, x, y, and z divide 
the region of the carbonyl group into eight octants.
The carbonyl group is the x-axis with the two other 
axes drawn through the midpoint of the double bond see
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+Z
+X
+Y
f ig  4-1
Fig. 4.1. The molecule is then viewed from the side , 
nearest the oxygen atom. The octants are a result of 
the three planes dividing the region of the carbonyl 
group. The front four octants are ignored since 
usually no atoms lie in front of the carbonyl group. 
Therefore, in the octant rule it is only the back four 
octants which are considered.
It is useful to consider the projection when 
cyclohexanone is drawn with the carbonyl at the bottom 
of the molecule. This can be seen in figure 4.2a. in 
which the projections of the axial and equatorial bonds 
are also shown. The signs obtained for the octants in 
Fig. 4.2b.are a result of the product of a given atoms
- 173 -
a a
upper left »*PPer right
+
+
lower left lower right
4-2a 4-2b
co-ordinates. Thus atoms lying in the upper left and 
lower right make positive contributions to the ORD 
curve. Atoms in the upper right and lower left make a 
negative contribution. Hydrogen atoms are ignored 
since their contributions are insignificant.
Equatorial substituents on either ot-carbon (with 
respect to the carbonyl carbon) make no contribution 
since they lie on the y-axis and one of its 
co-ordinates is equal to zero.
Applying the octant rule to the compounds (46) and 
(190) the following observations were made. In the
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isocoumarin (190) the methoxyl group at carbon-4 
whether axial or equatorial will lie on the z-axis (see 
figure 4.3). Therefore, the product of its 
co-ordinates will
Cl
OHMeO
OH
(46)
OMe
CHMeO
OH
(190)
Cl
r©0 CH3
CH
OH
i-rO
CH,
CH,
upper left upper right
-h
lower left lower right
fig4-3
-  175 -
be zero. This means that the methoxyl group will make 
no contribution to the sign of the ORD curve.
Similarly, since the aromatic ring is planar and lies 
along the y-axis this also makes no contribution to the 
sign of the ORD curve. Therefore, the sign of the ORD 
curve will be determined by the methyl group at 
carbon-3.
For the isocoumarin (46), the ORD curve has the same 
sign as the ORD curve for ochratoxin A (129) which from
CH
PhCH
co2h OH
(129)
degradation studies has been shown to have the •
R-configuration at C-3. Therefore, the isocoumarin 
(46) has an R-configuration at C-3 and also the methyl 
group adopts a pseudo-equatorial conformation at this 
carbon. Applying the octant rule to this molecule 
reveals that the methyl group occupies the bottom right 
hand octant.
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For the trans compound (190) the n.m.r., chemical 
shift and coupling constant (J 2Hz) strongly suggest 
that the methyl group is occupying a pseudo-axial 
site. If the octant rule is applied to this compound 
with the R-stereochemistry at C-3 maintained (as in 
(190) with the methyl group adopting a pseudo-axial 
conformation) it can be seen from diagram 4.3 that the 
methyl group occupies the top right octant. This 
predicts that structure (190) will have an opposite ORD 
curve to that of the isocoumarin (46). Compounds (46) 
and (190) have 3R-configurations but different 
conformations at carbon-3. Application of the octant 
rule predicts that these compounds should have opposite 
ORD curves. This agrees with the ORD curves obtained 
experimentally.
The -^-H n.m.r. data is consistent with the methyl 
group adopting a pseudo-axial conformation. If the 
octant rule is applied to the isocoumarin (196) with 
S-configuration at C-3 and with the methyl occupying a 
pseudo-axial site the following observation was found. 
The methyl group of compound (196) occupied the same 
octant as the methyl group of the isocoumarin (46). 
Isocoumarin (46) has 3R-configuration with the methyl 
group pseudo-equatorial. If the isocoumarin (47) 
isolated had the S-configuration at C-3 with the methyl 
group adopting a pseudo-axial site then the ORD curves
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Cl
CHMeO
OH
(46)
Cl
eo
OH
OH
Cl MeO
MeO CH
OH
(196)
►Me
MeO
CH.
OH
of this isocoumarin (47) and the natural product (46) 
would have been the same. The fact that different ORD 
curves are obtained is because the isocoumarins (46) 
and (190) have the same configuration at C-3 but have 
different conformations at this carbon. Hence the 
structure of perimacol is (194) and likewise the 
structure of the dimethyl ether is (190).
Further evidence for these conclusions is contained in 
a report by Okunu et al1^4 who were studying
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Cl 9 OH
MeO CH MeO
OH 0
CH
(46) (47)
metabolites produced by the fungus Valsa ceratosperma. 
They isolated the new isocoumarins (197) and (198) and 
observed similar chemical shifts for the methyl
doublets as had been observed for the corresponding 
doublets in the cis dimethyl ether (179) and the trans 
dimethyl ether (190). Opposite ORD curves were 
obtained for the isocoumarins (197) and (198). The cis 
isocoumarin (197) had a similar ORD curve to the
Cl OR
OR 0
R = H (194)
R = Me (190)
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CH, OH
CH
OH
(197)
CH3 o h
CH
(198)
Cl OMe
MeO
OMe
(179)
OR
OHMeO
OR
R = Me 
R=H (:94
MeO
Cl
CH
OH
(46)
isocoumarin (46) and the trans isocoumarin had a 
similar ORD curve to perimacol (194). This is further 
evidence that for a trans isocoumarin, opposite ORD 
curves can be obtained which can be related to the 
conformation of the methyl substituent at carbon-3, 
whilst the configuration is the same.
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Cl OR OMe
MeO
O
CH MeO
OMe
CH
OR
R = H (194) (182)
R = CH3 (190)
The small coupling constant between H-3 and H-4 in the 
dimethyl ether of perimacol (190) and hence perimacol 
(194) can be explained.
The coupling constant between H-3 and H-4 (J 7Hz) in the 
isocoumarin (182) agrees well with the Karplus 
equation^-^ for a dihedral angle of approximately 
150°. However, the introduction of a bulky chlorine 
atom at carbon-5 in (190) causes a conformational 
change of the molecule. The dihedral angle between 
H-3 and H-4 is reduced to approximately 60° thereby 
giving a smaller coupling constant. The 
conformational change that has occurred is due to the 
steric interaction between the methoxyl group at 
carbon-4 and the chlorine atom at carbon-5. The 
chlorine atom forces the methoxyl group into a more
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axial-like conformation thereby causing H-4 to move 
into a more equatorial like conformation. The dihedral 
angle is reduced resulting in a smaller coupling 
between H-3 and H-4.
4.5 Attempts to Synthesise 4-Hydroxyisocoumarins
A synthesis of the ethers (164) and (165) was reported 
earlier in this chapter. The methyl ether (164) was 
converted to the homophthalic acid derivative (150) and 
subsequently converted to the dimethyl ether of 
perimacol (190). It was anticipated that application 
of the same reactions to the benzyl ether (165) would 
lead to the isocoumarin (157). This could be converted 
to the 4-hydroxyderivative (160) which after further 
reduction, demethylation and chlorination would yield 
the synthetic perimacol (194). However, when the benzyl 
ether (165) was treated with LDA and dimethyl carbonate 
no clean isolable product was obtained. A number of 
products may be formed from the dianion species (I) 
which could react with the dimethyl carbonate. It was 
thought that the species (II) would be the more stable 
since the negative charge can be delocalised by the 
aromatic ring and the carboxyl group. Due to the 
number of products formed, it is suggested that 
competing reactions are taking place.
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OMe
OMe
MeO COoH MeO. CHOR
CO,H
OMeOMe OMe
R=Me (164) fi50] (190)
R=CH2Ph (165)
OHOR
CHMeOCHMeO
OH
(194)
It was hoped that the 4-hydroxyisocoumarin (160) could 
still be synthesised by employing a different 
protecting group. The t-butyldimethylsilyl (TBDMS) 
protecting group was chosen due to its stability in 
basic conditions. Treatment of 2-brorno-3, 5- 
dimethoxybenzylalcohol (172) with t-butyldimethyl- 
silylchloride and imidazole in DMF yielded the TBDMS
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MeO
CO.
OMeMeO
OCH2Ph
©
Ph
OMe
MeO
OMeO
ether (199). This was treated with n-butyllithium 
followed by carbon dioxide to give the acid (200). An 
n.m.r. of the crude product suggested that the desired 
compound had been formed. However, after column 
chromatography, the acid cyclised to the undesired 
phthalide derivative (173). This highlights the main 
problem in synthesising 4-hydroxyisocoumarins.
t
Although the 4-hydroxyisocoumarin (160) was not 
synthesised via the homopthalic acid route, it appears 
to be the most promising synthetic route to these types 
of compound. By the choice of a suitable protecting
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MiO
x c
OMe 
(172)
OH
MeO" Y ^ Y ^ otbdms
OMe
(199)
Me
°v r^rVs|i^ ^ o t b d m s
^ Y ^ ^ C0 2H
OMe
(200)
group, this route could be employed to synthesise a 
number of novel 4-hydroxyisocoumarins.
-  185 ~
5. ISOTOPE SHIFT STUDIES
5.1 Introduction
The isocoumarin (201) isolated after the feeding of 
CD3~13c02Na to Periconia macrospinosa gave an 
interesting ^-shift result.
cosx
CARBON
MeO-
OH
3
4a
8
0 04, 0 08, 0-12 
0 03, 0 07, 0-10 
004
(201)
In the 13C n.m.r. spectrum of the isocoumarin (201), 
the signals for carbons 3, 4a and 8 showed upfield 
shifted signals due to the presence of ^-deuterium 
atoms. These shifted signals are commonly called
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^-shifts. ^-Shifts were observed for the signal due to 
carbon-3 of 0.04, 0.08 and 0.12 p.p.m. indicating the 
presence of 1, 2 and 3 deuterium atoms at carbon 9 
respectively. A ,3-shift was also observed for the 
signal from carbon-8 which was due to a deuterium being 
present at carbon-7. Interestingly ^-shifts observed 
for carbon-4a showed shifts of 0.03 p.p.m., 0.07 p.p.m. 
and 0.10 p.p.m. This result suggests that a deuterium 
adopting an axial conformation is producing one shift 
and a deuterium adopting an equatorial conformation is 
producing another. The third shift (0.10 p.p.m.) is 
the additive value of the other two shifts and is 
observed when there are two deuterium atoms present at 
carbon-4. Thus it was decided to investigate this 
further. In particular, to assign unambiguously the 
shifted signals arising from the equatorial and axial
deuterium atoms causing the shift.
5.2 Isotope Effects of Nuclear Shielding
Isotope effects have been known for a long time and
several reviews e x i s t . 135-142 ^  was found that the
size of the shift is related to the distance the 
isotope is from the nucleus under observation and to
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the shielding range of the resonant nucleus.
Therefore, it is observed that the largest isotope 
shifts occur when there is a large change in mass upon 
substitution. In general the size of the isotope 
nuclear shielding is related to the number of atoms 
which have been isotopically substituted. Isotope 
effects can occur over one, two or three bonds, giving 
rise to the a, $ or y shifts respectively. The shifts 
can be observed over more than three bonds, but it is 
generally a rare occurrence.
In this study, the effects of deuterium on the chemical 
shifts of 13c nuclei have been studied. The size of 
the isotope effect depends on the hybridization of
atoms, i.e. sp2 or sp3, involved at the observed
/
carbon and at the carbon bearing deuterium. In the 
following sections the hybridization at the observed 
carbon and the carbon bearing deuterium are signified 
by the notation Csp3D Csp3 etc.
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5.3 Deirterium Isotope Effects on 13c Nuclear
Shielding
5.3.1 Csp3p Csp3 systems
5.3.1.1 q-shifts in Csp3p Csp3 systems
Generally it has been found for deuteriated methanes 
that an isotope effect of +0.187 p.p.m. per deuterium 
is common. These values have been shown to be 
a d d i t i v e . 1^3 effect of +0.36 p.p.m. per deuterium
has been observed for straight chain 
-CD2 ~groups. in the case of cyclohexanes larger 
values have been observed.145,146 interestingly, an 
axial and an equatorial deuterium have been shown to 
give different a-shift values in cyclohexane. It has 
been demonstrated that the smaller shift is due to the 
deuterium occupying the equatorial s i t e .  -^46,147
5.3.1.2 >6-Shift.s in Csp3p Csp3 systems
The effect over two bonds - known as the ,3-shift - is 
smaller than the corresponding a-shifts and is less 
than 0.1 p.p.m. The line broadening that is caused by 
unresolved carbon deuterium coupling is in most cases 
negligible as 2j (c_1h ) and hence 2j (C-D) are 
small. For saturated open chain hydrocarbons ^-shift
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values are approximately + 0 .0 8  p . p . m . 145 For cyclic 
hydrocarbons, the values are slightly greater than +0.1 
p.p.m. with the exception of cyclopropane which is 
+ 0 .0 6 4  p.p.m.145 in cyclohexane, a difference has 
been observed in the ,3-shift value arising from an 
equatorial deuterium and the value arising from an 
axial d e u t e r i u m . 146 Gorinl48 has found a 
relationship between the size of the ,3-shift and the 
substituent on the ,3-carbon. The smaller the ,3-shift 
value observed, the more electronegative is the 
substituent at the carbon under observation.
5.3.1.3 y-Shift-s in Csp3p Csp3 systems
The shift values observed over three bonds - Y“slllfts ” 
are quite small and in many cases are not resolved 
under the experimental conditions used. The values are 
generally close to +0.02 p . p . m . 135
5.3.2 Csp^P Csp3 systems
This type of effect is observed in alkyl-substituted 
aromatics and carbonyl compounds.
5.3 .2.1 >3-shift.s in Csp^P Csp3 systems
For deuteriated toluenes (202), an additive ,3-shift 
value of +0.034 p.p.m. per deuterium has been observed.
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Ethylbenzene-a-d (203) (+0.0296 p.p.m.) and
isopropylbenzene-a-d,(204), (+0.0296 p.p.m.) show
comparible effects. The /S-shift value obtained for
acetone-D5 (-0.28 p.p.m.) was the first negative
The $-shift values observed at carbon-4 in a variety 
of substituted camphors (205) all showed positive 
shifts. However, the values observed at carbon 2 in 
the same derivatives all showed negative shifts. 
Negative shift values have been partly attributed to 
hyperconjugation.
0 ‘0296p.p,m 0.0296 p.p.m.
(202) (204)
isotope value to be reported.149 Negative values 
have been reported for substituted camphors (2 0 5 ).1^0
Isotope effects are caused by differences in
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Me Me
V
(205)
X=Me  
= CI 
= NO.
vibrational zero-point energy. These differences are 
related to the inductive and hyperconjugative effects 
of the s u b s t i t u e n t s .151,152 The observation of 
isotope effects can be explained by two phenomena:
1) the more electron-donating ability of a deuterium 
atom compared to that of a proton
2) the reduced hyperconjugative ability of a C-D 
bond compared to that of a C-H bond
Long range isotope effects have been observed in 
toluene.153 por toluene d^, d2 and d3 the 
effects are additive as mentioned earlier. 
Interestingly, for toluene d3 are the effects that 
are observed over three (y-shifts) and over five bonds
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(e-shifts). These two values are negative, y - s h i f t  
(-0.0016 p.p.m.), e-shift (-0 . 0 1 2 1 p.p.m.) whereas the
5-shift value (over four bonds) is zero.
In toluene d3 (206) the negative isotope effects 
occur at carbons where hyperconjugative interactions 
might contribute. The y-shift being less than the 
e-shift may be due to the inductive effect of the C-D 
bond adding to the value of the y-shift.
Further evidence that hyperconjugation is important can 
be found when the y-shift values of ethylbenzene-a-d^ 
(3) (+0.002 p.p.m.) and isopropylbenzene-a-d-L
(+0.0143 p.p.m.) are compared.154 por ethylbenzene 
and isopropylbenzene the ortho effect becomes
increasingly positive and the para effect is 
diminished.
Aromatic
ring
Comparing with toluene, it was found that negative 
isotope shifts were observed at the ortho and para 
positions. Without knowing the population of the 
different rotational isomers present it can be assumed 
that the Ca-D bond for ethylbenzene and 
isopropylbenzene occupies a position less favourable 
for hyperconjugation. This is indicated by the Newman 
projections A and B. Since hyperconjugation is 
associated with a negative value, this is somewhat 
diminished and a more positive value is observed.
5.3.3 Csp^D Csp  ^systems
These are found in olefins and aromatics including 
heteroaromatics.
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5.3.3.1 a-Shifts in Csp^p Csp2 systems
The a-shift value often found in olefins is 
approximately +0.2 p.p.m. However, the a-shift value 
for aromatic hydrocarbons is between +0.24 p.p.m. and 
+0.31 p.p.m.
5.3.3.2 >$—Shifts in Csp^D Csp  ^systems
For olefins and aromatics the ^-shifts observed are of 
similar magnitude and are approximately +0.1 p.p.m.
For polycyclic aromatics the ^-shifts can vary from 
+0.05 p.p.m. to +0.12 p . p . m . 155 Tine size of the 
$-shift is controlled by the effects that the 
substituents have on the vibrational modes of the 
aromatic carbons.15 5
5.4 Synthesis of Deuterium-labelled Isocoumarins
A number of deuterium-labelled isocoumarins (207), 
(208), (209), (210) and (211) were synthesised. This
was to determine whether the larger shift observed at 
carbon-4 for the isocoumarin (201) was caused by the 
axial or equatorial deuterium.
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CD.MeO
OH
Met
OH
CH
(207) (208) (209)
CHMeO Me<
OH
(210) (211)
These studies would also check that the conclusions as 
to the origins of the three shifted signals arising 
from carbon-4a are correct.
When a cyclohexane ring contains trigonal carbon atoms 
its shape is distorted from that of a normal chair. By 
considering cyclohexene (212) it can be seen that the 
ethylenic carbons and the two adjacent allylic carbons 
(i.e. 3 and 6) are in a plane. However/ the atoms on 
the other side (i.e. 4 and 5) are normally staggered as 
in cyclohexane. The hydrogen (or other) atoms attached
-  196 -
a
3 a
a
(212)
to atoms 4 and 5 occupy normal equatorial and axial 
positions. Those attached to atoms 3 and 6 are 
imperfectly staggered and do not take up the normal 
equatorial and axial positions. These atoms are said 
to occupy pseudo-equatorial and pseudo-axial 
positions. The 6-membered ring in (213) is not a true 
cyclohexane shape due to the presence of the sp2
CH
H
3
on o
(213)
hybridised carbons. Therefore, substituents at carbons
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3 and 4 will occupy pseudo-equatorial and pseudo-axial 
sites. The methyl group at carbon-3 being the only 
substituent occupies a pseudo-equatorial position. 
Therefore, a substituent at carbon 4 which is cis to 
the methyl group will occupy a pseudo-axial site. 
Similarly, a substituent that is trans to the methyl 
group will occupy a pseudo-equatorial site.
5.4.1 Synthesis of [4,4#9y9,9-2H^]-4-Chloro-3,4-
dihydro-8-hydroxy-6-methoxy-3-methylisocoumarin
(217)
The synthesis of the isocoumarin (96) is described in 
Chapter 3. The pentadeuterioisocoumarin (214) was 
obtained in good yield from the isocoumarin (96) by 
refluxing in a mixture of sodium deuterioxide, 
deuterium oxide and sodium borohydride. Selective 
demethylation gave (21S) which was chlorinated using 
sulphuryl chloride which afforded the desired labelled 
isocoumarin (207).
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Me MeO- -CD
OMe OMe
(96)
(214)
CDMeO-
Me
OHOH
(215) (207)
Reagents: (i) NaOD, D20; (ii) NaBH4 7
(iii) AlCl3 /PhN0 2 ; (iv) SO2CI2
5.4.2 Synthesis of [3R*,4R*][4, 9, 9, 9, - H^4.]-5-
Chloro-3,4-dihydro-8-hydroxy-6-methoxy-3- 
methy1isocoumarin (208)
A synthesis of the keto-acid (102) is described in 
Chapter 3. The keto-acid (102) was heated at reflux in 
a solution of sodium deuterioxide and deuterium oxide
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Reagents:
CHMeO MeO CD3
OMe OMe
(1°2) (216)
dii_
CDMeO
MeO
OMe
OMe
(217)
(218)
Cl
CDMei Me
OH OH
(219) (2 08)
(i) NaOD, D20; (ii) Ac20, EtOAc, HCIO4 ;
(iii) H2 /Pd; (iv) AlClj, PhN02;
(v) S02C12
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which gave the penta-deuterio keto-acid (216). The 
isocoumarin (217) was formed by acid treatment of the 
keto-acid (216). The dihydroisocoumarin (218) was 
obtained by hydrogenation of (217) using a palladium 
catalyst. This gave the relative cis stereochemistry 
between the CD3 group at carbon-3 and the deuterium 
at the 4-position. Demethylation using aluminium 
chloride gave the mono hydroxyisocoumarin (219) which 
was chlorinated as before yielding the desired 
isocoumarin (208).
5.4.3 Synthesis of [3R*y4R*][4-^H]-5-Chloro-3#4-
dihydro-8-hydroxy-6-methoxy-3-methylisocoumarin 
(209)
A synthesis of 4-carboxy-6,8-dimethoxy-3-methyl- 
isocoumarin (95) is described in Chapter 3. Treatment 
of the 4 -carboxyisocoumarin (95) with deuterium oxide 
resulted in exchange of the acid proton for a 
deuterium. Heating the isocoumarin (95) led to 
decarboxylation and retention of the deuterium at the
4-position which gave (220). The relative cis 
stereochemistry was obtained between the deuterium and 
methyl group by hydrogenation which resulted in (2 2 1 ). 
Demethylation with aluminium chloride afforded the 
8-hydroxyisocoumarin (2 2 2 ) which was converted to the
5-chloroisocoumarin (209) as before using sulphuryl 
chloride.
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Reagents:
CHMeO.Me
OMeOMe
jiil
MeO CHMe
OHOMe
MeO
(209)
(i) D20 7 (ii)A ; (iii) H2 /Pd;
(iv) A1C13/ PhN02 7 (v) S02C12
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5.4.4 Synthesis of C3-^H]-5-Chloro-3,4-dihydro-8- 
hydroxy-6-methoxy-3-methylisocaumarin (210)
CHCH3 MeOMeO
"D
OMe OMe
(223)96
Cl
CHMeO
OH
MeO
OH
(224)
Reagents: (i) NaBD4 ; (ii) A 1C1 3 , PhN02;
(iii) S02Cl2
The synthesis of the isocoumarin (96) is described in 
Chapter 3. Reduction of the isocoumarin (96) with 
sodium borodeuteride afforded the dihydroisocoumarin 
(223). 1h N.m.r. revealed that deuterium was present 
at carbon-3. Selective demethylation gave (224) which
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was chlorinated with sulphuryl chloride to give the 
desired compound (2 1 0 ).
5.4.5 Synthesis of [3R*, 4S*]C3>4/9-jH^3~5-
Chloro-3,4-dihydro-8-hydroxy-6-methoxy-3-methyl 
isocoumarin (211)
"9QrCH- lii MeO
OMe
(96)
H,D
MeO MeO
OH OH
(226) (211)
Reagents: (i) D2 ; (ii) AICI3 , PhN0 2 ,*
(iii) SO2CI2
Reduction of the isocoumarin (96) with deuterium gas, 
formed by the dropwise addition of deuterium oxide onto 
lithium metal, yielded the isocoumarin (225).
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Selective demethylation afforded (226) which was 
chlorinated using sulphuryl chloride to give the 
desired isocoumarin (211).
The 1h n.m.r., n.m.r. and mass spectrum of the 
final compound (211) revealed that a deuterium atom had 
also exchanged with a proton from the methyl group.
Fukushima and G a l l a g h e r l 5 6  obtained a similar result 
when they were studying the catalytic reduction with 
deuterium on a variety of steroids. Hydrogenation and 
saponification of cholesterol acetate in the presence 
of deuterium gave cholestane-3$-ol which had 2.55D 
(gram atoms of deuterium per mole of compound).
Reducing a number of steroids in an analogous manner, 
they showed that the secondary alcohol group at C-3 did 
not have an influence on the reaction. It was found 
that the reduction of a tertiary carbon was not a 
controlling factor. Also, the long side chain of the 
sterols had no influence upon the reduction. This 
conclusion was drawn because all of these reductions 
gave compounds which had more than two deuterium atoms 
per mole of product.
They showed that 16% of the total isotope incorporated 
appeared at C-7, the carbon atom immediately adjacent 
to the double bond. It was also found that there was 
no isotopic substitution at C-4.
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HO
A mechanism has been proposed which allows for the 
introduction of more than two deuterium atoms. The 
first step in the reduction of cholesterol is the 
formation of the complex I. Allowing for steric 
considerations at the ring juncture, attack by a 
deuterium occurs at the 5-position giving the 
half-hydrogenated intermediate II. This intermediate 
II is then further reduced to give the species III, 
which is de-adsorbed from the catalyst surface.
However, it is possible for the intermediate II to form 
complexes I or IV by dissociation of the hydrogen at 
carbon 5 or carbon 7 from the catalyst. The 
intermediate IV is in equilibrium with deuterium and 
other species of half-hydrogenated states V and VII. 
Reduction of either of these species with deuterium
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gives the product VIII which has deuterium atoms 
present at carbons 5, 6 and 7. It is also possible for 
the complex V to equilibrate with VI in which deuterium 
is found at carbon 5 and carbon 6. Further reduction 
of VI with deuterium gives the tetradeuteriated species 
IX in which deuterium is present at carbons 5, 6a, 6$ 
and 7. A combination of species III, VIII and IX 
accounts for the isotope distribution that is found 
experimentally.
The same principle can be applied to the reduction of 
the isocoumarin (96) with deuterium gas giving the 
dihydro compound (225). This was found to contain some 
deuterium in the terminal methyl carbon.
Different catalysts were used for the reduction of the 
isocoumarin (96) and cholesterol. However, the results 
were similar and therefore it is possible to draw an 
analogy between the reduction of cholesterol with 
deuterium gas and the isocoumarin (96) with deuterium 
gas.
It is proposed that the first step is the formation of 
a complex I. This can then be attacked by deuterium at 
either carbon 3 or carbon 4 giving the different
- 208 -
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species II and IV. Since carbon 4a is a tertiary- 
carbon, species II cannot lose hydrogen and form a 
different complex to I. Therefore, species II can be 
further reduced giving the product III which can be 
removed from the surface of the catalyst by 
de-adsorption. However, species IV may form the 
intermediate V by dissociation of hydrogen at carbon 9 
or it may be further reduced also giving the product 
III. Reduction of this intermediate V would then give 
VI. Further reduction would lead to the formation of 
the trideuteriated isocoumarin VII. Interestingly, 
only a very small exchange of the 4^-hydrogen of 
compound (225) was observed.
5.5 Deuterium N.m.r.'s of Biosynthetic and Synthetic 
I socoumar ins
5.5.1 Introduction
The deuterium n.m.r. was obtained of the final 
synthesised isocoumarin to confirm that the deuterium 
atom was occupying the correct site. In the proton 
n.m.r. spectrum of the isocoumarin (46) the chemical 
shifts for the equatorial and axial protons are 
different. The shift of the equatorial proton is 
further downfield and appears at 53.21 p.p.m. whereas
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CHMeO
(46)
the axial proton appears at 5 2.65 p.p.m. The chemical 
shifts in the deuterium n.m.r. correlate directly with 
the chemical shifts in proton n.m.r. Therefore, 
deuterium n.m.r. would unambiguously assign which 
proton had been exchanged by a deuterium atom in the 
final product (see Figure 5.1).
Figure 5.1 (d), the deuterium n.m.r. for compound 
(211), shows that some of the methyl hydrogens have 
been exchanged by deuterium. The peak at 54.62 p.p.m. 
represents the presence of a deuterium at carbon 3.
Thus it can be seen that approximately one hydrogen 
atom has been exchanged per molecule of isocoumarin at 
the methyl group. The deuterium n.m.r. shows that most 
of the deuterium at C-4 is present in the equatorial
- 211
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site. However, a small amount is present at the axial 
site showing that a slight loss of stereoselectivity 
has occurred. This is probably due to an exchange 
mechanism.
5.9 13C N .m.r. and Shifted Peaks
13C N.m.r. spectra of the various deuteriated 
isocoumarins were obtained on the Bruker 360 MHz 
spectrometer in Edinburgh. The shifted values listed 
in Table 5.8 for the deuteriated isocoumarins (201), 
(207), (208), (209), (210) and (211) show that the
effect of each deuterium atom on the magnitude of a 
particular shift value is approximately additive in 
agreement with earlier c o n c l u s i o n s . I33
5.9.1 Carbon-3 Shifts
Carbon-3 in the biosynthetic isocoumarin (201) shows 
/S-shift values of 0.04, 0.08 and 0.12 p.p.m. due to 
CDH2 / CD2H and CD3 respectively. Each deuterium 
atom contributes 0.04 p.p.m. to the shift value. In 
the synthetic isocoumarin (207), a shifted value of 
0.21 p.p.m. is observed. This is accountable to a 
total of 5 deuteriums which arise from 4 -D2 + CD3 .
From the biosynthetic experiment it is known that the
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deuterium atoms at carbon-9 give an additive shift 
value of 0.12 p.p.m. Subtraction shows that the two 
deuterium atoms at carbon- 4 give an additive /6-shift 
value of 0.09 p.p.m. at carbon-3.
For the isocoumarin (208), shifts of 0.13 and 0.17 
p.p.m. are observed. These shifts correspond to 
4-axial D + CD2H and 4-axial D + CD3 respectively.
It was shown by n.m.r. that some exchange of a 
methyl deuterium by a hydrogen atom had taken place. 
When three deuterium atoms are at carbon-9 an effect of
0.12 p.p.m. is observed. Therefore, the 4-pseudo-axial 
deuterium causes a shift of 0.05 p.p.m. at carbon-3. 
Further support that the pseudo-axial deuterium causes 
a shift of 0.05 p.p.m. can be found from compound
(209). A /6 -shift of 0.048 p.p.m. is observed which is
caused by the sole deuterium at carbon-4 which is 
pseudo-axial. The additive value of the two deuterium 
atoms at carbon 4 is 0.09 p.p.m. From the results 
obtained it has been shown that the pseudo-axial
deuterium gives a shift of 0.05 p.p.m. Therefore, the
pseudo-equatorial deuterium must cause a shift of 0.04 
p.p.m. The observation at carbon-3 for the isocoumarin 
(211) is more complex. Here /6 -shift values of 0.035 
and 0.08 p.p.m. were found. The value of 0.035 p.p.m. 
corresponds to the presence of the pseudo-equatorial 
deuterium at carbon-4. The value of 0.08 p.p.m.
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corresponds to the presence of the pseudo-equatorial 
deuterium plus CH2D. Each deuterium at carbon-9 
causes a shift of 0.04 p.p.m. Therefore, it is evident 
that the pseudo-equatorial deuterium is having an 
effect of 0.04 p.p.m. at carbon-3.
For the isocoumarin (210) an a-shift of 0.40 p.p.m. is 
observed at carbon-3 which has a coupling constant of 
J 23 Hz. This was also found to be in agreement for 
the isocoumarin (211). Although slightly more complex 
this compound (210) showed an a-shift of 0.39 p.p.m. 
and a coupling constant of J 23 Hz. Further shifts of
0.425 p.p.m. and 0.47 p.p.m. were observed at C-3 in 
the isocoumarin (211). These are the additive values 
of the a-shift plus each of the different ^-shifts,
1.e. (0.39 + 0.035), (0.39 + 0.08 p.p.m.).
5.9.2 Carbon-4 shifts
For the isocoumarins (209) and (208) which have 
pseudo-axial deuteriums at the 4-position, a-shifts of 
0.37 p.p.m. and 0.44 p.p.m. were recorded 
k respectively. For the isocoumarin (208) the presence 
of the deuterium atoms at carbon-9 has an effect at 
carbon-4. A y-shift °f 0.07 p.p.m. is observed. 
Therefore, the value of 0.44 p.p.m. is the a + y 
additive shift value. Subtracting the y-shift value
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gives a shift of 0.37 p.p.m. which is in agreement with 
the value obtained at C-4 for the isocoumarin (209). 
These a-shifts recorded at the benzylic positions 
correspond well with the a-shift observed at the same 
position in ethylbenzene (203) (0.35 p.p.m.).154 ^
y-shift of 0.025 p.p.m. is observed from carbon-9 to 
carbon-4 for the isocoumarin (211) which has one 
deuterium present at the methyl carbon.
For isocoumarins (210) and (211) /6-shifts were observed 
at carbon 4 and were 0.125 p.p.m. for both compounds. 
This is unusually large for a /6-shift.
5.9.3 Carbon 4a shifts
From the biosynthetic experiment, three shifts were 
observed at carbon-4a in the isocoumarin (201) of 0.03, 
0.07 and 0.1 p.p.m. The differences were thought to 
arise when the deuterium is pseudo-axial or 
pseudo-equatorial. The value of 0.1 p.p.m. is thought 
to occur when both deuteriums are present at carbon 4.
Interestingly, for the synthetic isocoumarin (207) the 
additive shift value obtained at carbon 4a was 0.09 
p.p.m. However, for the isocoumarin (201) the value 
obtained from the biosynthetic feedings was 0.10 
p.p.m. In the synthetic isocoumarins (208) and (209)
- 216 “
the deuterium atom is pseudo-axial at C-4. It was 
found that for the isocoumarin (208) a /3-shift value at 
carbon-4a was 0.06 p.p.m. A /3-shift recorded at the 
same carbon in the isocoumarin (209) gave a value of 
0.072 p.p.m. The only difference between the two 
compounds is the presence of the deuterium atoms at 
carbon-9 in compound (208). Therefore it is concluded 
that these deuterium atoms have an overall effect of 
-0.01 p.p.m. at carbon 4a. This would explain the 
observed difference between the additive shift value of 
0.09 p.p.m. for the synthetic isocoumarin (207) and the 
biosynthetic derivative (201) of 0.1 p.p.m.
Similarly, the difference between compounds (208) and
(209) can be explained in this way. For the 
isocoumarin (211) in which the deuterium at carbon -4 
is pseudo-equatorial a shift of 0.03 p.p.m. was 
observed. Therefore, it was found that two different 
deuterium atoms each gave a different shift value. The 
values obtained were in close agreement with the values 
obtained from the biosynthetic experiment. Thus it can 
be noted that the shift of 0.03 p.p.m. arises from the 
pseudo-equatorial deuterium. Likewise, the shift of 
0.07 p.p.m. arises from the pseudo-axial deuterium. A 
similar observation has been found by Simpson and 
S t e n z e l ^3 who also found that an axial deuterium 
caused a larger shift.
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5.9.4 Carbon-5 shifts
MeO
OH
CH, MeO CH,
Cl D D
Me
OH
CH, MeO
OH
CH,
No shifts were observed for the isocoumarins (201),
(210) and (211). The shifts that were observed for the 
isocoumarins (207) (208) and (209) were all
and were all negative. The sign of the shift can be 
explained in terms of hyperconjugation (see Section 
5.3.2.1). These shifts occur at positions where 
hyperconjugation interactions may contribute. A 
similar observation occurred with toluene ot-d3 where 
negative isotope effects were observed at the
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y-position. For the isocoumarins (208) and (209), in 
which the deuterium at carbon 4 is pseudo-axial, a 
Y-shift of -0.04 p.p.m. was observed. However, for the 
isocoumarin (207) in which there are two deuterium 
atoms at carbon 4, a Y“s^ ift of -0.03 p.p.m. was 
observed. This suggests that the pseudo-equatorial 
deuterium is having an effect of +0.01 p.p.m. at carbon 
5. This difference may be due to the equatorial 
deuterium causing a slight change in conformation 
thereby reducing the Y~isotope shift.
5.9.5 Carbon 8a shifts
Only the isocoumarins (207) and (208) show a shift at 
carbon-8a. Surprisingly, no shift was observed at 
carbon-8a for the isocoumarins (209) and (211) which 
both had a deuterium present at carbon 4. The shifts 
observed at carbon 8a were Y“s^ ifts an(^  were negative. 
The negative sign can be explained as above in terms of 
hyperconjugation. The values obtained for the 
isocoumarins (207) and (208) of -0.0024 p.p.m. and 
-0.0022 p.p.m. respectively were similar. It would 
appear that for carbon 8a the presence of the 
pseudo-equatorial deuterium has no effect on the size 
of the shift. Insufficient data was obtained for this 
carbon to make any definite conclusions.
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5.9.6 Carbon 9 shifts
Only two isocoumarins (210) and (211) showed isotope 
effects at carbon 9. The isocoumarin (210) gave a 
/S-shift of 0.13 p.p.m. This is also observed for the 
isocoumarin (211), and is an unusually large ^-shift. 
The presence of the deuterium attached to carbon 9 
gives an a-shift of 0.40 p.p.m. which has a coupling 
constant of J 20 Hz.
5.10 Conclusions
From these results it can be seen that the deuterium 
shift values of the various deuteriated isocoumarins 
are largely understood. In particular, the carbon-4a 
$-shift values for the biosynthetic isocoumarin (201) 
have been assigned. The shift values of 0.03 and 0.07 
are due to the presence of a pseudo-equatorial and a 
pseudo-axial deuterium at carbon-4 respectively. The 
shift value of 0.10 p.p.m. is due to the presence of 
two deuteriums at carbon-4.
These results imply that deuterium from 
CD3^^C02Na is incorporated into position 4 of the 
isocoumarin at both pseudo-equatorial and
pseudo-axial sites. Loss of deuterium at this position 
appears to be non-stereospecific suggesting that a 
non-enzymic exchange has taken place.
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EXPERIMENT AL
General Procedures
Melting points were determined on a Kofler hot-stage 
apparatus and are uncorrected. Infra-red spectra were 
recorded for potassium bromide discs (unless otherwise 
stated) on a Perkin-Elmer 580 spectrometer. The following 
abbreviations are used: s - strong, m - medium, w - weak and
br - broad.
Proton nuclear magnetic resonance spectra were determined on 
a Perkin-Elmer RB spectrometer using deuterio chloroform as 
solvent (unless otherwise stated). Me^Si was used as 
internal standard. The following abbreviations are used: 
s - singlet, d - doublet, t - triplet, q - quartet, m - 
multiplet, dd - double-doublet, dq - double quartet and 
br - broad. Carbon nuclear magnetic resonance spectra were 
determined on a Bruker WP 360 spectrometer in the pulsed 
F. T. mode using deuterio chloroform as solvent and Me^Si as 
internal standard.
Mass spectra were obtained with a MS12 or MS902 mass 
spectrometer.
All apparatus and solutions involved in the growth of the 
micro-organism were sterilised before and after use in an 
autoclave.
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Preparative thin layer chromatography was carried out using 
Merck Kieselgel GF254. Analytical thin layer chromatography 
was carried out on commercial plates with a 0.25 mm layer of 
the same silica gel.
Organic solutions were evaporated on a rotary evaporator 
under reduced pressure; solutions in organic solvents were 
dried over anhydrous magnesium sulphate.
- 225 -
Culture and harvesting of Periconia macrospinosa
Stock cultures of Periconia macrospinosa (CMI 24411) were 
maintained on potato-dextrose agar slopes. The slopes were 
inoculated with a spore inoculum from the master strain (or 
from earlier sub-cultures) and incubated at 25 °C for 14 days 
after which time they were used as inocula for large-scale 
cultures or stored at 4 °C.
Large-scale cultures of P. macrospinosa were grown as surface 
cultures in Roux bottles on a solution of glucose (50 g), 
sodium nitrate (2 g), potassium chloride (1 g), magnesium 
sulphate (1 g), dipotassium hydrogen orthophosphate (0.5 g), 
ferrous sulphate (0 . 0 1  g), yeast extract (1 g) in distilled 
water (1 L). After 21 days incubation at 25 °C (during 
which time the pH of the culture medium increased from 5 to 
7.5) the mould had formed a thick black surface mat and the 
medium had become cloudy and dark brown in colour. The 
mycelium was separated from the culture medium and dried over 
P2 O 5 . The culture medium was continuously extracted with 
ethyl acetate for 24 hours.
Isolation of methyl-2-allyl-3,5-dichloro-l,4-dihydroxy- 
cyclopent-2 -eneoate (cryptosporiopsinol)
The ethyl acetate extract of P. macrospinosa culture medium 
was dried and evaporated to leave a brown gum (typically 
1 g/L of medium). The extract was first passed through a
- 226 -
short column of silica gel (2.5 x 1 cm) under suction (water 
pump), using ethyl acetate as eluent, to remove highly polar 
resinous material and then subjected to preparative t.l.c. 
using chloroform as eluent. Cryptosporiopsinol (RF 0.2) was 
isolated as a colourless oil which crystallised on standing 
(typical yield: 0.5 g/L of medium). Recrystallised from
dichloromethane/hexane as cubes, m.p. 120-121 °C (lit., ^9 
121-122 °C). V m a x . 3 500s, 3 460s 1 710s, 1 655w and 1 
608w cm-1; 5(CDC13 ) 6.10 (2 H, m, Ha and Hb), 4.47 (2 H, m,
H4 and H 5), 3.90 (3 H, s, OMe), 2.90 (1 H, br, 6-0H), 1.78 (3 
H, m, -CH3 ) p.p.m; $ c (CDC13) 172.22, 137.24, 134.49, 132.91, 
120.61, 87.38, 75.50, 66.10 54.37, 19.41 p.p.m; m/z 
266/268/270 (M+ ).
Isolation of 5-chloro-3,4-dihydro-8-hydroxy-6-methoxy-
3-methylisocoumarin
The dried mycelium (typical dry weight: 1 g/L of medium) was
powdered and extracted in a soxhlet apparatus (ethyl acetate; 
24h). The ethyl acetate extract was evaporated to give an 
oily residue which was subjected to preparative t.l.c. 
(chloroform/ petroleum ether 40-60 then chloroform). The 
dihydroisocoumarin was obtained as a colourless crystalline 
residue (typical yield 90 mg/g dry mycelium).
Recrystallised from ethyl acetate/petroleum ether 40-60 as 
needles, m.p. 122-123 °C (lit., ^  123-124 °C); V max.
1 655s, 1 620s, 1 580m, cm"1 ; &(CDC13 ) 6.43 (1 H, s, Ar-H),
4.65 (1 H, m, 3-H), 3.92 (3 H, s, -OMe), 3.25 (1 H, dd, J 3
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and 17 Hz, -CH2-), 2.75 (1 H, dd, J 3 and 17 Hz, -CH2-), 1.49 
(3 H, d, J 6 Hz, -CH3 ) p.p.m; 7)c (CDC13 ) 176.44, 162.93
161.02 137.62 124.12 111.45 101.63 74.90 57.45 32.13 20.63 
p.p.m; m/z 242/244(M+ ).
Harvesting of Gilmaniella humicola
Spores of Gilmaniella humicola NRNL 5487 were grown on a 
medium consisting of glucose ( 2 0  g), malt extract (2 g), 
yeast extract ( 2 g), peptone (2 g) potassium dihydrogen 
phosphate (2 g) and magnesium sulphate ( 2 g) in distilled 
water (1 L). Erlenmeyer flasks (500 ml) containing 150 ml 
of the sterile medium were inoculated with 1 ml of spore 
suspension and shaken on a rotary shaker at 27 °C. After 6 
days the mycelium and the medium were extracted with ethyl 
acetate and the organic layer washed with water. The 
organic extract was dried (MgSO^) and evaporated giving a 
brown residue.
Isolation of Dechloromicroline
The extract was first passed through a short column of silica 
gel (2.5 x 1 cm) under suction (water pump), using ethyl 
acetate as eluent to remove highly polar resinous material 
then subjected to preparative t.l.c. using ether as eluent. 
Dechloromicroline (Rp0.4) was isolated as an oil, typical 
yield ^v45 mg/L. V max. 3 500 br, 1 670 m, cm"1 ; 'd (CDC13 ) 
6.10-6.60 (3 H, m, H-2,3,5) 4.50 (1 H, br, OH) 3.42 (2 H, m,
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H-13) 1.45-2.10 (3 H, m, H- 8 , 9) 1.92 (3 H, d, J 6.7 Hz H-l),
1.39 (3 H, s, -CH3 ) m/z 264 (M+ ).
Oxidation of Dechloromicroline
A cold solution of dechloromicroline (40 mg) in acetone 
(5 ml) was treated with Jones reagent ( C r O ^ ^ S O ^ )  (0.3 ml). 
After 10 mins ethanol (2 ml) was added to destroy excess 
reagent and the reaction mixture then diluted with 
dichloromethane (50 ml). The organic solution was washed 
with water (3 x 20 ml), brine (2 x 10 ml) dried and
evaporated giving the crude product. This was purified by
preparative t.l.c. eluting with hexane/ethyl acetate 3:1,
(15 mg 37%) m.p. 153-156 °C (lit. , 9 6 153-158 °C); Vmax.
1 780m, 1 740m, 1 680m cm-1; fr(CDCl3 ) (360 MHz) 6.13 (1 H, 
dq, 0.8 and 15.8 Hz H-3) 6.09 (1 H, dq, J 6.4 and 15.8 Hz,
H-2) 6.06 (1 H, s, H-5) 5.22 (1 H, d J 11.4 Hz, H-13b) 4.07
(1 H, d, J 11.4 Hz, H-13a) 2.34 (1 H, dd, J 4.9 and 8.0 Hz,
H-9) 1.87 (3 H, dd, J 0.8 and 6.4 Hz, CH3 ) 1.76 (1 H, dd, J
5.5 and 8.0 Hz, H- 8 a) 1.45 (3 H, s, H-14) 1.10 (1 H, dd, J
4.9 and 5.5 Hz, H- 8 b) p.p.m. m/z 260 (M+ ).
FEEDING EXPERIMENTS
1. Periconia macrospinosa
Feeding experiments to Periconia macrospinosa were 
carried out on day 14 and the fungal broth was
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extracted on day 21. The isocoumarins (75) and (78) 
were fed to the fungus as their sodium salts. The 
isolation of labelled 5-chloro-3,4-dihydro-6-hydroxy-8- 
methoxy-3-methylisocoumarin (46) and cryptosporiopsinol 
(47) was as described for the unlabelled metabolites. 
The results from the feeding experiments are described 
in chapter 2 .
2. Gilmanella humicola
The isocoumarins (50) and (103) labelled with 1Z*C and 
o
H respectively were fed as their sodium salts to 
Gilmaniella humicola on day 4. The fungus was grown 
as described above and the broth and mycelium were 
extracted after day 6 . The dechloromicroline was 
purified and oxidised to the crystalline derivative 
(104) as described for the unlabelled material. The 
derivative (104) was recrystallised to constant 
activity. The results are discussed in chapter 3.
Data for Radioactive Feeding
wt of isocoumarin (50) = 50 mg Total activity = 1654 Bq
fed
wt of bislactone (104) = 9.2 mg Total activity = 135.6 Bq
recovered
Therefore % incorporation = 135.6 x 100 = 8.2%
1654
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Ethyl 1,2-dihydro-o-orsellinate1^7
Sodium (23 g) was dissolved in dry ethanol (300 ml); ethyl 
acetoacetate (124 ml) and ethyl crotonate (112 ml) were added 
and the mixture was refluxed for 2 h then stirred overnight 
at room temperature. The mixture was acidified with 5% 
sulphuric acid and then filtered. The filtrate was then 
diluted with water ( 2 0 0  ml) and extracted with chloroform.
The organic extracts were dried and evaporated to leave an 
oily product which was chilled until crystallisation began, 
diluted with hexane, then left standing at 0 °C overnight.
The product was collected by filtration and recrystallised 
from benzene/hexane. (90 g, 46%), m.p. 90 °C (lit.,1^®
89-90 °C); 6  (CDCI3 ) 9.68 (1 H, s, OH), 5.51 (1 H, s, 3-H),
4.26 (2 H, q, J 7 Hz, 0CH2 CH3 ), 3.08 (1 H, d, J 10 Hz, 1-H),
2.8-2.00 (3 H, m, 5H and 6H ) , 1.28 (3 H, t, J 7 Hz, OCH2 CH3 ), 
1.08 (3 H, d, J 6 Hz, -CHCH3 ) p.p.m.; m/z 196 (M+ ).
1 CTQ
Ethyl-3,5-dibromo-o-orsellinate
A solution of bromine (71 g, 23 ml) in glacial acetic acid 
(30 ml) was added with stirring to a solution of ethyl 
1 ,2 -dihydro-o-orsellinate (25 g) in glacial acetic acid 
( 2 0 0  ml) at such a rate that the temperature of the reaction 
mixture remained above 60 °C. The reaction mixture was 
stirred for 16 h then poured onto iced water (1 L); a white 
precipitate of ethyl-3 ,5-dibromo-o-orsellinate separated and 
was collected by filtration, washed with water and air dried.
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A portion was recrystallised from dichloromethane/hexane.
(26 g, 58%), m.p. 104 °C (lit. , 1 5 9 105-106 °C); 6(CDC13 ),
4.45 (2 H, q, J 8 Hz, -CH2 CH3 ), 2.67 (3 H, s, Ar-CH3 ), 1.41 
(3 H, t, J 8 Hz, -CH2 CH3 ) p.p.m; m/z 352, 354 (M+ ).
Ethyl-o-orsellinate
Ethyl-3,5-dibromo-o-orsellinate (20 g) was dissolved in 
sodium hydroxide solution (2 M; 240 ml) and Raney nickel 
alloy (20 g) was added portionwise with stirring at 0 °C. 
After complete addition of the alloy the mixture was stirred 
at 0 °C for a further 1 h then filtered through celite. The 
filtrate was poured onto ice-cold concentrated hydrochloric 
acid (150 ml) and the acidic solution extracted with ether (3 
x 50 ml). The ethereal extracts were dried and evaporated 
to give the product which was recrystallised frpm aqueous 
acetic acid as needles. (7 g, 67%), m.p. 129-130 °C 
(lit. , 1 6 0  131-133 °C); Vmax. 3 360br, 1 640s, 1 580m cm"1 ; 
6 ((CD3 )2 CO) 6.26 (2 H, m, Ar-H), 4.39 (2 H, 9, J 7 Hz, 
-OCH2 CH3 ), 2.47 (3 H, s, Ar-CH3 ) 1.38 (3 H, t, J 7 Hz, 
-CH2 CH3 ) p.p.m; m/z 196 (M+ ).
Ethyl-3-chloro-o-orsellinate
A solution of chlorine (17 g) in glacial acetic acid (200 ml) 
was added with stirring and ice cooling to a solution of 
ethyl-1 ,2 -dihydro-o-orsellinate (24 g) in glacial acetic acid 
(100 ml) in a closed system. The reaction mixture was
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stirred at room temperature for 0.5 h then at 60 °C for 3 h 
and then poured onto iced water (1 L ) . The precipitate was 
separated by filtration, washed with water and dried. A 
portion was recrystallised from dichloromethane/hexane as 
needles. (13 g, 46%), m.p. 120-122 °C (lit. , 8 0  120-124 °C);
Vmax. 3 375br, 1 640s, 1 600m cm-1; 6(CDC13 ) 6.43 (1 H, s,
Ar-H), 4.43 (2 H, q, J 7 Hz, -OCH2 CH3 ), 2.50 (3 H, s,
Ar-CH3 ), 1.40 (3 H, t, J 7 Hz, 0CH2 CH3 ) p.p.m; m/z 230 232 
(M+ ).
2,4-Dimethoxy-6-methylbenzoic acid
To a solution of ethyl-o-orsellinate (8 g) in anhydrous 
acetone (160 ml) was added dimethylsulphate ( 1 2 ml) and 
anhydrous potassium carbonate (20 g). The mixture was 
heated at reflux for 8 h with stirring. On coqling, the 
reaction mixture was filtered and the precipitate washed with 
acetone (3 x 50 ml). The combined organic solutions were 
evaporated leaving a dark brown oily residue. The residue 
was dissolved in ether ( 1 0 0  ml) and washed with aqueous 
ammonia solution (10%, 3 x 30 ml), sodium hydroxide solution 
(10%, 3 x 25 ml), and water (3 x 20 ml). The ether solution 
was evaporated to give a pale oil. The oil was suspended in 
potassium hydroxide solution (1 0 %, 1 0 0  ml) and heated at 
reflux for 6 h. On cooling, the basic solution was washed 
with ether (3 x 20 ml). The basic solution was acidified 
with concentrated hydrochloric acid at 0 °C and then 
extracted with ethyl acetate (4 x 25 ml). This was dried
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and evaporated giving the desired compound which was 
recrystallised from dichloromethane/hexane as prisms (6.5 g, 
81%), m.p. 140 °C (lit. , 8 0  140 °C ; ymax. 1 680s, 1 600s 
cm-1; '0 (CDCI3 ) 6.40 (2 H, m, 2Ar-H), 3.93 (3 H, s, OMe)
3.83 (3 H, s, OMe), 2.53 (3 H, s, Ar-CH3 ) p.p.m.; m/z 196 
(M+ ).
3-Chloro-2,4-dimethoxy-6 -methylbenzoic acid
Prepared by the methylation and hydrolysis of 
ethyl-3-chloro-o-orsellinate (8 g) by the foregoing method. 
Recrystallised from dichloromethane/hexane as prisms. (6.3 
g, 78%); m.p. 152-153 °C (lit. , 1 6 1  154-156 °C); >'max.
1 690s, 1 585s cm-1; 'b(CDCl3 ) 10.90 (1 H, br, OH), 6.59 (1 
H, s, Ar-H), 3.96 (3 H, s, OMe), 3.91 (3 H, s, OMe), 2.45 (3 
H, s, Ar-CH3 ) p.p.m.; m/z 230 232 (M+ ).
3,5-Dimethoxyhomophthalic acid
n-Butyllithium (54 ml; 1.5 M in hexane) was added to a 
solution of diisopropylamine (8.2 g, 11.36 ml) in dry 
tetrahydrofuran (THF) (25 ml) under nitrogen at 0 °C with 
stirring. After 10 mins the solution was cooled to -78 °C 
and a solution of 2,4-dimethoxy-6 -methylbenzoic acid (4 g) 
and dimethyl carbonate (4.4 g, 4.12 ml) in THF (25 ml) was 
added dropwise during 15 mins. The cooling bath was removed 
and the solution allowed to warm to room temperature. After 
4 h, water (30 ml) was added and the suspension stirred for
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16 h. The organic solvents were removed by evaporation and 
the resulting aqueous solution was washed with ether (3 x 30 
ml). After acidification with dilute hydrochloric acid, the 
solution was extracted with ethyl acetate (3 x 30 ml). The
combined extracts were dried and evaporated to give
3,5-dimethoxyhomophthalic acid which was recrystallised from 
acetone/hexane as prisms. (3.6 g, 74%) m.p. 170-171 °C 
(lit. , 1 6 2  172-173 °C); ymax. 3 000-2 700br, 1 680s, 1 600s, 
1 585m cm-1; ft((CD3 )2 C0) 6.59 (2 H, s, Ar-H), 3.91 (3 H, s,
OMe), 3.87 (3 H, s, OMe), 3.79 (2 H, s, -CH2 ) p.p.m.; m/z 
240 (M+ ).
4-Chloro-3,5-dimethoxyhomophthalic acid
Prepared by treatment of 3-chloro-2,4-dimethoxy-6—  
methylbenzoic acid (5.5 g) by the foregoing method.The 
product was recrystallised from dichloromethane/hexane (5.1 
g, 78%) m.p. 143-144 °C (lit. , 8 0  141-146 °C); ymax. 3 000-2 
600br, 1 720s, 1 610s, 1 590m, cm"1 ; § (CD3 OD) 6.82 (1 H, s,
Ar-H), 3.88 (3 H, s, OMe), 3.85 (3 H, s, OMe), 3.75 (2 H, s, 
-CH2 ) p.p.m.; 274 276 (M+ ).
- 235 -
Homophthalic acid1 6 2
Indene (18 ml) was added dropwise to a stirred solution of 
potassium dichromate (60.7 g) and concentrated sulphuric acid 
(180 ml) in water (900 ml) at such a rate that the 
temperature of the reaction was maintained at 65 °C + 2 °C. 
After the addition was complete the reaction was stirred at 
65 °C for a further 2 h. The flask was cooled to 20 °C then 
further cooled by use of an ice-bath to 0 °C. The flask was 
then stirred at 0 °C for a further 5 h. The product was 
collected by filtration, washed with water and dried ( 2 0 g, 
72%) m.p. 140-141 °C (lit., 1 6 2  140-142 °C); §(CD3)2CO 7.88
(1 H, dd, J 2 and 8 Hz, H- 8 ) 7.40 (3 H, m, Ar-H), 4.06 (2 H, 
s, CH2 ) p.p.m. m/z 178 (M+ ).
3,5-Dimethoxyhomophthalic anhydride
A solution of 3,5-dimethoxyhomophthalic acid (4 g) in acetyl 
chloride (20 ml) was heated at reflux for 0.5 h, by which 
time the solution was homogenous. After cooling, the 
solution was diluted with light petroleum (b.p. 40-60 °C) 
until the product began to crystallise from solution. The
product was isolated by filtration, washed with light 
petroleum (b.p. 40-60 °C) and air dried. (3.1 g, 84%), m.p. 
159-160 °C (lit., 1 6 3  160-162 °C); ymax. 1 715s, 1 660s,
1 610s, 1 580m cm-1; M C D C 1 3 ) 6.46 (1 H, d, J 2 Hz, Ar-H), 
6.34 (1 H, d, J 2 Hz, Ar-H), 3.98 (2 H, s, Ar-CH2 ), 3.95 (3 
H, s, OMe), 3.90 (3 H, s, OMe) p.p.m.; m/z 222 (M+ ).
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Homophthalic anhydride
Prepared by treatment of homophthalic acid (1 g) by the 
foregoing method. (820 mg, 80%) m.p. 138-139 °C (lit., 16Zf 
139-140 °C); 6 (CDCI3 ) 7.94 (1 H, dd J 1 and 8 Hz, H-8 ),
7.30 (3 H, m, Ar-H), 3.87 (2 H, s, CH2 ) p.p.m.; m/z 162 
(M+ ).
4-Carboxy-6,8 -dimethoxy-3-methylisocoumarin
To a solution of 3,5-dimethoxyhomophthalic anhydride (250 mg) 
in anhydrous THF (30 ml) was added acetic anhydride (0.15 ml) 
and dry pyridine (0.2 ml). The solution was stirred at room 
temperature for 40 mins then a further portion of acetic 
anhydride (0 . 2  ml) was added and the solution was heated at 
gentle reflux for 1 h. After cooling, the solution was 
evaporated and the residue dissolved in dilute aqueous sodium 
hydrogen carbonate. The basic solution was washed with 
ether (3 x 25 ml) then acidified cautiously with dilute 
hydrochloric acid and extracted with ethyl acetate 
(3 x 25 ml). The combined extracts were dried and 
evaporated to give the product as a white crystalline 
compound which was recrystallised from ethyl acetate/hexane 
(200 mg, 67%); m.p. 147-148 °C (lit., 8 0 145-147 °C) (Found: 
C, 59.22; H, 4.52%; M+ , 264.062 C ^ H ^ O ^  requires C, 59.09;
H, 4.58%; M, 264.0636); ymax. 1 745s, 1 705s, 1 650s,
1 605m, 1 570m cm"1 ; 6 ((CD3 )2 CO) 6.57 (1 H, d, J 1 Hz,
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Ar-H), 6.41 (1 H, d, J 1 Hz, Ar-H), 3.98 (3 H, s, -OMe), 3.94 
(3 H, s, -OMe) 2.59 (3 H, s, -CH3 ) p.p.m.
4-Carboxy-3-methy1isocoumarin
Prepared by treatment of homphthalic anhydride (250 mg) by 
the foregoing method. The product was recrystallised from 
ethyl acetate/hexane (210 mg, 72%); ymax. 3 300br, 1 750s,
1 700s, 1 650s, 1 600m, 1 575m cm-1; & (CDCI3 ) 8.23 (1 H,
dd, and 8 Hz, H- 8 ), 7.50 (3 H, m, Ar-H), 2.63 (3 H, s, Me) 
p.p.m.; m/z 204 (M+ ).
6 ,8-Dimethoxy-3-methylisocoumarin
4-Carboxy-6,8-dimethoxy-3-methylisocoumarin (250 mg) was 
heated to just below its m.p. (140-150 °C) for 10 mins by 
which time carbon dioxide evolution had ceased. The residue 
was purified by preparative t.l.c. (ethyl acetate as eluent) 
to give 6 ,8-dimethoxy-3-methylisocoumarin. Recrystallised 
from ethanol as plates (190 mg, 90%), m.p. 156-157 °C 
(lit. , 1 6 5  157-158 °C); (Found: C, 65.57; H, 5.58%; M + ,
220.0736. CF2 H^2°4 requires C, 65.43; H, 5.49%; M, 
220.0732); ymax. 1 710s, 1 665m, 1 600s,
1 570s cm-1; 5(CDC13 ) 6.46 (1 H, d, J 2 Hz, Ar-H), 6.34 (1
H, d, J 2 Hz, Ar-H), 6.12 (1 H, s, 4-H), 4.01 (3 H, s, OMe),
3.94 (3 H, s, OMe), 2.21 (3 H, s, Ar-CH3 ) p.p.m.
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3,4-Dihydro-6,8-dimethoxy-3-methylisocoumarin
6 .8-Dimethoxy-3-methylisocoumarin (250 mg) was heated under 
reflux in aqueous sodium hydroxide solution (10%, 15 ml) for
1 h. Sodium borohydride (50 mg) was added with stirring and 
the mixture heated under reflux for 30 min; more sodium 
borohydride (50 mg) was added and heating was continued for a 
further 30 min. The hot solution was filtered and the 
filtrate was acidified with hydrochloric acid. The acidic 
solution was extracted with ethyl acetate, dried and 
evaporated to yield 3 ,4-dihydro-6,8-dimethoxy-3- 
methylisocoumarin which was recrystallised from ether/hexane 
as needles (175 mg, 70%), m.p. 125-126 °C (lit., 16^
125-126 °C; >max. 1 710s, 1 660m, 1 600s, 1 575m cm”1 ; 
^(CDC13 ) 6.41 (1 H, d, J 2 Hz, Ar-H), 6.31 (1 H, d, J 2 Hz, 
Ar-H), 4.51 (1 H, m, 3-H), 3.92 (3 H, s, OMe), 3,87 (3 H, s, 
OMe), 2.83 (2 H, m, 4-H), 1.45 (3 H, d, J 7 Hz, -CH3 ) p.p.m.; 
m/z 222 (M+ ).
3 14-Dihydro-6,8-dimethoxy-3-methylisocoumarin
Palladium on charcoal (10%, 75 mg) was added to a solution of
6 .8-dimethoxy-3-methylisocoumarin (250 mg) in ethyl acetate 
( 2 0  ml) and the mixture hydrogenated at room temperature for 
16 h. The catalyst was removed by filtering through celite. 
The ethyl acetate was evaporated to give the desired product 
which was recrystallised from ether/hexane as needles.
(225 mg, 90%); m.p. 125-126 °C same data as above.
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4-Carboxy-3,4-dihydro-3-methylisocoumarin
Palladium on charcoal (10%, 50 mg) was added to a solution of
4-carboxy-3-methylisocoumarin (250 mg) in ethyl acetate 
(25 ml). The mixture was then hydrogenated at room 
temperature and atmospheric pressure for 16 h. The catalyst 
was filtered through celite and washed with ethyl acetate.
The organics were evaporated giving the title compound which 
was recrystallised from ether/hexane ( 2 2 0  mg, 8 8 %); m.p.
142-143 °C; S ( C D C 1 3 ) 8.12 (1 H, dd, J 2 and 8 Hz, H-8 ),
7.40 (3 H, m, Ar-H), 4.81 (1 H, dq, J 3 and 8 Hz, H-3) 3.46 
(1 H, d, J 3 Hz, H-4) 1.56 (3 H, d, J 8 Hz, Me) p.p.m.; m/z 
206 (M+ ).
4-Chloro-3,4-dihydro-3-methylisocoumarin
Lead tetraacetate (2.63 g) was added to a solution of 
N-chlorosuccinimide (938 mg) and 4-carboxy-3,4-dihydro-3- 
raethylisocoumarin (250 mg) in dry DMF (10 ml) and glacial 
acetic acid (2 ml) under nitrogen. The flask was warmed to 
40-50 °C and stirred for 40 mins. The solution was allowed 
to cool and diluted with water (60 ml). The aqueous 
solution was extracted with ethyl acetate. The organic 
extracts were washed with water (3 x 15 ml), sodium 
bicarbonate solution (3 x 15 ml) and brine (2 x 15 ml). The
organics were then dried and evaporated. The product was 
purified using preparative t.l.c. eluting with 
diisopropylether to give the desired compound. (25 mg, 40%);
- 240 -
5>(CDC13 ) 8.16 (1 H, dd, J 2 and 8 Hz, H-8 ), 7.55 (3 H, m, Ar- 
H), 5.00 (1 H, d, J 1.5 Hz, H-4), 4.88 (1 H, dq, J 1.5 and 7 
Hz, H-3), 1.67 (3 H, d, 7 Hz, -CH3 ) p.p.m.; m/z 196/198 
(M+ ).
3,5-Dimethoxytoluene1 6 5
Orcinol (12.4 g) in dry acetone (125 ml) containing anhydrous 
potassium carbonate (55 g) and dimethyl sulphate (19 ml) was 
heated at reflux for 8 h with stirring. After cooling, the 
solution was filtered and the residue washed with acetone (2 
x 50 ml). The combined organic solutions were evaporated to 
give an oil which was dissolved in ether (100 ml). The 
organic layer was washed with ammonia solution (10%, 4 x 
25 ml), sodium hydroxide solution (10%, 3 x 20 ml), and water 
3 x 20 ml). The organics were dried and evaporated to give 
an oil which was purified by distillation (11.08 g, 73%),
(60 °C/0 .8 mm Hg); 5(CDC13 ) 6.30 (3 H, s, Ar-H), 3.73 (6 H, 
s, 2 x OMe), 2.27 (3 H, s, -CH3 ) p.p.m.; m/z 152 (M+ ).
2-Bromo-3,5-dimethoxytoluene1 6 6
Bromine (1.6 ml) in 1,2-dichloroethane (10 ml) was added with 
stirring during 5 minutes to a solution of 3,5- 
dimethoxytoluene (5 g) in 1,2-dichloroethane (50 ml).
Stirring was continued for a further 20 min. at room 
temperature. The organic solution was washed with water (3 
x 2 0  ml) dried and evaporated to give an oil which
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crystallised on standing. The product was recrystallised 
from methanol as cubes (5.3 g, 70%), m.p. 57 °C (lit., 1 6 6  
57 °C); § (CDCI3 ) 6.29 (1 H, d, J 3 Hz, Ar-H), 6.19 (1 H, d,
J 3 Hz, Ar-H), 3.78 (3 H, s, OMe), 3.69 (3 H, s, OMe), 2.30 
(3 H, s, Ar-Me) p.p.m.
2.4-Dimethoxy-6-methylbenzoic acid
n-Butyllithium (5.4 ml, 1.5 M in hexane) was added to a 
stirred solution of 2-bromo-3,5-dimethoxytoluene (2 g) in THF 
(50 ml) at -78 °C under nitrogen. The solution was stirred 
at this temperature for 15 minutes and then poured onto an 
excess of crushed dry ice. The solution was allowed to warm 
to room temperature and water (25 ml) was added. The 
organic solution was evaporated and the aqueous solution was 
washed with ether (3 x 25 ml). The aqueous solution was 
then acidified with dilute hydrochloric acid. The acidic 
solution was extracted with ethyl acetate. The organic 
extracts were dried and evaporated yielding the desired 
compound which was recrystallised from dichloromethane/hexane 
(1.45 g, 85%) m.p. 140 °C same data as above.
2 14-Dimethoxy-6-(2-oxopropyl)benzoic acid
3.5-Dimethoxyhomophthalic acid (2 g) was added portionwise to 
a mixture of acetic anhydride (4 ml) and dry pyridine (1 ml). 
After 5 minutes, dry ether (15 ml) was added and stirring 
continued for 2 h. Sodium hydroxide solution (150 ml; 4 M)
- 242 -
was slowly added and the mixture refluxed until all the solid 
material had dissolved. The solution was cooled, washed 
with an equal volume of dichloromethane then cautiously 
acidified. The acidic solution was extracted with ethyl 
acetate (3 x 30 ml) which was dried and evaporated to give a 
solid which was recrystallised from acetone (1.4 g, 70%), 
m.p. 139-140 °C (Found: C, 60.49; H, 5.71%; M+ , 238.084;
°12H14°5 requires C, 60.48; H, 5.93%; 238.084); ymax.
1 710s, 1 680s, 1 600s cm"1 ; 3((CD3 )2 C0) 6.48 (1 H, d, J 2
Hz, Ar-H, 6.39 (1 H, d, J 2 Hz, Ar-H) 3.99 (2 H, s, -CH2 ), 
3.85 ( 6 H, s, 2 x OMe), 2.29 (3 H, s, -CH3 ) p.p.m.
3-Chioro-2,4-dimethoxy-6 -(2-oxopropyl)benzoic acid
Prepared by treatment of 4-chloro-3,5-dimethoxyhomophthalic 
acid (2 g) by the foregoing method. The product was 
recrystallised from acetone as cubes (1.4 g, 70%), m.p.
143-144 °C (Found: C, 52.78, H, 4.85, Cl, 12.78%; M+ 
272.045, 274.042. 0 -^2 ^ 3 0 5 0 1  requires C, 52.85; H, 4.80;
Cl, 13.00%; 272.043, 274.040). ymax. 1 710s, 1 680s,
1 600s cm"1 ; $((CD3 )2 C0) 6.60 (1 H, s, Ar-H), 4.05 (2 H, s,
-CH2 ) 3.90 (6 H, s, 2 x OMe) 2.05 (3 H, s, -CH3 ) p.p.m.
6 ,8-Dimethoxy-3-methylisocoumarin
2,4-Dimethoxy-6-(2-oxopropyl) benzoic acid (500 mg) was 
dissolved in a solution of acetic anhydride and perchloric
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acid in ethyl acetate (50 ml; made up by the method of 
Edwards and R a o ^ ^ )  and allowed to stand at room temperature 
for 10 minutes. The solution was then washed with water (3 
x 50 ml) and sodium hydrogen carbonate solution (3 x 30 ml), 
dried and evaporated giving a brown solid. The product was 
purified by column chromatography eluting with ethyl acetate 
and recrystallised from ethanol (330 mg, 71%) m.p. 156-157 °C 
same data as above.
7-Chloro-618-dimethoxy-3-methylisocoumarin
Prepared by treatment of 3-chloro-2,4-dimethoxy-6-(2- 
oxopropyl)benzoic acid (500 mg) by the foregoing method.
The product was recrystallised from dichloromethane/hexane as 
cubes. (300 mg, 64%) m.p. 182-190 °C (decomp.), (lit ., 
187-200 °C (decomp.) (Found: C, 56.56; H, 4.3$; Cl, 13.90%
C 1 2 H 1 1 O4 CI requires C, 56.59; H, 4.35; Cl, 13.92%); ymax. 
1 715s, 1 670s, 1 590m, 1 556m cm-1; ^(CDC13 ) 6.53 (1 H, s,
Ar-H), 6.22 (1 H, s, 4-H), 3.98 (6 H, s, 2 x OMe), 2.21 (3 H, 
s, -CH3 ) p.p.m.; m/z 254 256 (M+ ).
7-Chloro-3 ,4-dihydro-6,8-dimethoxy-3-methylisocoumarin
Palladium on charcoal (10%, 75 mg) was added to a solution of 
7 -chloro-6 ,8 -dimethoxy-3-methylisocoumarin (250 mg) in ethyl 
acetate ( 2 0 ml) and the mixture hydrogenated at room 
temperature for 16 h. The catalyst was filtered through 
celite and the ethyl acetate evaporated to give the desired
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product which was recrystallised from dichloromethane/hexane 
(225 mg, 90%), m.p. 155-156 °C (lit., 8 0  154-157 °C); Vmax. 
1 710s, 1 665s, 1 595m, 1 550m cm"^; A(CDCl 3 ) 6.59 (1 H, s, 
Ar-H), 4.55 (1 H, m, 3-H), 3.92 ( 6 H, s, 2 x OMe), 2.86 (1 H, 
br, s, 4-H), 2.76 (1 H, br, s, 4-H), 1.42 (3 H, d, J 7 Hz, 
-CH3 ) p.p.m.; m/z 256 258 (M+ ).
[lftl ft3 l^3tt3 , — H^c; ] —2 ,4-Dimethoxy-6-(2 1 -oxopropyl) benzoic 
acid
2,4-Dimethoxy-6-(2-oxopropyl)benzoic acid (500 mg) was added 
to a solution of sodium (90 mg) in D 2 O (15 ml) and the 
solution heated at reflux for 2 h. After cooling, the 
solution was acidified with dilute hydrochloric acid, then 
extracted with ethyl acetate (3 x 25 ml) dried and evaporated 
giving the desired deuterio compound which was recrystallised 
from acetone (490 mg, 95%), m.p. 139-140 °C; ^(( 0 0 3 )2 )6 0 )
6.46 (1 H, d, J 2 Hz, Ar-H, 6.37 (1 H, d, J 2 Hz, Ar-H), 3.85 
( 6 H, s, 2 x OMe) p.p.m.; m/z 243 (M+ ) data identical with 
unlabelled material.
[ll>l ,,3,t3 ,>3 1 — H^c; ] -3-Chloro-2,4-dime thoxy-6 -( 2 1 - 
oxopropyl)benzoic acid
Prepared by treatment of 3-chloro-2,4-dimethoxy-6-(2- 
oxopropyl)benzoic acid (500 mg) by the foregoing method (490 
mg, 9 5 %) data identical with unlabelled material.
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^((CD 3 )2 CO) 6.60 (1 H, s, Ar-H) 4.05 (6 H, s, 2 x OMe) 
p.p.m.; m/z 277 279.
14 3 - 6 ,8 -Dime thoxy-3-methyl iso coumar in
[1',11,3',3',3-2H 5 ]-3-Chloro-2,4-dimethoxy-6-(2'- 
oxopropyl)benzoic acid was cyclised to the isocoumarin by the 
same method described for the unsubstituted compound (300 mg, 
6 6 %) same data as unsubstituted compound. ^(CDC13 ) 6.40 (1 
H, d, J 1 Hz, Ar-H), 6.27 (1 H, d, J 1 Hz, Ar-H), 6.05 (0.12 
H, s, 4-H), 3.94 (3 H, s, OMe), 3.86 (3 H, s, OMe) p.p.m. 
m/z 224 (M+ ).
[4 ,,-<t^ t-^-^H/[ ]-7-Chloro-6,8-dimethoxy-3-methylisocoumarin
Prepared by cyclising [1’,1',3',3’,3'-^H^]-3-Chloro-2,4- 
dimethoxy-6 -(2 ’-oxopropyl)benzoic acid to the isocoumarin by 
the foregoing method (300 mg, 6 6 %) data identical with 
unsubstituted compound. c) (CDCI3 ) 6.53 (1 H, s, Ar-H), 6.10 
(0.26 H, s, 4-H), 3.97 (6 H, s, 2 x OMe); m/z 258 260 (M+ ).
[4-^H^]-6 ,8-Dimethoxy-3-methylisocoumarin
A suspension of 4-carboxy-6,8-dimethoxy-3-methylisocoumarin 
(160 mg) in D£ 0  ( 1 0  ml) was stirred at room temperature for
15 minutes, then the D2 O was removed by evaporation. This 
compound was then heated at 140-150 °C for 15 minutes by 
which time carbon dioxide evolution had ceased. The residue
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was purified by column chromatography eluting with ethyl 
acetate giving the desired [4-^H-^]-6 ,8 -dimethoxy-3 - 
methylisocoumarin ( 1 1 0  mg, 82%) data identical with 
unsubstituted compound. ^(CDC13 ) 6.40 (1 H, d, J 1 Hz, 
Ar-H), 6.28 (1 H, d, J 1 Hz, Ar-H), 6.05 (0.2 H, s, 4-H),
3.94 (3 H, s, OMe), 3.88 (3 H, s, OMe), 1.99 (3 H, s, -CH3) 
p .p .m ., m /z 221.
o
[ 4 , 4 He;3-3,4-Dihydro-618 -dimethoxy-3-methylisocoumarin
6 ,8-Dimethoxy-3-methylisocoumarin (200 mg) was added to a 
solution of sodium (40 mg) in D 2 O (15 ml) and the solution 
heated under reflux with stirring for 1 h. Sodium 
borohydride (45 mg) was added portionwise and the mixture 
heated at reflux with stirring. After 30 minutes more 
sodium borohydride (45 mg) was added and reflux continued for 
a further 30 minutes. The solution was cooled and washed 
with ether (3 x 15 ml), acidified with dilute hydrochloric 
acid and then extracted with ethyl acetate (3 x 25 ml).
This was then dried and evaporated leaving a crystalline 
compound which was recrystallised from ether/hexane (190 mg, 
93%). Data identical with unsubstituted compound.
^(CDC13 ) 6.40 (1 H, d, J 1 Hz, Ar-H), 6.29 (1 H, d, J 1 Hz, 
Ar-H, 4.46 (1 H, br, s, 3-H), 3.87 (3 H, s, OMe), 3.84 (3 H, 
s, OMe) p.p.m.; m/z 227.
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O
[4 ,-X, o^X- H/j ] -3 14-Dihydro-6,8-dimethoxy-3-methylisocoumarin
r\
H^]- 6 ,8 -Dimethoxy-3-methylisocoumarin (300 mg) was 
hydrogenated by the same method used for the unsubstituted 
compound. The product was recrystallised from ether/hexane 
(260 mg, 8 6 %). Data identical with unsubstituted compound. 
6(CDC13 ) 6.40 (1 H, d, J 1 Hz, Ar-H), 6.29 (1 H, d, J 1 Hz, 
Ar-H), 4.48 (1 H, br, s, 3-H), 3.88 (3 H, s, OMe), 3.85 (3 H,
s, OMe), 2.76 (1.1 H, br, s, 4-H) p.p.m; m/z 226.
[4,4, x^-^H/j ]-7-Chloro-3,4-dihydro-6,8-dimethoxy-3- 
methylisocoumarin
[4 ] -7-Chloro-6,8 -dime thoxy-3-me thy lisocoumar in
(500 mg) was hydrogenated by the foregoing method. The 
product was recrystallised from ether/hexane (430 mg, 8 6 %). 
Data identical with unsubstituted compound. 6 (0 0 0 1 5 ) 6.65 
(1 H, s, Ar-H), 4.77 (1 H, br, s, 3-H), 3.98 (6 H, s, 2 x
OMe) 3.05 (1 H, s, 4-H) p.p.m; m/z 260 262.
[4-^H^]-3,4-Dihydro-6,8 -dime thoxy-3-methylisocoumarin
[4-^H^]-6 ,8 -Dimethoxy-3-methylisocoumarin (100 mg) was 
hydrogenated by the foregoing method. The product was 
recrystallised from ether/hexane. Data identical with 
unsubstituted compound. 6(CDC13 ) 6.41 (1 H, d, J 1 Hz, 
Ar-H), 6.31 (1 H, d, J Hz, Ar-H), 4.50 (1 H, m, 3-H), 3.92
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(3 H, s, OMe), 3.87 (3 H, s, OMe), 2.79 (1 H, br, s, 4-H),
1.95 (3 H, d, J 7 Hz, -CH3 ) p.p.m; m/z 223 (M+ ).
[3- H ^ ]-3,4-Dihydro-6,8-dimethoxy-3-methylisocoumarin
6 ,8-Dimethoxy-3-methylisocoumarin (250 mg) was heated under 
reflux in sodium hydroxide solution (10 %, 15 ml) for 1 h. 
Sodium borodeuteride (50 mg) was added with stirring and the 
mixture heated under reflux for 30 min; more sodium 
borodeuteride (50 mg) was then added and heating continued 
for a further 30 minutes. The hot solution was filtered and 
the filtrate acidified with dilute hydrochloric acid. The 
acidic solution was extracted with ethyl acetate (3 x 25 ml), 
dried and evaporated giving the required deuterio compound 
which was recrystallised from ether/hexane (170 mg, 6 8 %). 
Data identical with unsubstituted compound. $ (CDC13 ) 6.38 
(1 H, d, J 1 Hz, Ar-H), 6.25 (1 H, d, J 1 Hz, Ar-H), 3.82 (6 
H, s, 2 x OMe), 2.86 (2 H, br, s, -CH2 ), 1.49 (3 H, s, -CH3) 
p.p.m; m/z 223 (M+ ).
[3,4, ~^H 3 3-3,4-Dihydro-6,8 -dimethoxy-3-methylisocoumarin
Deuterium gas, formed by the dropwise addition of D20 onto 
lithium metal, was bubbled into a solution of 6 ,8 -dimethoxy-
3-methylisocoumarin (100 mg) in ethyl acetate (25 ml) with 
10% palladium on charcoal (30 mg) under an atmosphere of 
nitrogen. The mixture was stirred at room temperature for 
16 h and then filtered through celite. The organic solution
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was evaporated giving the required deuterio compound, which 
was recrystallised from ether/hexane (92 mg, 91%). Data 
identical with unsubstituted compound. 6(CDC13 ) 6.40 (1 H, 
d, J 1 Hz, Ar-H), 6.28 (1 H, d, J 1 Hz, Ar-H), 4.51 (0.3 H, 
m, 3-H), 3.90 (3 H, s, OMe), 3.83 (3 H, s, OMe), 2.80 (1.3 H, 
m, 4-H), 1.41 (2 H, m, -CH2 D) p.p.m; m/z 224 (M+ ).
[3,4 ,(<-^H3 ] -7-Chloro-3,4-dihydro-6,8-dimethoxy-3- 
methylisocoumarin
Prepared by the treatment of 7-chloro-6,8 -dimethoxy-3-methyl- 
isocoumarin (200 mg) by the foregoing method. The product 
was recrystallised from dichloromethane/hexane (182 mg, 90%). 
Data identical with unsubstituted compound. 6(CDC13 ) 6.59 
(1 H, s, Ar-H), 4.55 (0.35 H, m, 3-H), 3.94 ( 6 H, s, 2 x 
OMe), 3.10 (1.3 H, m, 4-H), 1.42 (2 H, m, -CH2 D) p.p.m; m/z 
259 261 (M+ ).
[ 4,4 , AV<-^Hq 3 -3,4-Dihydro-8-hydroxy-6-me thoxy-3- 
methylisocoumarin
To a solution of [4,4,(<, <,x-^H5 ]-3,4-dihydro-6,8 -dimethoxy-3- 
methylisocoumarin ( 2 0 0  mg) in freshly distilled nitrobenzene 
(16 ml) was added powdered aluminium chloride (600 mg). The 
solution was stirred at 50-60 °C for 6 h, then poured onto 
iced water and acidified with dilute hydrochloric acid. The 
acidic solution was extracted with ether (4 x 20 ml), and the 
combined organic solutions were extracted with sodium
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hydroxide solution (5 %, 3 x 15 ml). The basic solution was 
washed with ether (3 x 10 ml) and then acidified. The 
acidic solution was extracted with ethyl acetate (4 x 20 ml), 
dried and evaporated leaving the title compound which was 
recrystallised from ether/hexane (152 mg, 80%) m.p. 95-96 °C. 
Data identical with unlabelled compound. cKCDC13 ) 6.35 (1 
H, d, J 1 Hz, Ar-H), 6.23 (1 H, d, J 1 Hz, Ar-H), 4.63 (1 H, 
br, s, 3-H), 3.81 (3 H, s, OMe) p.p.m; m/z 213 (M+ ).
[ 4 , 4 , 4 . 4 " ^  ]-3,4-Dihydro-8-hydroxy-6-methoxy-3- 
methylisocoumarin
Prepared by the treatment of [4,o<,x,x-^H^]-3,4-dihydro-8- 
hydroxy-6-methoxy-3-methylisocoumarin (200 mg) by the 
foregoing method. The product was recrystallised from 
ether/hexane (150 mg, 80%). Data identical with unlabelled 
compound. 6 (0 0 0 1 3 ) 6.35 (1 H, d, J 1 Hz, Ar-H), 6.23 (1 H, 
d, J 1 Hz, Ar-H), 4.63 (1 H, br, 3-H), 3.80 (3 H, s, OMe),
2.80 (1.1 H, m, 4-H) p.p.m; m/z 212 (M+ ).
[4-^H-^ ] -3,4-Dihydro-8-hydroxy-6-methoxy-3-methylisocoumarin
Prepared by the treatment of [4-^H^]-3,4-dihydro-6,8- 
dimethoxy-3-methylisocoumarin (100 mg) by the foregoing 
method. The product was recrystallised from ether/hexane 
(70 mg, 74%). Data identical with unlabelled compound.
6(CDC13 ) 6.38 (1 H, d, J 1 Hz, Ar-H), 6.25 (1 H, d, J 1 Hz,
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Ar-H), 4.65 (1 H, br, 3-H), 3.81 (3 H, s, OMe), 2.85 (1 H,
br, 4-H), 1.49 (3 H, d, J 7 Hz, -CH3 ) p.p.m.; m/z 209 (M+ ).
[3-^H^]-3,4-Dihydro-8-hydroxy-6-methoxy-3-methylisocoumarin
Prepared by the treatment of [3-^H^]-3,4-dihydro-6,8 - 
dimethoxy-3-methylisocoumarin (100 mg) by the foregoing 
method. The product was recrystallised from ether/hexane 
(70 mg, 74%). Data identical with unlabelled compound. 
6(CDC13 ) 6.38 (1 H, d, J 1 Hz, Ar-H), 6.24 (1 H, d, J 1 Hz,
Ar-H), 3.80 (3 H, s, OMe), 2.84 (2 H, m, 4-H), 1.49 (3 H, d,
7 Hz, ~CH3 ) p.p.m.; m/z 209 (M+ ).
[3,4, ] -3,4-Dihydro-8-hydroxy-6-methoxy-3-
methylisocoumarin
Prepared by the treatment of [3,4,fX-^H 3 ]-3,4-dihydro-6,8- 
dimethoxy-3-methylisocoumarin (200 mg) by the foregoing 
method. The product was recrystallised from ether/hexane 
(145 mg, 77%). Data identical with unlabelled compound. 
6(CDC13 ) 6.35 (1 H, d, J 1 Hz, Ar-H), 6.25 (1 H, d, J 1 Hz, 
Ar-H), 4.66 (0.1 H, m, 3-H), 3.81 (3 H, s, OMe), 2.85 (1.1 H, 
m, 4-H), 1.49 (2 H, m, -CH2 D) p.p.m.; m/z 210 (M+ ).
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[4 ]-7-Chloro-3,4-dihydro-6,8-dihydroxy-3-
methylisocoumarin
To a solution of [4,x,:x,‘j(”^H^]-7-Chloro-3,4-dihydro-6,8- 
dimethoxy-3-methylisocoumarin (100 mg) in dichloromethane (25 
ml) was added boron tribromide (0.5 ml, 1.0 M in 
dichloromethane) at -70 °C. The solution was allowed to 
warm to room temperature and then stirred for 16 h. Ether 
(5 ml) was added then water (5 ml) (cautiously!). The 
organic layer was dried and evaporated giving a crystalline 
compound which was recrystallised from ethyl acetate/hexane 
(55 mg, 62%) m.p. 193-195 °C. Data identical with 
unsubstituted compound.8^ ^((CD3 )2 C0) 6.39 (1 H, s, Ar-H), 
4.74 (1 H, m, 3-H), 2.96 (1.2 H, m, 4-H) p.p.m.; m/z 232 234 
(M+ ).
[4,4 ,p<t,x»x.-^ Hc; 3 ~ 3 ,4-Dihydro-6,8-dihydroxy-3-methylisocoumarin
Prepared by the treatment of [4,4,o<> 3”3,4-dihydro-6,8 -
dimethoxy-3-methylisocoumarin (200 mg) by the foregoing 
method. The product was recrystallised from acetone/hexane 
(165 mg, 80%). Data identical with unsubstituted compound. 
M ( C D 3 )2 C0) 6.28 (2 H, s, Ar-H), 5.20 (2 H, br, 2 x OH),
4.66 (1 H, br, 3-H) p.p.m.
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[3,4 ]-7-Chloro-314-dihydro-6,8-dihydroxy-3-
methylisocoumarin
Prepared by the treatment of [3,4, -^H3 ]-7-Chloro-3,4- 
dihydro-6 ,8 -dimethoxy-3-methylisocoumarin (100 mg) by the 
foregoing method. The product was recrystallised from ethyl 
acetate/hexane (60 mg, 67%). Data identical with 
unsubstituted compound. o C C CD^^CO) 6.39 (1 H, s, Ar-H), 
4.73 (0.3 H, m, 3-H), 2.95 (1.3 H, m, 4-H), 1.44 (3 H, d, J 7 
Hz, “CH 3 ) p.p.m.
[4,4, x, X,X-^Hc; ] -5-Chloro-3,4-dihydro-6-hydroxy-8-methoxy-3- 
methylisocoumarin
To a solution of [4,4,*,/,/-^H5 ]-3 ,4 -dihydro-6 -hydroxy-8 - 
methoxy-3-methylisocoumarin (100 mg) in anhydrous ether (40 
ml) was added sulphuryl chloride (0.6 ml). The solution was 
kept in the dark for 1 h at room temperature, then the excess 
sulphuryl chloride was destroyed with water. The organic 
layer was dried and evaporated leaving a crystalline compound 
which was recrystallised from ethyl acetate/hexane (95 mg, 
81%) m.p. 121-123 °C. Data identical with unsubstituted 
compound. ^(CDC13 ) 6.40 (1 H, s, Ar-H), 4.65 (1 H, m, 3- 
H), 3.92 (3 H, s, OMe) p.p.m; m/z 247 249 (M+ ).
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[4 ]-5-Chloro-3,4-dihydro-8-hydroxy-6-methoxy-3-
methylisocoumarin
Prepared by the treatment of [4,o<,x,X“^H^]-3,4-dihydro-8- 
hydroxy-6-methoxy-3-methylisocoumarin (50 mg) by the 
foregoing method. The product was recrystallised from ethyl 
acetate/hexane (48 mg, 82%). Data identical with 
unsubstituted compound. M C D C I 3 ) 6.42 (1 H, s, Ar-H), 4.64 
(1 H, m, 3-H), 3.92 (3 H, s, OMe), 3.20 (1 H, m, 4-H) p.p.m.; 
m/z 246 248 (M+ ).
[4-^H^]-5-Chloro-3,4-dihydro-8-hydroxy-6-methoxy-3- 
methylisocoumarin)
Prepared by the treatment of [4-^H-^3”3,4-dihydro-8-hydroxy-6- 
methoxy-3-methylisocoumarin (50 mg) by the foregoing method. 
The product was recrystallised from ethyl acetate/hexane (45 
mg, 78%). Data identical with unsubstituted compound. 
c) (CDCI3 ) 6.43 (1 H, s, Ar-H), 4.64 (1 H, m, 3-H), 3.91 (3 H, 
s, OMe), 3.20 (1 H, m, 4-H), 1.55 (3 H, d, J 7 Hz, -CH3 ) 
p.p.m.
[3-^H^]-5-Chloro-3,4-dihydro-8-hydroxy-6-methoxy-3- 
methylisocoumarin
Prepared by the treatment of [3-^H^3~3,4-dihydro-8-hydroxy-6- 
methoxy-3 -methylisocoumarin (50 mg) by the foregoing method. 
The product was recrystallised from ethyl acetate/hexane
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(45 mg, 78%). Data identical with unsubstituted compound. 
6 ( C D C 1 3 ) 6.40 (1 H, s, Ar-H), 3.92 (3 H, s, OMe), 3.20 (1 H, 
d, J 3 Hz, H-4), 2.75 (1 H, d, J 3 Hz, H-4) 1.49 (3 H, s, 
-CH3 ) p.p.m.
3,4,cn-^H3 3 ~3-Chloro-3,4-dihydro-8-hydroxy-6-methoxy-3- 
methylisocoumarin
Prepared by the treatment of [3 ,4 ,'X-^H3 ]-3 ,4 -dihydro-8 - 
hydroxy-6-methoxy-3-methylisocoumarin (50 mg) by the 
foregoing method. The product was recrystallised from ethyl 
acetate/hexane (48 mg, 82%). Data identical with 
unsubstituted compound £>(CDCl3 ) 6.42 (1 H, s, Ar-H), 3.92 (3 
H, s, OMe), 2.75 (1 H, m, H-4), 1.49 (2.1 H, m, CH2 D) p.p.m.
[4>x.-\,X~^H/| ]-5 , 7-Dichloro-3,4-dihydro-6,8-dihydrpxy-3- 
methylisocoumarin
Prepared by the treatment of [4,'X,'X>x“^H^]-7-Chloro-3,4- 
dihydro-6 ,8-dihydroxy-3-methylisocoumarin (150 mg) by the 
foregoing method. The product was recrystallised from ethyl 
acetate/hexane (140 mg, 80%). Data identical with 
unsubstituted compound. ^(CDC^), 4.64 (1 H, m, H-3), 3.91 
(3 H, s, OMe), 3.20 (1 H, m, H-4) p.p.m.
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[314 ]-5 t7-Dichloro-3,4-dihydro-6,8-dihydroxy-3-
methylisocoumarin
Prepared by the treatment of [3,4,x -^H3 ]-7 -Chloro-3 ,4 - 
dihydro-6 ,8-dihydroxy-3-methylisocoumarin (120 mg) by the 
foregoing method. The product was recrystallised from ethyl 
acetate/hexane (105 mg, 82%). Data identical with 
unsubstituted compound. 3.20 (1 H, m, H-4), 1.49 (3 H, s, 
-CH3 ) p.p.m.
Methyl-3,5-dimethoxybenzoate
3,5-Dihydroxybenzoic acid (20 g) dissolved in dry acetone 
(500 ml) with anhydrous potassium carbonate (100 g) and 
dimethyl sulphate (40 ml) was heated at reflux for 8 h with 
stirring. After cooling, the solution was filtered and the 
residue washed with acetone (3 x 50 ml). The combined 
acetone solutions were evaporated and the brown residue was 
dissolved in ether (150 ml). The organic solution was 
washed with ammonia solution (10 %, 3 x 50 ml), water (2 x 50
ml), dried and evaporated. The residue crystallised on
standing and was recrystallised from methanol (20.4 g; 78%), 
m.p. 40-41 °C (lit. , 1 6 7  42 °C); 'MCDCI3 ) 7.19 (2 H, m, J 1 
Hz, 2 x Ar-H), 6.67 (1 H, m, J 1 Hz, Ar-H), 3.92 (3 H, s,
OMe), 3.84 (6 H, s, 2 x OMe) p.p.m; m/z 196 (M+ ).
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3 t5-Dimethoxybenzyl alcohol
Methyl-3,5-dimethoxybenzoate (10 g) was dissolved in dry THF 
(15 ml) and added dropwise to a stirred suspension of lithium 
aluminium hydride (2.4 g) in dry THF (250 ml) and heated at 
reflux for 5 h. After cooling, water (2.4 ml) was added 
cautiously followed by sodium hydroxide solution (15 %, 2.4 
ml) and more water (7.2 ml) with stirring. The granular 
aluminium hydroxide was filtered through celite and washed 
with ether (150 ml). The organic solutions were evaporated 
to give a colourless oil which crystallised on standing and 
the product was recrystallised from diisopropylether as 
needles (7 g; 81%), m.p. 44-46 °C (lit.,^8  ^ 47 °C);
C> (CDCI3 ) 6.52 (2 H, m, J 1 Hz, 2 x Ar-H), 6.39 (1 H, m, J 1 
Hz, Ar-H), 4.62 (2 H, s, Ar-CH2 ), 3.82 ( 6 H, s, 2 x OMe) 
p.p.m; m/z 168 (M+ ).
2-Bromo-3,5-dimethoxybenzyl alcohol
N-Bromosuccinimide (5.27 g) was added portionwise over 10 
minutes to a solution of 3,5-dimethoxybenzyl alcohol (5 g) in 
carbon tetrachloride (250 ml) and the flask warmed to 70 °C 
for 40 minutes. The reaction mixture was filtered whilst 
still warm and then diluted with ether (150 ml). The 
organics were then washed with water (3 x 50 ml) and 
saturated brine (2 x 50 ml) dried and evaporated to give a 
white crystalline compound which was recrystallised from 
acetone/hexane as fine needles (6 . 6  g, 90%) m.p. 96 °C
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(lit . , 1 2 1 96 °C); (Found: C, 43.58; H, 4.26; Br, 32.73%,
M+ 245.9888, 247.9879. CgH-^^O^Br requires C, 43. 75; H, 
4.49; Br, 32.34%, M 245.9888, 247.9868); £  (CDC13 ) 6.73 (1
H, d, J 2 Hz, Ar-H), 6.47 (1 H, d, J 2 Hz, Ar-H), 4.75 (2 H, 
s, Ar-CH2 ), 3.90 (3 H, s, OMe), 3.84 (3 H, s, OMe) p.p.m.
2-Bromo-3,5-dimethoxybenzylmethyl ether
A solution of 2-bromo-3,5-dimethoxybenzyl alcohol (3.5 g) in 
dry THF (25 ml) was added dropwise to a stirred suspension of 
sodium hydride (1.02 g) and methyl iodide (1.77 ml) in dry 
THF (30 ml). The mixture was stirred for 1 h at room 
temperature after which time water (25 ml) was added 
cautiously to destroy the excess sodium hydride. The 
organics were evaporated and the resulting aqueous solution 
was extracted with ether (3 x 25 ml). The extracts were 
washed with water, brine, dried and evaporated leaving an oil 
which crystallised on standing. The crude product was 
recrystallised from ether as cubes (2.9 g, 78%) m.p.
57-58 °C; (Found: C, 45.93; H, 4.80; Br, 30.42%, M +
260.0037, 262.0025. C-^QH- 3^ 0 3 Br requires C, 45.99; H, 5.01;
Br, 30.60%, M 260.0044, 262.0024); 6(CDC13 ) 6.61 (1 H, d, J
1 Hz, Ar-H), 6.44 (1 H, d, J 1 Hz, Ar-H), 4.53 (2 H, s, Ar-
CH2 ), 3.88 (3 H, s, OMe), 3.83 (3 H, s, OMe) 3.49 (3 H, s,
OMe) p.p.m.
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2-Bromo-3,5-dimethoxybenzylbenzyl ether
A solution of 2-bromo-3,5-dimethoxybenzyl alcohol (5 g) in 
dry THF (25 ml) was added dropwise to a suspension of benzyl 
chloride (3.5 ml) and sodium hydride (1.46 g) in dry THF 
(80 ml) and the mixture stirred at reflux for 16 h. After 
cooling, water (30 ml) was added cautiously and the organics 
evaporated. The resulting aqueous solution was extracted 
with ethyl acetate (3 x 30 ml), washed with water, brine, 
dried and evaporated. The crude product was distilled at 
high vacuum to remove any excess benzyl chloride and the 
resulting residue was recrystallised from ether (4.7 g; 69%)
m.p. 49-50 °C (Found: C, 57.18; H, 5.33; Br, 23.31%, M+
336.0365, 338.0347. C^ 0H-^yO3 Br requires C, 56.98; H, 5.08; 
Br, 23.70%, M 336.0356, 338.0336); y max. 1 600m, 1 585s,
1 575s; ^(CDC13 ) 7.37 (5 H, m, Ar-H), 6.77 (1 H, d, J 2
Hz, Ar-H), 6.42 (1 H, d, J 2 Hz, Ar-H), 4.65 (4 H, s,
Ar-CH2 ), 3.87 (3 H, s, OMe), 3.81 (3 H, s, OMe) p.p.m.
2-Carboxy-3,5-dimethoxybenzylmethyl ether
n-Butyllithium (1 ml; 1.5M in hexane) was added to a stirred 
solution of 2-bromo-3,5-dimethoxybenzylmethyl ether (300 mg) 
in THF (20 ml) at -78 °C under nitrogen. After stirring for 
2 0  minutes at this termperature the solution was poured onto 
an excess of dry ice. The solution was allowed to warm to 
room temperature and water (20 ml) was added. The organics 
were evaporated and the resulting aqueous solution was washed
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wit h ether (3 x 15 ml) and then acidified with dilute 
hydrochloric acid. The acidic solution was extracted with 
ethyl acetate (3 x 20 ml) dried and evaporated to give a 
white compound which was recrystallised from ether (228 mg, 
87%) m.p. 98-100 °C (Found: C, 58.41: H, 6.41%, M+ 226.0844
C11H14°5 requires C, 58.38; H, 6.24%, M 226.0837); ymax.
3 300br, 1 680s, 1 600s; f>(CDCl3 ) 6.95 (1 H, d, J 1 Hz,
Ar H), 6.47 (1 H, d, J 1 Hz, Ar-H), 4.83 (2 H, s, Ar-CH2), 
3.99 (3 H, s, OMe), 3.89 (3 H, s, OMe), 3.49 (3 H, s, OMe) 
p.p.m.
2-Carboxy-3,5-dimethoxybenzylbenzyl ether
Prepared by treatment of 2-bromo-3,5-dimethoxybenzylbenzyl 
ether (500 mg) by the foregoing method. The product was 
recrystallised from ether as cubes (375 mg, 83%) m.p.
77-78 °C (Found: C, 67.56; H, 5.98% M+ 302.1160, C 1 7 H 1 8 0 5
requires C, 67.54; H, 6.00% M 302.1149); 6 (CDC13 ) 7.36
(5 H, m, Ar-H), 6.98 (1 H, d, J 1 Hz, Ar-H), 6.46 (1 H, d, J 
1 Hz, Ar-H) 4.91 (2 H, s, Ar-CH2 ), 4.64 (2 H, s, Ar-CH2 ),
3.95 (3 H, s, OMe), 3.86 (3 H, s, OMe) p.p.m.
x ,3,5-Trimethoxybenzoic acid
n-Butyllithium (4.3 ml; 1.5M in hexane) was added to a 
solution of diisopropylamine (1 ml) in dry THF (10 ml) under 
nitrogen at 0 °C with stirring. After 10 minutes the 
solution was cooled to -78 °C and a solution of 2-carboxy-
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3,5-dimethoxybenzyl methyl ether (400 mg) and dimethyl 
carbonate (0.45 ml) in dry THF (15 ml) was added dropwise 
during 15 minutes. The cooling bath was removed and the 
solution allowed to warm to room temperature. After 4 h 
water ( 2 0  ml) was added and the suspension stirred at room 
temperature for 16 h. The organics were evaporated and the 
resulting aqueous solution was washed with ether (3 x 30 ml). 
After acidification with dilute hydrochloric acid, the 
product was extracted with ethyl acetate (3 x 20 ml), dried 
and evaporated giving a crystalline compound, which was 
recrystallised from chloroform (350 mg, 73%) m.p. 158 °C 
(Found: C, 53.42; H, 5.37%, M+ 270.0720, C1 2 H 1 4 O 7 requires
C, 53.33; H, 5.22%, M 270.0735); V max. 3 000-2 700br,
1 680s, 1 600s, 1 585m, cm“^; 6 (CD3 )2 CO 6.72 (1 H, d, sJ
1 Hz, Ar-H), 6.65 (1 H, d, J 1 Hz, Ar-H), 5.18 (1 H, s, -CH), 
3.90 (3 H, s, OMe), 3.86 (3 H, s, OMe), 3.39 (3 H* s, OMe) 
p.p.m.
4,6,8-Trimethoxy-3-methylisocoumarin
X ,3,5-Trimethoxyhomophthalic acid (150 mg) was dissolved in a 
solution of acetic anhydride ( 2 0 ml) and dry pyridine (1 ml) 
and the mixture was heated at reflux for 2 h. After 
cooling, the mixture was poured onto a suspension of ethyl 
acetate (30 ml) and ice/water (80 ml) and stirred at room 
temperature for 1 h. The aqueous solution was extracted 
with ethyl acetate (3 x 25 ml). The organic extracts were 
washed with sodium bicarbonate solution, brine, dried and
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evaporated giving a crystalline compound which was 
recrystallised from ethyl acetate/hexane ( 9 5 mg, 6 8 %) m.p. 
122-123 °C (Found: C, 62.43; H, 5.59%, M+ 250.0845,
c 13h 14°5 re(luires C, 62.38; H, 5.64%, M 250.0837); V max.
1 735s, 1 720s, l 670m, l 600s, 1 570s cm”1 ; 6 (CDC13 ) 6.60
(1 H, d, J 1 Hz, Ar-H), 6.45 (1 H, d, J 1 Hz, Ar-H), 3.95
(3 H, s, OMe), 3.92 (3 H, s, OMe), 3.74 (3 H, s, OMe) p.p.m.
3S*4S*3,4-Dihydro-4,6 ,8-trimethoxy-3-methylisocoumarin
Palladium on carbon (10%, 20 mg) was added to a solution of
4, 6 ,8-trimethoxy-3-methylisocourmarin (100 mg) in ethyl 
acetate (20 ml) arid the mixture hydrogenated for 24 h. The 
catalyst was filtered through celite and washed with ethyl 
acetate. The combined organics were evaporated giving the 
crude product which was recrystallised from ethyl . 
acetate/hexane (80 mg, 80%); ymax. 1 735s, 1 715s, 1 670m, 
1 600s, 1 570s cm”1 ; 6 (CDCI3 ) 6.50 (2 H, m, Ar-H), 4.53
(2 H, m, H-3 and H-4), 3.92 (3 H, s, OMe), 3.90 (3 H, s,
OMe), 3.34 (3 H, s, 4-0Me), 1.43 (3 H, d, J 7 Hz, Me) p.p.m.
m/z 252.
3R*4S*3,4-Dihydro-4,6 ,8 - trimethoxy-3-methylisocoumarin
A solution of 4, 6 ,8-trimethoxy-3-methylisocoumarin (200 mg) 
in sodium hydroxide solution (20 ml, 15%) was heated at 
reflux with stirring for 1 h. Sodium borohydride (30 mg) 
was added portionwise and the solution stirred at reflux for
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30 mins. A further portion of sodium borohydride (30 mg) 
was added and the solution stirred at reflux for a further 30 
mins. The solution was filtered hot and allowed to cool.
The aqueous solution was acidified with dilute hydrochloric 
acid and extracted with ethyl acetate. The organics were 
dried and evaporated giving the crude product which was 
purified as a mixture (trans: cis 2 :1 ) using preparative
t.l.c. eluting with ether. 0.4 trans ^ ( C D C ^ )  6.50
(2 H, m, Ar-H), 4.10 (2 H, m, H-3 and H-4) 3.92 (6 H, s, 2 x 
OMe), 3.53 (3 H, s, 4-0Me), 1.38 (3 H, d J 7 Hz Me) p.p.m.
3S*4S*5-Chloro-3 t4-dihydro-4,6 ,8-trimethoxy-3- 
methylisocoumarin ~
Sulphuryl chloride (0.3 ml) was added to a solution of 
3S*4s*3,4-dihydro-4,6 ,8-trimethoxy-3-methylisocoumarin (40 mg 
and the solution was left standing in darkness for 1 h.
Water (30 ml) was added and the organic layer separated.
The organic layer was washed with a further portion of water, 
brine, dried and evaporated giving the crude product which 
was purified by preparative t.l.c. as an oil eluting with 
chloroform. 6(CDC13) 6.70 (2 H, m, Ar-H), 4.44 (2 H, m,
H-3 and H-4), 4.00 (3 H, s, Ar-OMe), 3.98 (3 H, s, Ar-OMe), 
3.40 (3 H, s, 4-OMe), 1.53 (3 H, d, J 8 Hz, Me) p.p.m; m/z 
274 276.
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3R*4S*5-Chloro-3,4-dihydro-4,618-trimethoxy-3-
methylisocoumarin
Prepared by the treatment of 3R*4S*3,4-dihydro-4,6 ,8 - 
trimethoxy-3-methylisocoumarin by the foregoing method. The 
product was obtained as an oil. 6(CDC13 ) 6.70 (2 H, m, 
Ar-H), 4.64 (2 H, m, H-3 and H-4), 4.01 (3 H, s, OMe), 3.97 
(3 H, s, OMe), 3.41 (3 H, s, OMe), 1.16 (3 H, d, J 8 Hz, Me) 
p.p.m; m/z 274 276.
2-Bromo-3,5-dimethoxybenzyltert-butyldimethylsilyl ether
tert-Butyldimethylsilyl chloride (785 mg) was added to a 
stirred solution of 2-bromo-3,5-dimethoxybenzyl alcohol (1 g) 
and imidazole (710 mg) in dry DMF (2 ml) at room temperature 
under nitrogen. The flask was stirred for 2 h at room 
temperature then water (50 ml) was added. The aqueous 
solution was extracted with ether (3 x 30 ml) washed with 
brine (2 x 15 ml) dried and evaporated. The product was 
purified by column chromatography eluting with hexane 
yielding an oil. (1 . 2  g, 61%); Vmax. 1 600m, 1 585s; 
S(CDC13 ) 6.75 (1 H, d, J 2 Hz, Ar-H), 6.40 (1 H, d, J 2 Hz, 
Ar-H) 4.65 (2 H, s, Ar-CH2 ), 3.85 (3 H, s, oMe) 3.81 (3 H, s, 
oMe) 1.52 (9 H, s, (CH3 )3 Si) 0.21 (3 H, s, CH 3 -Si) 0.19 (3 H, 
s, CH 3 ~Si) p.p.m.; m/z 360 362.
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5,7-Dimethoxyphthalide
n-Butyllithium (1.2 ml; 1.5 M in hexane) was added to a 
stirred solution of 2-bromo-3, 5-dimethoxybenzyltert- 
butyldimethylsilyl ether (400 mg) in dry THF (20 ml) at 
-78 °C under nitrogen. After stirring for 20 minutes at 
this temperature the solution was poured onto an excess of 
dry ice. The solution was allowed to warm to room 
temperature and water (20 ml) was added. The aqueous 
solution was extracted with ethyl acetate. The organics 
were dried and evaporated giving the crude product which 
after chromatography rearranged to 5,7-dimethoxyphthalide, 
m.p. 148-150 °C (Ut., 1 2 0  146-148 °C); j/' max. 1 750m,
1 600s; M C D C 1 3 ) 6.52 (1 H, m, Ar-H), 6.49 (1 H, m, Ar-H), 
5.17 (2 H, s, Ar-CH2 ), 3.97 (3 H, s, OMe), 3.91 (3 H, s, OMe) 
p.p.m.; m/z 294.
[2 f-^Cj2,4-dimethoxy-6-(2-oxopropyl)benzoic acid
Radioactive acetic anhydride (4.8 ul) was added to a stirred . 
solution of 3 ,5-dimethoxyhomophthalic acid (170 mg) in dry 
THF (10 ml) at room temperature. After 5 mins acetic 
anhydride (0 . 4  ml) and pyridine (0 . 2  ml) were added and the 
flask was stirred at room temperature for 2 h. The solution 
was added to aqueous sodium hydroxide solution (1M: 100 ml)
and the flask heated at reflux for 2 h. After cooling, the 
basic solution was washed with ehter (3 x 25 ml) and then 
acidified with dilute hydrochloric acid. The acidic
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solution was extracted with ethyl acetate, dried and 
evaporated to give the desired compound which was 
recrystallised from acetone (120 mg, 71%). The 
reduction and demethylation was carried out as for the 
unlabelled isocoumarin.
- 267 -
REFERENCES
1. R. B. Herbert, ’The Biosynthesis of Secondary
Metabolites', Chapman and Hall, London, 1981.
2. J. Mann, 'Secondary Metabolism', Clarendon Press,
Oxford, 1980, pp 279-304.
3. J. M. Tedder, A. Nechvatal, A. W. Murray and
J. Carnduff, 'Basic Organic Chemistry Part 4 Natural 
Products', Wiley, London 1972, pp 1-22.
4. K. B. G. Torssell 'Natural Product Chemistry', Wiley,
Chichester, 1983, pp 3-25.
5. J. N. Collie, J. Chem. Soc., 1893, 122, 329; ibid,
1907, 1806.
6 . A. J. Birch and F. W. Donovan, Aust. J . Chem. , 1953, 6_,
360.
7. A. J. Birch, R. A. Massey-Westropp and C. J. Moye,
Aust. J . Chem. , 1955, 8, 538.
8 . J. D. Bu'Lock, H. M. Smalley and G. N. Smith,
J . Biol. Chem., 1962, 237, 1778.
- 268 -
9. J. S. E. Holker, M. Kaneda, S. E. Ramer and
J. C Vederas, J. Chem. Soc., Chem. Comm., 1987, 1099.
10. M. J. Garson and J. Staunton, Chem. Soc. Rev., 1979, 
539.
11. T. J. Simpson Nat. Prod. Rep., 1985, 2 , 321.
12. T. J. Simpson in ’Modern Methods of Plant Analysis’,
ed., H. F. Linskens and J. F. Jackson, Springer-Verlag, 
1986, vol. 2 , p 1 .
13. T. J. Simpson, Chem. Soc. Rev. , 1987, lj3, 123.
14. J. C. Vederas, Nat. Prod. Rep., 1987, 277.
15. D. Rittenberg in 'Isotopic and Cosmic Chemistry’, ed., 
H. Craig, S. L. Miller and G. J. Wasserburg, North 
Holland c o : Amsterdam, 1964, pp 60-70.
16. H. B. Erlenmeyer, W. Schoenhauer and H. Sullman, 
Helv. Chim. Acta, 1936, 1_9, 1376.
17. J. L. Marshall, Carbon - carbon and carbon - proton 
n.m.r. couplings: Verlag Chemie International
Deerfield Beach.
- 269 -
18. R. Benn and H. Gunther, Angew. Chem., Int. Ed. Engl., 
1983, 22, 350.
19. A. Bax and R. Freeman, J . Magn. Reson. , 1981, 42^ 164.
20. D. W. Brown, T. T. Nakashima and D.L Rabenstein,
J. Magn. Reson.. 1981, 45^ 302.
21. D. M. Doddrell, D. T. Pegg and M. R. Bendall, J. Magn.
Reson. , 1982, 4_8, 323.
22. A. A. Maudsley, L. Mtiller and R. D. Ernst, J. Magn. 
Reson. , 1977, 28., 463.
23. G. Bodenhausen and R. Freeman, J. Am. Chem. Soc., 1978, 
100, 320.
24. A. Bax, R. Freeman, T. A. Frenkeil and M. H. Levitt,
J. Magn. Reson. , 1981, 4_3, 478.
25. H. Seto, L. Cary and M, Tanabe, J. Chem. Soc., Chem.
Comm., 1973, 867.
26. R. Bentley and S. Gatenbeck, Biochem. , 1965, 4^, 1150.
27. J. A. Gudgeon, J. S. E. Holker and T. J. Simpson, 
J. Chem. Soc., Chem. Comm., 1974, 636.
J. A. Gudgeon, J. S. E. Holker, T. J. Simpson and 
K. Young, Bioorg. Chem. , 1979, 8 ,^ 311.
J. S. E. Holker, E. O ’Brien, R. N. Moore and
J. C. Vederas, J. Chem. Soc., Chem. Comm., 1983, 192.
J. S. E. Holker and T. J. Simpson, J . Chem. Soc., 
Perkin Trans. 1 . 1981, 1397.
R. G. Brereton, M. J. Garson and J. Staunton, J. Chem. 
Soc., Perkin Trans. 1 . 1984, 1027.
J. S. E. Holker and T J Simpson, Phytochemistry, 1977, 
16, 229.
A. J. Birch, T. J. Simpson and P. W. Westerman, Tet.
Lett. , 1975 , 4173: A. J. Birch, J. Baidas,
J. R. Hlubuceck, T. J. Simpson and P. W. Westerman,
J. Chem. Soc., Perkin Trans. 1 , 1976, 898.
U. Sankawa, Y. Ebizuka, H. Noguchi, Y. Isikawa,
S. Kitighawa, Y. Yamamoto, T. Kobayashi, Y. Iitak and 
H. Seto, Tetrahedron, 1983, _3£ 3583.
H. Batiz-Hernandez and R. A. Benheim, ’Progress in 
Nuclear Magnetic Resonance Spectroscopy’ ed.,
J. W. Ensley, J. Feeney and L. H. Sutcliffe, Oxford 
University Press, 1967, pp 63-85.
- 271 -
36. D. H. Williams and I. Howe, 'Principles of Organic Mass
Spectroscopy1 McGraw-Hill, London, 1972, pp 1-49.
37. J. P. Bloxsidge, J. A. Elvidge, D. K. Jaiswal,
J. R. Jones and R. Thomas, J. Chem. Res. (S), 1977,
258.
38. J. M. A. Al-Rawi, J. A. Elvidge, D. K. Jaiswal,
J. R. Jones and R. Thomas, J. Chem. Soc., Chem. Comm., 
1974, 220; J. A. Elvidge, D. K. Jaiswal, J. R. Jones 
and R. Thomas, J. Chem. Soc., Perkin Trans. 1 , 1977, 
1080.
39. A. J. Birch, G. E. Blance and A. H. Smith,
J. Chem. Soc., 1958, 4582; K. Mosbach, Acta Chem.
Scand. , 1960, lj+, 457.
40. E. A. Evans, D. C. Warrell, J. A. Elvidge and
J. R. Jones, ’Handbook of Tritium N. M. R. Spectroscopy
and Applications', Wiley, Chichester, 1985, pp 169-171.
41. T. J. Simpson and G. I. Stevenson, J. Chem. Soc.,
Chem. Comm., 1985, 1822.
42. F. J. Leeper and J. Staunton, J . Chem. Soc., 
Chem. Comm., 1982, 911.
- 272 -
43. C. R. McIntyre, T. J. Simpson, D. J. Stenzel,
A. J. Bartlett, E. O ’Brien and J. S. E. Holker,
J. Chem. Soc., Chem. Comm., 1982, 781.
44. J. B. Stothers in 'Topics and Carbon-13 N. M. R.
Spectroscopy', ed., G. C. Levy, Wiley, New York, 1974, 
p 230.
45. P. E. Hansen, Ann. Rep. NMR Spectrosc., 1983, 15^ , 105.
46. G. C. Levy, Acc. Chem. Res. , 1973, 161.
47. M. J. Garson,, R. A. Hill and J. Staunton, J. Chem.
Soc., Chem. Comm., 1977, 624.
48. M. J. Garson, R. A. Hill and J. Staunton,
J. Chem. Soc., Chem. Comm., 1977, 921.
49. R. A. Hill, R. H. Carter and J. Staunton,
J. Chem. Soc., Chem. Comm., 1975, 380.
50. C. Abell and J. Staunton, J. Chem. Soc., Chem. Comm., 
1981, 856.
51. J. K. Chan, R. N. Moore, T. T. Nakashima and J. C.
Vederas, J. Am. Chem. Soc., 1983, 105, 3334.
R. N. Moore, G. Bigam, J.K. Chan, A. M. Hogg, T. T. 
Nakashima and J. C Vederas, J . A m . Chem. Soc., 1985, 
107, 3694.
T. J. Simpson and D. J. Stenzel, J. Chem. Soc., Chem. 
Comm., 1982, 1074.
C. Abell and J. Staunton, J. Chem. Soc., Chem. Comm., 
1984, 1005.
F. J. Leeper and J. Staunton, J. Chem. Soc., Perkin 
Trans. 1 , 1984, 2919.
A. Stoessl and J. B. Stothers, Can. J. Chem., 1983, 6 3 , 
1766.
A. Stoessl and J. B. Stothers, J. Chem. Soc., Chem. 
Comm., 1982, 880.
E. R. Klein and P. D. Klein, Biomed. Mass Spectrom., 
1978, 5_, 425.
J. P. Kintzinger in 'N. M. R. 17 Basic Principles and 
Progress; Oxygen-17 and Silicon-29? ed., P. Diehl,
E. Fluck and R. Kosfield, Springer- Verlag, New York,
- 274 -
60. J. P. Kintzinger in fN. M. R. of Newly Accessible
Nuclei’, ed., P. Laszlo, Academic Press, New York,
1983, vol. 2, p 79.
61. J. F. King, S. Konieczny, K. Khemani and J. B.
Stothers, J . A m . Chem. Soc., 1983, 105, 6514.
62. G. Lowe and S. J. Salamone, J. Chem. Soc., Chem. Comm., 
1983, 1392.-
63. U. Sankawa, Y. Ebizuka, H. Noguchi. Y. Ishikawa,
S. Kitagawa, T. Kobayashi and H. Seto, Heterocycles,
1981, 16j_ 1115.
64. J. W. Emslo.^, J. Feeney and L. H. Sutcliffe, ’High
Resolution Nuclear Magnetic Resonance Spectroscopy', 
Pergamon Press, New York, 1966, p 1045.
65. T. St. Amour and D. Fiat, Bull. Magn. Reson., 1979, 1_,
118.
6 6 . H. A. Christ, P. Diehl, H. R. Schneider and H. Dahn,
Helv. Chim. Acta, 1961, 44, 865.
67. C. Abell, C. Sutkowski and J. Staunton, J . Chem. Soc.,
Chem. Comm., 1987, 586.
- 275 -
6 8 . D. D. Hackney, J. A. Sleep, G. Rosen, R. L. Hutton and
P. D. Boyer, in 'N. M. R. and Biochemistry: A
Symposium Honouring Mildred Cohn’, ed., S. J. Opella 
and P. Lu, Marcel Dekker, New York, 1979, p 299.
69. J. M. Risley and R. L. Van Etten, J. Am. Chem. Soc., 
1979, 101, 252.
70. D. J. Darensbourg, J. Organomet. Chem., 1979, 174, 70.
71. J. C. Vederas, J . Am. Chem. Soc. , 1980, 102, 374.
72 C. J. Jameson, J. Chem. Phys. , 1977, 6jS, 4983.
73. J. C. Vederas and T. T. Nakashima, J. Chem. Soc., Chem.
Comm., 1980, 183.
74. R. N. Moore, J. Diakur, T. T. Nakashima, S. L. McLaren 
and J. C. Vederas, J. Chem. Soc., Chem. Comm., 1981, 
501.
75. J. C. Vederas, Can. J. Chem, 1982, 6£, 1637.
76. J. C. Vederas, 'Mycotoxins and Phycotoxins' eds.,
P. S. Steyn and R. Vleggar, Elsevier Science Publ., 
Amsterdam, 1986, pp 97-108.
- 276 -
77.
78.
79.
80. 
81.
82.
83.
84.
85.
W. J. McGahren, J. M. Van den Hende and L. A. Mitscher, 
J . Am. Chem. Soc., 1969, 91 , 157.
G. M. Strunz, A. S. Court, J. Komlossy and
M. A. Stillwell, Can. J. Chem. , 1969, 4_7, 2087 and
3700.
D. Giles and W. B. Turner, J . Chem. Soc., C ., 1969, 
2187.
G. B. Henderson, Ph.D. Thesis, Glasgow, 1982.
J. S. E. Holker and K. Young, J. Chem. Soc., Chem.
Comm., 1975, 525.
W. D. Hewson and L. P. Hager, ’The Porphyrins’, vol. 7, 
ed., D. Dolphin, Academic press, New York, 1979, 
pp 295-325.
A. R. Battersby, J. A. Martin and E. Brochmann-Hanssen, 
J . Chem. Soc., 1967, 1785.
G. W. Kirby, S. R. Massey and P. Steinreich, J. Chem. 
Soc., Perkin Trans. 1 , 1972, 1642.
H. J. Lee and G. R. Waller, Phytochemistry, 1972, 11, 
965 .
- 277 -
8 6 . W. S. MacLachlan, Ph.D. Thesis, Glasgow, 1985.
87. J. Diakur, T. T. Nakashima and J. C. Vederas, Can. J.
Chem., 1980, 58, 1311.
8 8 . J. M. Risley and R. L. Van Etten, J . Am. Chem. Soc.,
1980, 1 0 2 , 4609.
89. J. M. Risley and R. L. Van Etten, J . Am. Chem. Soc.,
1980, 102, 6699.
90. J. Barber, J. L. Cornford, T. D. Howard and
D. Sharpless, J. Chem. Soc., Perkin Trans. 1 , 1987, 
2743.
91. P. Bollinger and T. Zardin Tartaglia, Helv. Chim.
Acta, 1976, 59_, 1809.
92. H. P. Weber and T. J. Petcher, Helv. Chim. Acta., 1976,
59, 1821.
93. K. K. Chexal, C. Tamm, J. Clardy and K. Hirotsu, Helv.
Chim. Acta, 1979, 62,, 1129.
94. R. F. Curtis, P. C. Harries, Ch. Hassall, J. D. Levi 
and D. M. Phillips, J. Chem. Soc., C., 1966, 168.
- 278 -
95. K. K. Chexal and Ch. Tamm, Helv. Chim. Acta., 1979, 62,
1129.
96. K. K. Chexal and Ch. Tamm, Helv. Chim. Acta., 1978, 61,
2002.
97. G. B. Henderson and R. A. Hill, J. Chem. Soc., Perkin
Trans. 1 , 1982, 1111.
98. R. A. Hill, Prog. Chem. Org. Nat. Prods., 1986, 4£, 1
(and references cited therein).
99. R. D. Barry, Chem.- Rev., 1964, ^4, 229.
100. R. B. Tirodkar and R. N. Usgaonkar, J . Ind. Chem. Soc.,
1969, 46, 935 .
101. I. Choksey and R. N. Usgaonkar, Ind. J . Chem., 1976,
14B, 596.
102. D. R. Nadkarni and R. N. Usgaonkar, Ind. J . Chem.,
1978, lj3B, 320.
103. J. N. Chatterjea, S. K. Mukherjee, C. Bhakta, H. C. Jha
and F. Zilliken, Chem. Ber., 1980, 113, 3927.
104. B. E. Edwards and P. N. Rao, J. Org. Chem., 1966, 31,
324.
- 279 -
105. J. M. Karplus, J. Am. Chem. Soc., 1963, 8^, 2870.
106. R. B. Tirodkar and R. N. Usgaonkar, Ind. J . Chem.,
1969, 7, 1114.
107. Organic Synthesis Collective Volume 3 449.
108. K. B. Becker, M. Geisel, C.  A. Grob and F. Kuhnen,
Synthesis, 1973, 493.
109. R. N. Hurd and D. H. Shah, J. Org. Chem., 1973, 38,
607.
110. G. H. Daub and W. S. Johnson, Org. React. , 1950, 6^, 1.
111. G. H. Daub and W. S. Johnson, J . Am. Chem. Soc., 1948,
70, 418.
112. W. I. Awad, M. F. El-Nawaihy and H. A. Abdel-Hamid,
Egypt. J. Chem., 1972, 15_, 297.
113. H. Arakawa, Bull. Chem. Soc. Japan, 1968, 4_1, 7083.
114. R. D. Hutchinson and P. S. Steyn, Tet. le11. , 1971, 12,
4033.
115. J. N. Chatterjea, B. K. Banerjee and H. C. Jha, J. Ind. 
Chem. Soc. , 1967, 44^ , 911.
- 280 -
116. A. R. Mehendale, A. V. R. Rao and K. Venkataraman, Ind. 
J. Chem., 1972, 10, 1041.
117. G. Berti, J . Org. Chem. , 1959, 24.> 934.
118. J. F. Grove and M. Pople, J. Chem. Soc., Perkin
Trans 1 . , 1979, 337.
119. J. S. Pizey in ’Pizey Synthetic Reagents1 vol 2 pp 1- 
64, Wiley, New York, 1974.
120. B. M. Trost, G. T. Rivers and J. M. Gold, J. Org.
Chem. , 1980, 4_5, 1835 .
121. P. D. Noire and R. W. Franck, Synthesis, 1980, 882.
122. W. E. Parnham and C. K. Bradsher, Acc. Chem. Res.,
1982, 12, 300.
123. W. E. Parnham and L. D. Jones, J . Org. Chem., 1976, 4 1 , 
1187.
124 W. E. Parnham and Y. A. Sayed, J . Org. Chem., 1974, 39, 
2053.
125. N. S. Narasimhan and R. S. Mali, Synthesis, 1983, 957.
- 281 -
126. J. March, 'Advanced Organic Chemistry, Reactions, 
Mechanisms and Structure, 3rd ed., p 103, Wiley, 1985.
127. E. L. Eliel, 'Stereochemistry of Carbon Compounds' 
pp 69-71, McGraw-Hill, London, 1962.
128. A. C. Regan and J. Staunton, J. Chem. Soc., Chem.
Comm., 1987, 520.
129. D. C. Aldridge, S. Galt, D. Giles and W. B. Turner,
J . Chem. Soc., C, 1971, 1623.
130. L. Camarda, L. Merfini and G. Nasini, Phytochemistry,
1976, 15, 537.
131. G. Assante, R. Locci, L. Camarda, L. Merlini and G. 
Nasini, Phytochemistry, 1977, 1_6, 243.
132. R. F. Curtis, C. H. Hassal and M. Nazar, J . Chem.,
Soc., C . , 1968, 85.
133. E. L. Eliel 'Stereochemistry of Carbon Compounds' 
pp 427-430, McGraw-Hill, London, 1962.
134. T. Okunu, S. Okawa, T. Goto, K. Sawai, H. Shirahama and
T. Matsumoto, Agric. Biol. Chem., 1986, _50, 997.
135. P. E. Hansen, Ann. Rep. N. M. R. Spect., 1983, _15.> 105.
- 282 -
136. H. Batiz-Hernandez and R. A. Bernheim, Progr. N. M. R. 
Spect. , 1967, 3>> 63.
137. W. T. Raynes in 'Specialist Periodical Report on 
N. M. R', vols. 2 and 3, ed., R. K. Harris, The 
Chemical Society, London, 1973, 1974.
138. R. B. Mallion in 'Specialist Periodical Report on 
N. M. R . ', vol. 4, ed., R. K. Harris, The Chemical 
Society, London, 1975.
139. R. Ditchfield in 'Specialist Periodical Report on 
N. M. R. ' vol. 5, eel., R. K Harris, The Chemical 
Society, London, 1976.
140. W. T. Raynes in 'Specialist Periodical Report on 
N. M. R.', vols. 7 and 8, ed., R. J. Abraham, The 
Chemical Society, London, 1978, 1979.
141. C. J. Jameson and J. Mason in 'Specialist Periodical 
Report on N. M. R . ', vol. 9. ed., G. A. Webb, The 
Chemical Society, London, 1980.
142. C. J. Jameson in 'Specialist Periodical Report on 
N. M. R . ', vol. 10, ed., G. A. Webb, The Chemical 
Society, London, 1981.
- 283 -
143. M. Alei and W. E. Wagerman, J . Chem. Phys., 1978, 68, 
783.
144. A. P. Tulloch and M. Mazureck, J. Chem. Soc.,
Chem. Comm., 1973, 692.
145. R. Aydin and H. Gunther, J. Am. Chem. Soc. , 1981, 103, 
1301.
146. R. Aydin and H. Gunther, Angew. Chem. , 1981, 93_, 1000.
147. V. A. Chertkov and N. M. Sergeev, J . Am. Chem. Soc., 
1977, 99, 6750.
148. P. A. J. Gorin, Can. J. Chem. , 1974, 5_2, 458.
149. G. E. Maciel, P. D. Ellis and D. C. Hofer, J. Phys.
Chem. , 1967, 71.> 2160.
150. D. G. Morris and A. M. Murray, J . Chem. Soc.,
Perkin Trans. II, 1976, 1579.
151. E. A. Halevi, Progr. Phys. Org. Chem., 1963, 1 , 109.
152. E. A. Halevi, M. Nussin and A. Ron, J . Chem. Soc.,
1963, 866.
- 284 -
153. R. K. Harris and R. H. Newman, J. Chem. Soc., 
Faraday Trans. II, 1977, 1204.
154. J. R. Wesener and H. Gunther, Tet. lett., 1982, 23, 
2845.
155. R. H. Martin, J. Moriau and N. Defay, Tetrahedron, 
1974, 30, 179.
156. D. K. Fukushima and T. F. Gallagher, J . Am.
Chem. Soc. , 1955 , 11_, 139.
157. C. R. Smith, J . Org. Chem. , 1960, 25_, 588.
158. R. Von Schilling and D. Vorlander, Ann., 1899, 308,
184.
159. M. V. Sargent, P. Vogel and J. A. Elix, J. Chem.
Soc., Perkin Trans. 1 , 1975, 1986.
160. A. Stpfau, Chim. Acta., 1933, 16, 283.
161. L. Fitzpatrick, T. Sala and M. Sargent, J. Chem.
Soc., Perkin Trans. 1 , 1980, 85.
162. E. Hardegger, W. Rieder, A. Nalser and F. Kugler,
Helv. Chim. Acta., 1966, 4_9, 1283.
- 285 -
163. W. Dieckmann Ber, 1944, V7, 1432.
164. R. H. Carter, R. M. Colyer, R. A. Hill and J. 
J. Chem. Soc.t Perkin Trans. 1, 1976, 1438.
165. J. R. Cannon, T. M. Cresp, B. W. Metcalf,
M. V. Sargent, G. Vinciguerra and J. A. Elix, 
J . Chem. Soc., 1971, 3495.
166. T. M. Cresp, M. V. Sargent, J. A. Elix and
D. P. H. Murphy, J. Chem. Soc., Perkin Trans. 
340.
Staunton,
1, 1973,
167. D. J. Hinchliffe, Ph. D. Thesis, Liverpool, 1969.
